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Abstract
Chronic obstructive pulmonary disease (COPD) is a major cause ofmorbidity
and mortality worldwide. The precise sequence of events in COPD is not
completely understood. Inflammation in the airways has been unanimously
seen by researchers as a pivotal factor, and cigarette smoking without doubt is
the main cause. Large proportions of heavy smokers, however, do not suffer
with COPD, suggesting a role of additional risk factors, e.g., respiratory tract
infections, in pathogenesis. The inflammatory response to cigarette smoke and
infectious agents is determined by the host's genetic make up. Cigarette
smoking, by altering the surface milieu of respiratory mucosa and by causing
immunosuppression increases the susceptibility of individuals to infection
with respiratory viral and bacterial pathogens. Virus infection has also been
recognized as a susceptibility factor for secondary bacterial infection.
An investigation into the role of individual genetic variations in inflammatory
cell and cytokine production and non-host factors involved in COPD is the
basis for development of more effective strategies to intervene in
pathogenesis, progression and exacerbation of COPD. The aims of this work
was to review the evidence for predisposing factors for COPD, with a
particular emphasis on respiratory tract infections, and to examine those
findings in relation to individual genetic variations and their interactions for
induction ofpro-inflammatory cytokine production in the respiratory tract.
In vitro models were developed to measure cytokine responses to various
agents implicated in COPD. These examined the interaction, antagonistic,
indifferent, additive or synergistic, between cigarette smoke and infectious
agents or their products on cytokine production. Haemophilus influenzae,
Streptococcus pneumoniae, Moraxella catarrhalis and respiratory syncytial
virus are common bacterial and viral pathogens isolated from this group of
patients. A human monocyte cell line in a model provided a consistent means
to examine these interactions, and human peripheral blood monocytes from
blood donors were used to study the individual variations in the responses.
Effects of virus infection on bactericidal activity of human monocytes
common bacterial respiratory pathogens were also examined. An epithelial
cell line and monocytes were investigated for the effects due to virus infection
on expression of some of the surface antigens relevant to bacterial binding and
immune response.
The agents used in the study elicited inflammatory responses that could
contribute to damage to the respiratory tract and these individual factors could
be more harmful in combination. Monocytes from only a proportion of
individuals exhibited extreme responses to these agents signifying the role of
individual genetic make up in inflammatory processes. Virus-infected
monocytes significantly decreased their ability to bind and kill bacteria.
Compared with uninfected cells, fewer bacteria bound to virus-infected cells
and intracellular bactericidal activity was also decreased. Virus-infected
epithelial cells expressed more surface antigens that have been reported to
bind respiratory tract bacterial pathogens, while virus-infected monocytes
expressed these antigens at lower levels, which offered an explanation to their
decreased bacterial binding and bactericidal activity.
These experimental findings, taken together with the review of the literature
presented in this work, suggested that exposure to a number of harmful factors
for longer periods in individuals with certain genetic profiles for inflammation
may cause significant damage to the respiratory tract resulting in COPD, and
exacerbation in its course. Further work to examine the individual genetic
make up and inflammatory cytokines in a population of patients with COPD
compared with non-COPD smokers would be required to substantiate this
hypothesis before investigating the possibility of therapeutic interventions to
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1. 1 Chronic obstructive pulmonary disease (COPD):
the magnitude of problem
Chronic obstructive pulmonary disease (COPD) is a destructive process in
the lungs characterised by features of chronic bronchitis affecting the
airways and emphysema affecting lung parenchyma. It is a major cause of
morbidity and mortality world-wide. It affects 16 million people in the
USA alone [Report by Centers for Disease Control and Prevention, 1993;
Borson, et al., 1998; Fiel 1996] and is the fourth leading cause of death
[Wise, 1997]. In relation to other major causes, the death rates due to
COPD and lung cancer have not declined over the past decades and not are
expected to decline [Thom, 1989; Skrepnek & Skrepnek, 2004; Wouters,
2004],
Among the risk factors, cigarette smoking has been the primary determinant
of pathogenesis and mortality due to COPD [Kuller, et al., 1989; Bohadana
et al., 2004; Marlow & Staller, 2004]. The prevalence of COPD is




aggressively promoted and marketed. Cessation of smoking does not result
in complete reversal of pathological changes caused by chronic smoking.
Deaths due to COPD resulted in a loss of 501,290 years of life per year
before the expected average age in the USA, and it is feared that due to
residual affects of smoking on health this burden would increase despite
falling trends in smoking habits [Davis & Novotny, 1989; Wise, 1997;
Skrepnek & Skrepnek, 2004; Wouters, 2004],
1. 2 Preview and definitions
1. 2. 1 Architecture of the lungs
Airways represent a serial branching system with which the parenchyma
comprising gas-exchange units, called acini, in the lungs connect with the
external air and gives rigidity and resilience to lungs. Airways are
classified on the basis of calibre into large airways that include trachea and
bronchi (about 5 generations of major branches), supported by the cartilage
rings and small airways, called bronchioles, consisting of about 15-20
generations of minor branches, tapering into the terminal bronchioles. An
acinus consists of a minute air sac, an alveolar duct and an apical bottleneck
like structure, the respiratory bronchiole, with which it connects with the
terminal bronchiole. With this anatomical arrangement the area of gas




Serous and mucous cells line the secretory glands that are present in the
large airways. Basal cells, goblet (secretory) cells and ciliated cells are the
main types present in the proximal parts of the lower airways while the
distal part are lined with Clara cells (cells involved in detoxification) and
ciliated cells [Bals, 1997], The 'ciliary escalator' starts at the most distal
parts of the tree and is responsible for bringing up the particulate deposits in
the tract. Mechanical, non-specific mucosal and immune defence systems
against particulate, chemical and microbial noxious agents that the lungs are
continuously exposed to are located in the airways.
1. 2. 2 Emphysema
Emphysema is defined as an irreversible distension of acini distal to the
terminal bronchioles, with destruction of alveolar septa without fibrosis
[Thurlbeck & Muller, 1994]. Classification of emphysema is based on the
pattern of involvement of acini. Centriacinar emphysema (CAE) involves
the destruction of the respiratory bronchioles, while both the respiratory
bronchioles and the peripheral parts of the acini are destroyed in panacinar
emphysema (PAE). The two patterns may coexist in various proportions in
the same patient, and result in imbalance of perfusion and ventilation in the





1. 2. 3 Chronic bronchitis
Chronic bronchitis is characterised by the presence of chronic productive
cough for more than 3 months for at least two consecutive years in patients
in whom other causes of chronic cough have been excluded [Martinez,
1998; Wilson et al., 1996], These symptoms are due to inflammation of the
large airways. Similar changes of the varying severity in the peripheral
airways, determine the degree of airflow obstruction, which often
accompanies chronic bronchitis [Niewoehner, 1988]. Chronic bronchitis,
however, can occur without obstruction although they often coexist.
1. 2. 4 Chronic obstructive pulmonary disease (COPD)
The clinical presentation of COPD is heterogeneous, composed of various
combinations of features of emphysema and chronic bronchitis. COPD is
characterised by increased airway resistance, hyperinflation and abnormal
tests of expiratory flow that do not improve markedly over several months
of observation, are worsened by episodes of infections and are only partially
reversed by bronchodilator drugs [Senior & Anthonisen, 1998],
The most easily measured indices of obstruction are taken from volume-
time plots of forced expiratory manoeuvres. The forced expiratory volume




predicted value for a given sex, age and height. The forced vital capacity
(FVC) is also reduced but to lesser degree than FEV1, hence the airway
obstruction is characterised by reduced FEV1/FVC percentage. The forced
expiratory time (the time taken to exhale fully after a full inspiration) is also
invariably prolonged (Figure 1.1).
Figure 1.1. Forced exhalation is delayed (blue line) and the
peak flow rate is lower in patients with COPD compared with
normal individuals.
The mean flow rate over the middle of the vital capacity is frequently more
severely diminished and is a more sensitive marker of the disease severity






maximal flow rates represent a complex and dynamic interplay among
intrinsic airway calibre, elastic recoil properties of the lungs and expiratory
collapse of intraparenchymal airways during forced exhalation and thus
make the middle flow rate a more sensitive indicator of disease.
The airway obstruction is progressive, and may be accompanied by airway
hyperirritability [Postma & Kerstjens, 1998]. The airway hyper-irritability,
however, has been shown not to cause COPD [van Schayck et al., 1994;
Silverman & Speizer, 1996]. The obstruction is precipitated by increased
resistance in the small airways and loss of elastic recoil of the lung [Saetta
et al., 1994],
COPD shares many features with bronchial asthma. The two conditions
have been classified by the 'Dutch Hypothesis' on chronic airway diseases
as manifestations of a single disease process. This hypothesis is based on
common histopathological and biochemical changes in the airways of some
asthmatic and some COPD patients [van Schayck et al., 1994], Further
support for this hypothesis is sought from bronchial hyperirritability
characteristic of bronchial asthma strongly associated with COPD [van
Schayck et al., 1994]. Airway inflammation is a hallmark of both
conditions, although in asthma this is mainly due to eosinophils and mast
cells, and in COPD due to neutrophils and macrophages [Sun et al., 1998],
The differences in the infiltrating inflammatory cells and cytokines (see




airways between the two conditions form the basis for the 'UK definitions'
which classify COPD separately from asthma [van Schayck, et al., 1994;
Postma & Kerstjens, 1998; Magnussen et al., 1998; Subramanian &
Guntupalli, 1994; Vermeire & Pride, 1991],
The relationship between emphysema, chronic bronchitis and bronchial
asthma is illustrated in Figure 1.2.
Figure 1.2. Schematic non-proportional representation showing
subsets of COPD patients with emphysema, chronic bronchitis and/or
bronchial asthma with features of airflow obstruction (coloured areas
in the box). The patients without airflow obstruction are not
classified as COPD (Areas 1, 2 and 3). Some bronchial asthmatic
patients have reversible airflow obstruction and are not classified as
COPD (Area 4). Airflow obstruction can be due to causes other than
COPD, e.g ., cystic fibrosis (represented by the area in the box
outside the circles). (Adapted from: No authors listed. Definitions,
epidemiology, pathophysiology, diagnosis and staging of COPD. Am
J Resp Crit Care Med 1995, 152: S78-S83, with permission of the





1. 3. 1 Emphysema
CAE, due to its effects on the respiratory bronchioles, causes more airflow
limitation than PAE, where recoil abnormalities in the lungs predominate
[Saetta et al., 1994], Damage and degradation of elastic fibres in the
alveolar septa are mediated by elastases and proteinases from neutrophils
[Hiemstra et al., 1998] or monocytes [Abboud et al., 1998]. Various
patterns of degeneration in the pulmonary elastic fibres are observed from
tissues obtained from patients with PAE due to alphai antitrypsin deficiency
or patients with CAE due to fine disruptions, vacuolar changes, fine
amorphous degeneration, and large deposits of amorphous material.
Incomplete polymerisation and abnormal elastogenesis of the fibres are
presumed to be due to abnormal elastinolytic activity in the lungs [Fukuda
et al., 1989; Tomashefski et al., 2004] which has been attributed to the
presence of excessive numbers of neutrophils and monocytes in the tissue
[Ofulue et al., 1998].
1. 3. 2 Chronic bronchitis
The pathological changes in chronic bronchitis consist of abnormalities in
the large and small airways and hypersecretion of mucous glands, The
submucosa of the large airways is thickened due to hypertrophy of mucus




Compared with normal large airways, the ratio of thickness of submucosa to
that of bronchial wall is increased in chronic bronchitis. The small airways
are the major site of obstruction are affected by Goblet cell hyperplasia,
mucosal and submucosal inflammatory cell infiltration, loss of cilia,
oedema, peribronchial fibrosis, smooth muscle hyperplasia and intraluminal
plugs. Mucosal abnormalities, inflammatory cellular infiltrate, increased
muscle and fibrosis in the bronchi are the hallmarks of chronic bronchitis in
smokers [Saetta et al., 1994; Shelhamer et al., 1995; Camner et al., 1973;
McDonald 2001].
Growth of myocytes in inflammatory conditions in bronchi might be
initiated due to their contact with inflammatory cells and their products
[Panettieri, 1998]. Neutrophil defensins and serine proteinases cause injury
to the pulmonary epithelium, decrease the frequency of ciliary beat and
increase mucus production [Hiemstra et al., 1998]. Neutrophil defensins
exhibited chemotactic activity for human blood monocytes in a dose-
dependent manner [Tkachenko et al., 1993; Territo et al., 1989] and caused
release of tumour necrosis factor-a (TNF- a) from monocytes [Misuno et
al., 1992; Chaly et al., 2000],
1. 4 Inflammation in COPD
Chronic inflammation has been widely considered as the underlying process




Understanding the mechanisms and causative agents leading to
inflammation in the airways is prerequisite to development of intervention
strategies and control of exacerbation in the course of illness. Inflammation
is initiated in bronchoalveolar epithelium, which also becomes its first main
target [Takizawa, 1998]. The cytokines and chemokines secreted by the
inflammatory cells in response to toxic and infectious stimuli are
responsible for more inflammatory cells trafficking to the site of
inflammation, tissue damage associated with fibrosis and hyperplasia,
increased production of sputum and some of the systemic symptoms
associated with COPD. A systemic review found higher levels of pro¬
inflammatory cytokines, C-reactive protein and leucocytosis in patients with
COPD compared with healthy people [Gan et al., 2004].
1. 4. 1 Inflammatory cells infiltrating the lungs
Bronchoalveolar lavage (BAL) and collagenase-dissociated lung tissue from
rats exposed for one months to cigarette smoke showed infiltration by
neutrophils. After one month of smoking, neutrophils were replaced by
macrophages that stayed until the end of observation period of 6 months.
The elastinolytic activity was demonstrated in samples with macrophages
only [Ofulue et al., 1998]. Lung biopsies obtained from non-smokers and
smokers during surgery were evaluated for amounts of lung parenchyma per
volume and the numbers of neutrophils, macrophages and T cells.




negatively correlated with the numbers of macrophages and T cells but not
with neutrophils [Finkelstein et al., 1995]. BALs from non-smokers and
smokers with or without chronic bronchitis were examined for
inflammatory cells. Compared with healthy smokers and non-smokers,
smokers with chronic bronchitis had increased macrophages, neutrophils
and T cells, while non-smokers with asthmatic bronchitis showed more
eosinophils and mast cells [Sun et al., 1998]. Neutrophils are recruited in
inflamed lung parenchyma and release of elastase by necrotic neutrophils
has been shown responsible for the effect [Kim & Nadel, 2004],
1. 4. 2 Cytokines in the lungs
Cytokines are an intricate network of soluble signalling substances that
dictate and control inflammation, immune responses, cellular growth and
fibrosis. Cytokines in the lungs can be divided in to three categories, pro¬
inflammatory, anti-inflammatory and growth-stimulatory. Pro¬
inflammatory cytokines, e.g., tumour necrosis factor a (TNF- a),
interleukin-1 (IL-1) interferons (IFNs) and IL-6, are essential to combat
infecting and invading agents [Ferrante, 1989; Nacy et al., 1991; Kawakami
et al., 1999; van Schaik et al., 1999; Neuzil et al., 1996; Standiford 1997;
Ehlers 2003]; however, their secretion in excessive quantities for prolonged
periods can be detrimental to the tissue [Dinarello 2003; Beading & Slifka
2004], While the primary role of anti-inflammatory cytokines, e.g ., IL-4




cytokines, overproduction of these cytokines might hamper the protective
role played by pro-inflammatory cytokines against noxious agents [Oswald
et al., 1992; Picard & Casanova 2004; Bastos et al., 2004; Aleman et al.,
2000]. Anti-inflammatory effects of IL-4 are well recognised; however, pre-
treatment, but not simultaneous treatment, with IL-4 potentiated production
of TNF-a from mouse macrophages stimulated with LPS [Major et al.,
2002], Chronic inflammation and fibrosis are often associated with over¬
production of tissue growth factors [Kim & Nadel, 2004], TNF-a in most
of the studies reported has been depicted as a central and main pro¬
inflammatory cytokine.
Compared with controls, patients with COPD had higher percentages of
IFN-y-producing CD4+ lymphocytes in their blood, characteristic of TH1
immune response, and lower percentages of IL-4-producing CD4+ cells,
characteristic of TH2 immune response [Majori et al., 1999]. TNF- a, IL-6
and IL-8 are involved in inflammation in COPD [Keatings et al., 1996;
Barnes, 2004], Damaged proteins formed in lungs during the process might
induce further secretion of pro-inflammatory cytokines [Koj et al., 1994;
Kim & Nadel 2004]. BAL from non-smokers with asthmatic bronchitis
showed IL-5 and granulocyte-macrophage colony stimulating factor genes
and proteins while samples from smokers with chronic bronchitis showed
IL-2, TNF-a and IL-8 [Sun et al., 1998], Production ofNO in patients with




Smoking in young healthy individuals decreases IL-6 response [McCrea et
al., 1994; Soliman, 1992] while it increased IL-6 production [Carpegnano et
al., 2003; Bucchioni et al., 2003] and IL-1 [Brown et al., 1989; Yamaguchi
et al., 1989] in COPD patients. Production of IL-8 from neutrophils and
eosinophils is enhanced in COPD in many studies [McCrea et al., 1994;
Pesci et al., 1998; Yamamoto et al., 1997; Perng et al., 2004]. Some
studies, however, have reported lower levels of IL-8 in COPD [Ohta et al.,
1998],
TNF- a is a pro-inflammatory and immune modulating mediator that plays
a central role in the pathophysiology of inflammation due to infection, toxic
or chemical injury to the tissues. Production ofNO is increased in patients
with COPD [Kanazawa et al., 1998]. While NO produced at normal
concentrations is protective to the airways, in higher concentrations it
causes tissue injury and increases inflammation [Kienast et al., 1996;
Drumm et al., 1999; Asano et al., 1994], TNF- a and NO have complex
mutual interactions and their production is differentially altered in response
to various conditions
1. 4. 2. 1 TNF-a
The suggestion that a substance with anti-tumour activity might exist was
first made in the light of spontaneous regression of tumour in some patients




TNF, was later found as a prototype of a family of molecules involved in
regulation of inflammation and immunity [Grass & Dower, 1995], The
inflammatory cells also exhibit receptors for the TNF superfamily
comprising ten receptor proteins. TNF is secreted by many cell types
including macrophages, CD4+ and CD8+ T cells [Ware et al., 1992],
adipocytes [Kern et al., 1995], osteoblasts [Modrowski et al., 1995],
keratinocytes [Lisby et al., 1995], colon epithelium [Jung et al., 1995], mast
cells [Bissonnette et al., 1995], dendritic cells [Zhou & Tedder, 1995],
pancreatic p cells [Yamada et al., 1993], astrocytes [Lee et al., 1993] and
monocytes [Frankenberger et al., 1996].
Human TNF-a is synthesised as a 233 amino acid transmembrane
(extracellular C-terminus) or a soluble residue [Grass & Dower 1995;
Pennica et al., 1984; Shirai et al., 1985], Expressed as membrane protein,
TNF-a has an extracellular domain of 176 amino acids, a transmembrane
region with 28 amino acids and an intracytoplasmic region of 29 amino acid
[Yamaguchi, et al., 1985]. The more potent soluble form [Decoster et al.,
1995] consisting of 157 amino acids is created by proteolytic conversion of
the transmembrane form by the TNF converting enzyme [Black et al., 1997;
Moss et al., 1997], The soluble form is circulated in the blood as a
homotrimer [Smith & Baglioni, 1987] in the range of 10-80 pg ml"1




TNF-a is a potent inducer of endothelial cells for production of intercellular
adhesion molecule 1 (ICAM-1), which is critical for recruitment of
phagocytes [Kyan-Aung et al., 1991]. TNF-a activates macrophages and
neutrophils, increases cytotoxicity, releases oxygen and nitrogen radicals
[Ferrante, 1989] and other cytokines, IL-6 and IL-8 [Kasahara et al., 1991;
Zoja et al., 1991; Kim & Nadel 2004; Paulnock & Coller 2001].
1. 4. 2. 2 Nitric oxide
It has been suggested that NO plays a role in mediating pulmonary injury,
and bronchial hyper-reactivity [Henriksen et al., 1999; De Boer et al.,
1998]. In the cells, NO is produced by nitric oxide synthetase (NOS). NO
in human airway tissue is localized to the airway epithelium, sensory
nerves, endothelium, vascular and airway smooth muscles and
inflammatory cells [Watkins et al., 1997; Nijkamp & Folkerts, 1995]. It is
generally agreed that at lower concentrations NO is protective and
regulatory in function; at higher concentrations it acts as a toxic factor. The
beneficial pulmonary vasodilatory, bronchodilatory, and bactericidal effects
of NO in patients with COPD might be offset by exudate formation, DNA-
toxicity and cytotoxicity which NO might cause in unbalanced state [Barnes
& Belvisi, 1993; Nussler & Billiar, 1993],
Two distinct types of mRNA encoding for NOS have been described:




two types coexist in human alveolar and bronchial epithelial cells and co¬
ordinate in a complex manner in the epithelial cells to protect the host from
microbial assault at the air/surface interface while shielding the host from
the induction of airway hyper-reactivity [Asano et al., 1994]. Constitutive
NO is responsible for bronchodilation and is protective to the airways
[Nijkamp & Folkerts, 1995]. Lack of constitutive NO production may be
associated with bronchial hyper-reactivity observed in virus infection
[Folkerts & Nijkamp, 1995]. The production of NO is much enhanced
during inflammation [Nijkamp & Folkerts, 1995].
Nitric oxide production by a human alveolar type II epithelium-like cell line
(A549) and a transformed human bronchial epithelial cell line (BEAS 2B)
was enhanced by culture in the presence of interferon gamma, interleukin 1-
(3, TNF-a and lipopolysaccharide [Asano et al., 1994],
Proinflammatory cytokines released in response to noxious agents modulate
vascular contractility, primarily through regulation of inducible nitric oxide
(NO), a potent vasodilatory factor [Geng & Hansson, 1992]. Vascular
endothelial NO production is constitutively controlled and modulated by
bradykinin, acetylcholine and epinephrine. Baseline tone is maintained in
partial relaxation due to NO [Moncada & Higgs, 1993], NO production
from alveolar macrophages is enhanced in the presence of virus infections




by episodic or habitual smoking [Kharitonov et al., 1995], which returns to
normal on cessation of smoking [Robbins et al., 1997].
1. 5 Aetiology and risk factors
1. 5. 1 Cigarette smoking
Cigarette smoking is without doubt the main cause of COPD. Both cross
sectional and longitudinal studies have shown that cigarette smoking causes
decline in FEV1, in a dose-dependent response [Narayan et al., 1996;
Kuschner et al., 1996], COPD is associated with the total numbers of
cigarettes smoked per year, current smoking status, smoking at an early age
and duration of smoking [Sherrill et al., 1990; Davis & Novotny, 1989;
Sherrill et al., 1994], A large proportion of heavy smokers (80-90%) do not
show significant decline in FEV1 and do not suffer with COPD [Sherman,
1991]. There are some clinical markers shown to be significantly
associated with the risk of development of COPD, e.g ., a decreased
FEV1 /vital capacity with a high nitrogen slope of the alveolar plateau in
smokers in their 50s [Stanescu et al., 1998], The factors that determine
whether the disease is mild and short-lived or severe and chronic are,
however, not clear. In some individuals, smoking causes well described
histopathological [Adesina et al., 1991; Ollerenshaw & Woolcock 1992],
cellular [Schaberg et al., 1992; Brown et al., 1989] and biochemical




abnormalities in the airways without causing COPD. These observations
indicate the existence of host and environmental factors that might
determine the outcome of the injury caused by smoking.
1. 5. 1. 1 Effects ofcigarette smoking on the respiratory system
Smoking causes three overlapping patterns of changes in the lungs: in the
proximal airways, mucus glands hypertrophy with mucus hypersecretion; in
the bronchioles, mucous hyperplasia and metaplasia and smooth muscle
hypertrophy and fibrosis; and damage to respiratory bronchiolitis resulting
in emphysema [Jeffery, 1991; Littman et ah, 2004],
Inhaling habits, smoking style, presence and type of filter and the kind of
tobacco smoked might have effects on the pathology in the lungs in
response to smoking [Wald et al., 1980; Lange et al., 1990; Wald & Watt,
1997]. The degree of smoking and depth of inhalation of smoke result in
either high nicotine uptake and airway smoke particle deposition associated
with chronic bronchitis or high alveolar smoke exposure with high CO
absorption associated with emphysema [Clark et al., 1998].
The alveolar epithelium is covered with an aqueous liquid, called surfactant,
which reduces the surface tension of the alveoli [Higenbottam, 1989],
Surfactant proteins are collagen-like glycoprotiens synthesised by distal
pulmonary epithelium. The surfactant also plays a protective role against




microorganism by macrophages and stores opsonins, e.g., immunoglobulins
and complement factors [Bisetti, 1989], Thinning of the surfactant layer
caused by smoking [Finley & Ladman, 1972; Betsuyaki et al., 2004]
impairs its protective role against toxic injury and microorganisms. The
other important mucosal protective mechanism, ciliary movements, is
slowed down by small quantities of whole smoke or its aqueous extract
[Stanley et al., 1986],
Cigarette smoking is associated with a decrease in natural killer (NK) cell
[Nair et al., 1990; Phillips et al., 1985], and neutrophil functions [Venge et
al., 1991; Moszczynski et al., 2001], Alveolar macrophage functions in
smokers are also impaired: Fc receptor affinity [Cosio et al., 1982] and C3
receptor expression [Gomez et al., 1982; Moszczynski et al., 2001] are
decreased resulting in altered bactericidal functions and defective
expression ofMHC class II molecules [Lensmar et al., 1998; Mancini et al.,
1993]. This affects antigen presenting activity and eventually T-cell
mediated responses. Smoking also reduces surface expression of various
molecules, e.g., lymphocyte function associated molecules, important in
optimum immune and inflammatory response against microbial pathogens
[Mancini et al., 1993]. Cigarette smoke may contribute to persistent
bacterial colonisation of the airways by immunosuppression and decreased
production of cytokines with antibacterial activity, thus increasing




1. 5. 2 Respiratory infections
Respiratory infection has been postulated as having a role in the
pathogenesis and progression of COPD [Tager & Speizer, 1975; Murphy &
Sethi 1992; Fagon & Chastre, 1996; Marin et al., 1989; Verghese & Berk,
1991; Drannik et al., 2004]. Treating exacerbations with antibiotics when
bacteria are isolated is a uniform practice. There are, however, two
difficulties. 1) While symptoms such as productive cough, purulent sputum
and dyspnoea could be due to infection, a non-infectious increase in the
underlying inflammatory process could cause similar symptoms. 2) The
incidence of microbial isolates from the respiratory tract during
exacerbation is not different from that during remission.
Whilst the airways are constantly bombarded with microbial agents, there
are efficient microbicidal mechanisms keeping the lungs relatively sterile.
Studies comparing bacterial isolates from patients with COPD and healthy
subjects have not been reported, but it is likely that more bacteria colonise
the lower airways and cause acute-on-chronic disease in COPD patients due
to structural derangement and possible interference with the local
bactericidal mechanisms. A proposed course ofCOPD highlighting the role
of respiratory tract infections is illustrated in Figure 1.3. Alternatively,
virulence of individual strains within a species might be responsible for
disease in some patients compared with colonisation with less virulent




1. 5. 2. 1 Microorganisms associated with COPD
Non-typeable Haemophilus influenzae, Streptococcus pneumoniae and
Moraxella catarrhalis are common bacterial species isolated from patients
during episodes of exacerbation in the course of COPD and asthma [Calder
& Schonell, 1971; Smith et al., 1976; Nicotra et al., 1986; Seddon et al.,
1992; Sethi et al., 2000]. Infectious aetiologies in severely ill hospitalised
patients with COPD, however, were found to be mostly viral and atypical
bacteria; the above bacterial pathogens were responsible for minority of
case [Lieberman et al., 2001],
Two reviews [Fagon & Chastre, 1996; Zalacain et al., 1997] did not find
differences in isolation of bacterial flora between patients with exacerbation
or with stable COPD. Other studies where samples were taken from the
lower respiratory tract, however, demonstrated differences [Monso et al.,
1995; Pela et al., 1998; Riise et al., 1994; Cabello et al., 1997]. Many of
these studies did not measure the density of colonisation by bacterial flora
[Beachey, 1981] of the respiratory tract during exacerbation and stable
periods in a given patient populations, nor did they consider the effect of
viral infections on the bacterial load or on the inflammatory response to
resident flora. The presence of bacteria in the normally sterile lower
respiratory tract, whether during stable COPD or acute exacerbations,
warrants investigation into their role in inflammation. Possible changes in




unrecognised host factor(s) in the respiratory tract, changes in the bacterial
phenotype [van Alphen et al., 1995] or virus infections. These changes in
bacterial colonisation of the lungs during exacerbations are expected to
disturb the fine-tuning of the cytokine production contributing to chronic
inflammation.
Studies comparing the tracheobronchial microflora during acute
exacerbation and during stable periods in the course of COPD showed
significant differences in isolation rates of influenza virus, respiratory
syncytial virus (RSV) [Mikhalchenkova et al., 1987; Iakovleva et al., 1987]
and rhinovirus [Monto & Bryan, 1978], Evidence of persistent infection
with RSV [Krivitskaia & Iakovleva, 1992; Krivitskaia et al., 1996;
Iakovleva et al., 1987] and adenovirus [Hogg, 2001] was found in the
respiratory tract in patients with COPD.
1. 5. 2. 1. 1H. influenzae
H. influenzae is a small (0.1 x 0.3 pm), non-spore-forming, Gram-negative,
pleomorphic coccobacillus (Figure 1.3). Some strains produce a
polysaccharide capsule, which determines the type a-f, type b being
responsible for most of invasive diseases due to this bacterium. The other
strains are non-typeable and non-invasive and cause disease only in subjects
with underlying physiological, immunological or anatomical abnormalities.
H. influenzae is an exclusively human pathogen, which resides principally
in the upper respiratory tract of 25-80% of population [Faden et al., 1996],
Non-typeable H. influenzae are implicated in infections affecting the course
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Figure 1.3. Gram negative coccobacilli of H. influenzae (x
1000).
1. 5. 2. 1. 2 S. pneumoniae
S. pneumoniae, commonly called the pneumococcus, is a member of
normal pharyngeal flora of about 24% of the population [Sener et al., 1998],
and it is an important human pathogen causing ear, upper and lower
respiratory tract infections and meningitis. It is a Gram-positive, non-
motile, capsulate diplococcus (Figure 1.4). Virulence has been related to
presence of capsule (Figure 1.5) and capsular serotypes have different
propensities for types of tissues and different age group affected [Bedos et
al., 1999], Of the 84 recognised capsular serotypes, 6, 19 and 15 were most
common in children with chronic inflammatory disease of the respiratory
tract [Katosova et al., 1990], Studies reporting most common serotypes in




Figure 1.4. S. pneumoniae in pairs from a sputum specimen
(Gram stain, xlOOO)





1. 5. 2. 1. 3M. catarrhalis
M. catarrhalis is a part of the normal flora of the upper respiratory tract in
as many as 50% of children and 5% of adults. It is responsible for a variety
of conditions, otitis media, conjunctivits, exacerbation of COPD [Bakri et
al., 2002] and, in immunocompromised hosts, invasive diseases, e.g .,
septicaemia and meningitis [Verduim et al., 2002], Pathogenicity of M.
catarrhalis is attributed to its release of lipopolysaccharides (LPS)
[Verduim et al., 2002] and there are indications that some strains express
endotoxins that elicit significantly greater levels of pro-inflammatory
cytokines [Braun et al, 2002], The bacteria are non-capsulate, non-motile
short rods, and appear as Gram-negative diplococci with long axes parallel
(Figure 1.6). Pathogenic strains grow on selective solid media containing
antibiotics but most non-pathogenic strains do not. Differences in other
attributes, e.g., complement sensitivity and adherence characteristic, have









1. 5. 2. 1. 4 Respiratory syncytial virus (RSV)
RSV is a ubiquitous, important viral respiratory tract pathogen. It causes
disease in children [Falsey, 1998; Han et al., 1999], Half of children are
infected in their first year of life and virtually all by the second year [Hall,
1980]. RSV is also an important pathogen in older age groups because
complete immunity does not follow RSV disease and reinfections are
common [Mlinaric-Galinovic et al., 1996; Sullender et al., 1998]. RSV
belongs to the genus Pneumovirus in the family of Paramyxoviridae. It is
an enveloped, large, negative-stranded single-stranded RNA virus,
heterogenous in shape and size (Figure 1.7).
Figure 1.7. Respiratory syncytial virus (electron micrograph).
The vims assembles at circumscribed regions on the plasma membrane of
the infected cells and matures by budding during which intracellular




membrane [Bachi, 1988]. Two antigenically distinct types of RSV,
designated A and B subgroups based on variation of the glycoprotein G, the
attachment protein, have been described [Coggins et al., 1998] and
associated with severity of disease [Homsleth et al., 1998].
1. 5. 3 Virus infections predispose to bacterial disease
Clinical, epidemiological and experimental evidence indicates that virus
infections can be predisposing factors for bacterial disease [Ramirez-Ronda
et al., 1981; Gwaltney et al., 1975; Hament et al., 1999; Levine et al.,
2004], Prior virus infections can predispose patients to secondary bacterial
diseases by a variety of mechanisms [Babiuk et al., 1988]. Factors
considered to contribute to this effect include: immune suppression [Babiuk
et al., 1988; Degre 1986]; local oedema formation and tissue injury; loss of
mucocilliary function and decreased bacterial clearance [Camner et al.,
1973]; formation of exudate that enhances bacterial growth [Babiuk et al.,
1988]; increased bacterial binding to virus infected cells [Raza et al., 1993;
Peltola & McCullers, 2004]; diminished phagocytosis [Solano et al., 1998;
Franke-Ullmann et al., 1995; Stockl et al., 1999]; and increased production
of inflammatory cytokines leading to immunopathology and tissue injury
[Beadling & Slifka, 2004].
Infection of epithelial cells with RSV increase binding of respiratory




1993; Patel et al., 1992; Jiang et al., 1999; Ogra, 2004], Patients with RSV
infections showed a significant rise in antibodies to H. influenzae, S.
pneumoniae and M. catarrhalis [Korppi et al., 1989]. Invasive disease due
to pneumococci followed infection with RSV [Kim et al., 1996], Invasive
infections due to pneumococci or H. influenzae were identified in 26%
children suffering with RSV. Similarly, 54% cases of invasive infection
with H. influenzae and 47% with pneumococci also had evidence of viral
infections [Takala et al., 1993].
1. 5. 4 Smoking and viral infections
Smoking affects the respiratory tract by many ways. Smoking enhances the
susceptibility of individuals to increased bacterial colonisation. Compared
with non-smokers, buccal epithelial cells of smokers bound in higher
numbers of S. pneumoniae [Mahajan & Panhotra, 1989; El Ahmer et al.,
1999; Raman et al., 1983; Cazzola et al., 1990], non-typeable Ii. influenzae
[El Ahmer et al., 1999; Piatti et al., 1997; Cazzola et al., 1990] and M.
catarrhalis [El Ahmer et al., 1999]. Smoking also increases susceptibility
to viral and bacterial infection [Marcy & Merrill, 1987],
1. 5. 5 Genetic factors in pathogenesis of COPD
Susceptibility to and/or progressions of some inflammatory conditions have
been associated with cytokine gene or major histocompatibility antigen




erythematosus in South Africa, a TNF-2 variant at locus TNF-238 was
shown to be significantly associated with white subjects and with HLA-
DR3, which also showed strong independent association with white
ethnicity compared with black [Rudwaleit et al., 1996], Ethnic differences
were found in genotypes of TNF and there linking to MHC alleles
[Gallagher et al., 1997]. Associations have been found between certain
TNF gene polymorphisms and rheumatoid disease [Mu et al, 1999],
myasthenia gravis [Skeie et al., 1999], cystic fibrosis [Hull & Thomson,
1998], primary biliary cirrhosis [Jones et al., 1999], and ulcerative colitis
[Bouma et al., 1999]. Similarly, the finding that many cigarette smokers
are spared from progressing into COPD is likely to be explained by genetic
polymorphisms. TNF2 (G to A replacement at -308 position)
polymorphism was over-represented in patients with chronic bronchitis
compared with school children and age and sex-matched control group
[Huang et al., 1997]. This finding was not, however, confirmed by
Ferrarotti et al. (2003) in an epidemiological study. Kucukaycan et al.
(2002) found +489G/A phenotype among several examined to be associated
with COPD. In mice, cigarette smoke-related lung injury was not observed
in animals with knocked-out TNF-a receptors [Churg et al., 2002]. TNF1
homozygosity, however, was more associated with childhood asthma




1. 5. 5. 1 Gene polymorphism in cytokine production and susceptibility
to infections
Variations in individual susceptibility to infection have aroused interest in
the investigation of polymorphism of relevant genes. Immune responses
and inflammatory cytokines have been reported to differ in several ethnic
groups. Several single nucleotide substitution polymorphisms in the TNF
gene have been described: the more regularly reported -238 and -308 and
newly identified -574, -856 and -862 [Uglialoro et al., 1998]. A G to A
exchange at position -308 of TNF promoter/enhancer region has been
described and associated with alteration of TNF expression in vitro in some
cell lines transfected by the altered gene [Kroeger et al., 1997], but not in
some other cell lines [Brinkman et al., 1995] and in patients with sepsis
compared with control [Stuber et al., 1995]. It is proposed that single
nucleotide mutation in the promoter region of TNF affects the binding of
nuclear factors, e.g., kappa B [Christman et al., 1998].
Samples from patient with severe sepsis were genotyped as either
homozygous for TNFB1 or TNFB2 or heterozygous, based on the
polymorphic site of the restriction enzyme Ncol within the TNF locus.
Compared with uneventful sepsis cases, increased TNF secretion and higher
prevalence of Ncol-digestion+ alleles TNFB2 were found in patients with




more significant for homozygous patients for TNFB2 compared with
heterozygous patients [Stuber et al., 1996]. The -308A TNF gene
polymorphism has been implicated in a higher susceptibility to cerebral
malaria [Wilson et al., 1997] and in sepsis [Hedberg et al., 2004].
Significant associations of the TNF gene promoter polymorphism at the -
238 position with chronicity of hepatitis B infection and at the -238 and -
308 positions with chronicity of hepatitis C infection [Lu et al., 2004;
Hohler et al., 1998; Thio et al., 2004] have been reported. TNF
polymorphism at position -308 has also been associated with the severity
and outcome of meningococcal disease [Nadel et al., 1996] and with
resistance to human cytomegalovirus infection [Hurme & Helminen, 1998].
Significant genetic components associated with both pro-and anti¬
inflammatory cytokine productions have been reported [Westendorp et al.,
1997].
1. 5. 5. 2 Host genetic factorsfor vulnerability to cigarette smoking and
COPD
The finding that many cigarette smokers do not progress into COPD might
indicate genetic polymorphism. Alphai-antitrypsin is an acute phase
protein with anti-proteases properties. It is produced in many inflammatory
conditions [Nelson et al., 1998], Deficiency of alphai-antitrypsin is
genetically determined and has been associated with early onset panacinar




association between the heterozygous state that affects 5-14% of the
population and lung function abnormalities [Sandford et al., 1999;
Silverman et al., 1998]. It has been postulated that alphai-antitrypsin
protects the lungs by degrading the proteolytic enzymes secreted by
inflammatory cells [Prescott et al., 1997]. Cigarette smoke is particularly
deleterious to persons homozygous (and possibly heterozygous) for alphai-
antitrypsin deficiency [Silverman et al., 1998].
Analysis of incidence of COPD in affected families indicates the presence
of other yet unknown genetic factors [Redline et al., 1989; Rybicki et al.,
1990]. Similar conclusions have been drawn from studies of twins and
first-degree relatives of patients of COPD [Silverman et al., 1998; Tager et
al., 1976 234; Redline et al., 1987]. Decreased prevalence of disease was
noticed with increasing genetic distance from the patients with COPD
[Fernandez et al., 1994]. Genetic rather than environmental factors
correlated with lung function in families [Kauffmann et al., 1989].
Relatives of the cases of COPD showed an increased incidence of COPD,
which was significantly associated with blood group A, but not with ABH
secretor status [Khoury et al., 1986].
1. 5. 6 Air pollution and occupation
The incidence and mortality rates of COPD are higher in heavily




et al., 2004], Associations have been found between the amount of sulphur
dioxide and particulate matter in the air and exacerbation of bronchitis
[Leuenberger 1995; Simpson et al., 1998; Kappos et al., 2004], Coal dust
exposure has been generally accepted as a causal factor in chronic
bronchitis and COPD.
1. 5. 7 Sex, race, and socio-economic status
Men suffer more than women do with respiratory symptoms when the
effects are measured independent of smoking [Sherrill et al., 1990; Pride &
Soriano, 2002], Female smokers, however, suffer higher degree of
morbidity compared with male smokers [Prescott et al., 1997; Varkey,
2004], Differences in mortality rates for COPD have been reported for
different ethnic groups in Europe [Home et al., 1989] and in the USA
[Hnizdo et al., 2004]. Lower socio-economic status is associated with
higher morbidity and mortality due to COPD [Sherrill et al., 1990; Hnizdo
et al., 2004],
1. 5. 8 Childhood respiratory virus infections
Significant association between childhood respiratory infections and the
later development of chronic bronchitis had been demonstrated [Ding,
1992], Repeated childhood respiratory infections were shown to have a
greater influence than cigarette smoking on the subsequent development of




smoke during childhood predisposes to recurrent respiratory infections
[Omenaass et al., 1995; Alder et al., 2001; Peat et al., 2001; Sockrider,
2004].
1. 6 Hypotheses
The hypotheses tested in these studies were focused on assessment of the
interactions of some of the factors perceived as responsible for contributing
to COPD or to exacerbation in its course. Following hypotheses were
tested:
o RSV and water soluble cigarette smoke extracts produce additive or
synergistic effects on monocytes of an increase in production of
TNF-a and/or a decrease in production ofNO;
o RSV infection enhances expression of potential bacterial receptors
on epithelial cells;
o RVS infection of monocytes decreases their capacity to bind and
phagocytose bacterial pathogens of the respiratory tract. It also






The objectives of the study were
1) To develop an in vitro method for measuring cytokine response to water
soluble components of cigarette smoke and infectious agents implicated in
COPD;
2) To assess inflammatory responses from monocytes from healthy
individuals to components of cigarette smoke extract and/or RSV;
3) To develop cell culture models to evaluate the effect of virus infection on
cell surface expression of antigens and binding of bacteria;
4) To develop methods to assess the effect of virus infection on





General Materials and Methods
All chemicals were of analytical grade and were obtained from BDH
Chemicals Ltd., UK unless otherwise indicated.
2. 1 Washing buffers
2. 1. 1 Phosphate-buffered saline (PBS) for washing bacteria
PBS contained 8 mM NaiHPCL, 1 mM KH2PO4, 3 mM KC1 and 0.15M
NaCl. This composition yielded a pH 7.2+0.1.
2. 1. 2 Dulbecco's PBS for washing cell lines
Dulbecco's PBS (DPBS) prepared from concentrated PBS (x 10) (Gibco)
without calcium and magnesium was used for washing the cells.
2. 2 Bacterial pathogens
2. 2. 1 Bacterial isolates
There were two isolates each of non-typeable Haemophilus influenzae
(HI1 and HI2), Moraxella catarrhalis (MCI and MC2) and Streptococcus




obtained from the Division of Medical Microbiology, University of
Edinburgh. H. influenzae and pneumococcal isolates were sensitive to
ampicillin. M. catarrhalis strain MCI was able to grow on New York City
medium with antibiotics selective for the pathogenic Neisseria species (see
under). M. catarrhalis MC2 did not grow on this medium.
2. 2. 2 Media
Modified New York City medium (MNYC) (Cherwell Laboratories Ltd.,
UK) (GC medium base (Difco, UK) was supplemented with 10% (v/v)
horse blood lysed by saponin (0.5% v/v) yeast dialysate (2.5% v/v),
glucose (0.1% w/v), lincomycin (1 pg/ml), colistin (6 pg/ml),
amphotericin B (1 pg/ml) and trimethoprim lactate (6.5 pg/ml)) was used
to culture Neisseria meningitidis. S. pneumoniae was grown on Columbia
blood agar, and M. catarrhalis and H. influenzae isolates on chocolate
agar with horse blood. The prepared media were obtained from Oxoid
Unipath Ltd, UK.
2. 2. 3 Maintenance, storage and preparation of bacteria
Aliquots of heavy bacterial suspensions in maintenance medium (MM)
(2.4.1.2) without antibiotics were stored at -20°C for up to 3 months for
use in monocytes (THP-1) bactericidal assays. Concentrations of live
bacteria in the frozen samples were determined by plating triplicate




determination of colony forming units (cfu) after overnight growth in 5%
C02 at 37°C.
Alternatively, bacterial cultures for use in other experiments were prepared
by reconstituting lyophilized strains in distilled water for 20 min and
plating them on appropriate media. The cultures were kept overnight at
37°C in 5% C02. For storage, colonies were emulsified in Microbank
beads (Pro-Lab Diagnostic, Ontario, Canada) and kept at -20°C to use
within three months. A fresh bead was used to inoculate the above plates
for each set of experiments. Overnight growths on plates were collected in
PBS and washed twice by twice centrifugation at 2500 g for 10 min before
use in the experiments. For each strain the bacterial concentration was
determined by light microscopy with a Thoma counting chamber for each
experiment. The bacterial suspensions were adjusted to provide a range of
ratios of bacteria per cell for use in the assays. .
2. 3. Labelling of bacteria
2. 3. 1 Fluorescein isothiocyanate (FITC) labelling
FITC (Sigma, Poole, Dorset, UK) was used for labelling the bacteria in
some assays. The solution of FITC (0.4% w/v) was prepared in a buffer
containing sodium carbonate (0.05 M) and sodium chloride (0.1 M) (pH





The washed bacterial pellet from culture plates was suspended in 2 ml of
FITC solution by gentle shaking at 37 C for 20 min. The FITC-labelled
bacteria were washed three times with DPBS and resuspended in MM
(2.4.1.2) without antibiotics. The bacterial concentration was adjusted as
described above.
2. 3. 2. Ethidium bromide (EB) labelling
In some experiments the bacteria were labelled with EB. Bacteria in
suspension were washed with PBS and fixed with 1% (V/V) buffered
paraformaldehyde (Sigma) for 30 min in a water bath at 37°C. The
bacteria were washed twice with PBS and incubated with 50 pg ml"1 EB
(Sigma) for 20 min in a water bath at 37°C. Samples were washed twice
to remove unbound stain,
2. 4 Tissue culture cell lines and media used
All the cell lines used were tested for mycoplasma with direct fluorescent
assay using fluorochrome Hoechst No. 33258, a nucleic acid stain
[Hessling et al., 1980], The cells were grown for 24-48 hours in antibiotic
free medium on cover slips (about 2 x 104 cells) in shell-vials. The cells
were fixed with acetone and incubated for 30 min with the stain (0.05
pg/ml in Flanks Medium without sodium bicarbonate). The monolayers




magnfication for cytoplasmic bacteria using fluorescent microscope
(Fluorescence, Leitz, Ortholux).
2. 4. 1 Cell culture media
2. 4. 1. 1 Growth medium (GM)
GM consisted of RPMI-1640 medium (Gibco, Paisley, UK) supplemented
with foetal calf serum (FCS) (Gibco) (10%, v/v), 100 U ml"1 penicillin G,
100 pg ml"1 streptomycin sulphate (Sigma, Poole, Dorset) and ImML-
glutamine (Gibco). RPMI-1640 was replaced in some assays with
Dulbecco's Modified Eagle's medium (DMEM) (Gibco, BRL, Glasgow,
UK) containing D-glucose (0.45 % w/v) and pyridoxine (4 mg L"1). The
rest of the additives remained the same,
2. 4. 1. 2 Maintenance medium (MM)
MM consisted of the same constituents as GM except the quantity of FCS
was reduced to 1% (v/v). In some assays involving live bacteria, MM
without antibiotics was used.
2. 4. 2 Cell cultures
2. 4. 2.1 HEp-2 cells
HEp-2 cell line (Flow Laboratories) was used in these studies. This
continuous cell line consists of transformed epithelial cells originating




Confluent monolayers of HEp-2 cells were obtained in 25 cm2 tissue
culture flasks (Costar) by growth in GM (containing RPMI-1640). The
monolayer was rinsed twice with phosphate buffered saline (PBSA). A
solution (2 ml) of 0.05% trypsin (w/v) and 0.02% EDTA (v/v) (Gibco)
was applied to the monolayer of cells in a 75 cm3 flask for 4-6 min at 37°C
to prepare a suspension for the next passage. For the experiments, the
cells were treated with EDTA only to preserve surface molecules from the
enzymatic degradation by trypsin. The effect of trypsin / EDTA on the
cells was terminated by suspending the cells in 5-10 ml of GM. Cells
were counted by preparing a dilution (1/10) of the cell suspension in 0.5%
trypan blue (w/v) in physiological saline (Northumbria Biological, UK)
and viable cells counted by light microscopy using an improved Neubauer
counting chamber. Cells from freshly confluent monolayers (4xl06 ml"1)
were suspended in 1 ml of GM with 10% (v/v) dimethyl sulphoxide
(DMSO) (Sigma) and stored in liquid nitrogen following gradual cooling
to -70°C. Frozen cells were resuscitated by rapid thawing at 37°C for
further use. The cells to use in experiment were adjusted to 1 X 106 ml"1 in
MM.
2. 4. 2. 1 THP-1 cells
The THP-1 (human monocyte / macrophage) cell line used in some
experiments was obtained from the European Collection of Animal Cell




2described above, continually grown in 25 cm tissue culture flasks
(Costar) in GM containing RPMI-1640 and mercaptoethanol (2 x 10"^ M)
at 37°C in 5% C02- The cells were harvested in MM without antibiotics
and adjusted at 1 X 106 ml"1 for use in the experiment.
2. 4. 2. 3 Buffy coatpreparations
One-day-old buffy coats from blood donors of group O, Rh+ screened for
presence of blood-borne viruses were obtained from the Scottish National
Blood Transfusion Service (SNBTS), Royal Infirmary, Edinburgh. Buffy
coats were diluted 1 in 4 with sterile phosphate buffered saline (PBS). The
diluted preparations (40 ml) were layered over 12 ml of Histopaque 1077
(Sigma, Poole, Dorset, UK) in 50 ml polypropylene conical tubes
(Greiner, Gloucestershire, UK). The tubes were centrifuged at 400 g for
30 min at 25°C. Mononuclear cells in the opaque band formed at the
interface of plasma and Histopaque were aspirated carefully. The cells
were washed twice in sterile PBS at 150 g for 10 min and the supernatant
discarded. The cells were resuspended in 20 ml of GM containing
DMEM, transferred to a 75 cm^ tissue culture flask (Greiner) and
incubated at 37°C for 30 min to separate monocytes from non-adherent
cells. The medium containing non-adherent cells was poured off and the
monocytes harvested by gentle scraping with a cell scraper in 20 ml of




exclusion method and the concentration of monocytes adjusted to 1X106
ml"1 in GM. The cells (1 ml) were distributed in 24-well tissue culture
plates (Costar) with 1X10^ cells in each well. Viability of cells at the end
of each experiment was also assessed by microscopic examination of cells
in the wells for exclusion of trypan blue.
2. 5 Standardisation of respiratory syncytial virus
(RSV)
2. 5. 1 RSV stock
The Edinburgh strain of RSV (subgroup A) was grown in HEp-2 cells.
One day old monolayers of HEp-2 cells were infected with at multiplicity
of infection (MOI) of 2-3 infectious particles per cell for one h. The
monolayer was maintained for 48 to 72 h at which time the cells started
fusing due to virus infection. The flask was frozen at -70°C and thawed to
lyse the cells to release the viruses. The virus suspension was adjusted to
2xl06 plaque forming units ml"1 using plaque assay described below.
Aliquots of the suspension were stored at -70°C for use in the experiments.
2. 5. 2 Plaque assay
HEp-2 cell monolayers were obtained by seeding 24-well tissue-culture
plates (Costar) which were incubated in 5% CO2 in air for 24 h at 37°C.




wells in quadruplicate (200 pi / well) and adsorbed to monolayers for 1 hr
at 37°C. The supernatant was removed from the wells and 1 ml of overlay
medium was added to each; this consisted of (methyl cellulose (3% w/v)
(Sigma) in Hank's buffered salt solution (Gibco) and NaHCC>3 (2 g f1)
mixed with maintenance medium at a ratio of 1:3. The plates were
incubated in 5% CO2 at 37°C for 3-4 days until syncytia / plaques
appeared in the monolayers. The monolayers were fixed with
formaldehyde in saline (10% v/v) for 10 min and staining solution was
used to examine cell monolayers for syncytia and plaque formation. The
staining solution contained crystal violet (0.13% w/v) and formalin (5%
v/v) in normal saline. After 20 min the wells were washed with tap water.
The monolayers were examined for plaques by inverted light microscopy
(Olympus CK2, Japan).
2. 6 Immunofluorescence reagents for detection of
RSV-infected cells
Antibodies from three sources directed to RSV antigens were used to
detect RSV-infected cells in different assays. The RSV reagent (Imagen,
Dako Diagnostics Ltd, UK) contains monoclonal antibodies conjugated to
FITC. These conjugated antibodies bind specifically to viral antigens
conserved among RSV subgroups. The reagent was used in a one-step




preparations were fixed in acetone for 10 min then incubated with 10 pi of
the reagent for 15 minutes at 37°C in a moist chamber. The excess reagent
was removed by gently washing the slide in an agitating bath containing
PBS for 5 min. The coverslips were mounted and examined using
fluorescence microscopy.
Alternatively, the cells in suspension (HEp-2, THP-1 or human blood
monocytes) were assessed for RSV infection with monoclonal anti-G
glycoprotein of RSV (mouse), kindly provided by Professor PJ Watt,
Southampton University, detected with FITC-conjugated rabbit anti-
mouse immunoglobulin (Serotec) (1/100). In some assays RSV- infected
cells were detected using a convalescent serum from a patient with RSV
infection (i.e., polyclonal human anti-RSV) previously absorbed with
THP-1 cells and appropriately diluted in PBS. FITC-conjugated anti-
human immunoglobulin antibodies (Sigma) were used to detect primary
antibodies on cells. The fluorescent RSV-infected cells were analysed by
flow cytometry (Section 4.2.4).
2. 7 Statistical methods
In comparative data analyses, two-tail, paired /-tests were employed to test
the significance, and values obtained were compared with non-parametric
tests. The data from measurements of cell surface antigens expression
were first converted to logarithms before testing with paired /-test.





The effect of infection with
respiratory syncytial virus and water-
soluble components of cigarette
smoke on production of inflammatory
mediators
3.1 Introduction
The influence of bacterial and viral infections and non-infectious air
pollutants such as cigarette smoke on the inflammatory and immune
responses underlies the pathological processes in the respiratory tissues. A
number of reports have examined the release of inflammatory mediators
from alveolar macrophages and there have been clinical and experimental
studies on smoking and virus infection as contributory factors to COPD
[Silverman & Spezier, 1996; Monto, 1995; Wedzicha, 2001]. Both TNF-a
and NO are important inflammatory mediators in COPD and asthma [Barnes
& Belvisi, 1993; de Godoy et al., 1996; Keating et al., 1996; Gan et al,.




Infection with RSV induces release of TNF-a and NO from human alveolar
macrophages, bovine peripheral blood mononuclear cells and a murine
monocyte cell line [Panuska et al., 1994; Frank et al., 1994; Dietzscold,
1995]. There are, however, conflicting reports on the effect of smoking on
TNF-a release [Tappia et al., 1995; Sauty et al., 1994; Kharitonov et al.,
1995; Laan et al,. 2004; drannik et al,. 2004] and NO release [Kharitonov et
al., 1995; Alving et al., 1993; Marteus et al,. 2004; Warke et al,. 2003;
Horvath et al,. 2004], Both episodic and habitual smoking reduced NO
exhalation [Kharitonov et al., 1995]; but, in pigs challenged with cigarette
smoke, a vasodilator response due to NO release was recorded [Alving et
al., 1993],
Both blood monocytes and alveolar macrophages can be infected with RSV
(Becker et al., 1992; Adair et al, 1992) and both cell types are expected to
be exposed to water-soluble components of cigarette smoke absorbed across
mucous surfaces. The aim of the present study was to assess the effect of a
water-soluble cigarette smoke extract (CSE) on release of TNF-a and NO
from peripheral blood monocytes infected with RSV. Because there is
evidence that TNF-a responses are under genetic control, which can
influence severity or fatal outcome of infection, [Westendorp et al., 1995,
1997; Gander et al,. 2004; D'Aiuto et al,. 2004], the study examined
monocytes from different blood donors to assess individual variations in




In this chapter release of TNF-a and NO from human blood monocytes
challenged with either RSV, a water-soluble cigarette smoke extract (CSE)
or both were evaluated. Since many virus infections stimulate release of
interferony (IFN-y) [Roberts et al., 1992] that might in turn mediate other
secretory functions, the effect of IFN-y on release of TNF-a and NO in this
system was also analysed. Nicotine is metabolised in the liver to cotinine,
which is secreted in body fluids including those of the respiratory tract
[Berkman et al., 1995]; therefore, the effects of nicotine and cotinine on
TNF-a and NO release were also examined.
3. 2 Methods
3. 2.1 Preparation of cigarette smoke extract
A water-soluble extract of cigarette smoke (CSE) was prepared (Fig 3.1) by
the use of a vacuum pump to pass the smoke of 10 filter-tipped cigarettes
(Benson & Fledges) through 100 ml of Dulbecco's Modified Eagle's
medium (DMEM) (Gibco) containing 0.45 % w/v D-glucose and 4 mg L"1
pyridoxin (Higashimoto, et al., 1992). To reduce LPS contamination, the
glass bottles used were heated at 134°C for 1 hr. The CSE was filtered with
a 0.2 pm filter (Millipore) and aliquots stored at -20°C for a maximum




Figure 3.1. Apparatus used to prepare water-soluble extract of
cigarette smoke.
3. 2. 2 Stimulation of monocytes
RSV stock was prepared as described in section 2.5.1 and used at a
multiplicity of infection of 2 (Panuska et al., 1995). The monocytes (2.4.2.3)
were cultured at 37°C in 5% CO2 for 24 hr in 1 ml of GM, CSE, RSV or
with both CSE and RSV. Samples were collected from each well after 48 hr
for determination of TNF-a (100 pi) and after 72 hr for determination of
NO (400 pi). Negative control samples to which no cells were added
included culture medium alone, medium with CSE and/or RSV. The




The proportion ofmonocytes infected with RSV in each sample 24 hr post¬
infection was determined by an indirect immunofluorescence technique with
monoclonal antibody against the glycoprotein G ofRSV (Raza, et al., 1993)
(section 2.6).
3. 2. 3 TNF-a bioassay
L-929 cells (a mouse fibroblast cell line) were used in a bioassay for TNF-a
activity as described by Delahook et al. [1995], Monolayers were cultured in
GM and maintained by splitting 1:10 twice weekly. Cells were dislodged by
a mixture of trypsin (0.005%, w/v) and EDTA (0.02%, v/v) and resuspended
in GM to 3.3 X 105 cells ml"1. Cells were dispensed in flat-bottom
microplates (Greiner) at 100 pi per well and incubated at 37°C in 5%CC>2
for 20 h. GM in each well was then aspirated, discarded, and replaced with
100 pi ofMM with 2 pg of actinomycin D ml"1 to stop further cell growth
without killing the cells.
The supernatant (100 pi) from stimulated monocytes was diluted 1:5 in MM
and added to wells in triplicate. The positive control consisted of ten fold
serial dilutions of a standard of recombinant TNF-a (National Institute for
Biological Standards and Control, Potters Bar, United Kingdom) at a
starting concentration of 1,000 IU ml"1. Negative controls consisted ofwells
without TNF-a. Plates were covered and incubated at 37°C in 5%C02 for 24




with 100 (j.1 of crystal violet solution containing crystal violet (0.5% w/v) in
20% in distilled water with methanol (20% v/v), filtered through a filter of
0.22 (om pore size before use. After 2 min, the plates were washed gently
under tap water to remove the excessive stain and dried with a hair dryer.
Each well received 100 pi of acetic acid (20%v/v), and the plates were read
at 585 nm on a plate reader. The content of TNF-a bioactivity was
calculated as percent of cells killed compared with controls.
3. 2. 4 Detection of NO
NO was detected as nitrite (ng ml"1) by the spectrophotometric assay
described by Zhang et al (1994). The samples were clarified by
centrifugation at 12,000 rpm with a microcentrifuge (Sorval MC 12C,
Dupont) for 5 min. Supernatants (400 pi) were reacted with equal volumes
of Greiss reagent which contained naphthylethylenediamine dihydrochloride
(0.3%, w/v) (Sigma), and sulphanilamide (1% w/v) (Sigma) in
orthophosphoric acid (5%, v/v) (BDH, Poole, UK), mixed 1:1 immediately
before use. After incubation for 10 min at room temperature, the absorbance
at 540 nm was determined with a spectrophotometer (Jeway 6100).
Concentrations of nitrites in the samples were derived from a standard curve





3. 2. 5 Statistical methods
The results obtained with buffy coats from 24 donors were assessed. The
results from some samples for some treatments could not be included due to
contamination of individual wells; therefore, the mean control values
corresponding to different experiments were not all the same. The data from
monocytes incubated with different agents were compared with those from
monocytes incubated with medium only. Comparisons were made also
between different treatment groups. The significance values obtained with
paired t tests of the data were similar to values obtained with a non-
parametric test (Wilcoxon's). The values obtained from t tests are presented
here.
3. 3 Results
3. 3.1 RSV infection of cells
On average, at 24 h post-infection more than 40% of monocytes from each
individual tested were infected with RSV. One way 'analysis of variance'





3. 3. 2 Assay standardisation
Ten-fold dilutions of CSE ranging from 0.1 to 0.0001 cigarette ml' were
tested with monocytes from 4 donors, and a dilution of 0.001 cigarette ml'
was selected for the assays on the basis of maximum effects on the
production of TNF-a and NO without killing the monocytes (Figure 3.2).
Doubling dilutions of IFN-y, nicotine and cotinine ranging from 400 ngml'
to 6.25 ng ml were tested [Geng et al, 1995]. A dose of 25 ngml' for these
reagents was used for further study (Table 3.1). More than 90% of
monocytes survived until the end of the experiments under the conditions




Figure 3.2. Viability of monocytes, cytotoxicity of L-9292 cells due
to TNF-a and levels of sodium nitrite produced by monocytes
incubated with various dilutions of CSE. (The values cell viability
obtained with tests substances were compared with those from test



































































Time course experiments with monocytes from 4 donors (6-72 h) found the
maximal TNF-a bioactivity occurred at 48 hours and nitrite accumulation at
72 hours in response to CSE (Figure 3.3).
6 hr 12 hr 18 hr 24 hr 48 hr 72 hr
Incubation
Figure 3.3. Time course experiments with monocytes from donors
showing maximal TNF-a bioactivity and nitrite accumulation in
response to CSE.
TNF-a activity was not detected in control samples without cells containing
culture medium or medium with CSE, RSV, CSE and RSV, IFN-y, nicotine
or cotinine. For detection of nitrites, the spectrophotometer was blanked on




effect due to presence of these agents was recorded at the optical density
used to detect sodium nitrite.
3. 3. 3 The effect of CSE and RSV infection on TNF-a bioactivity
The TNF-a bioactivities expressed as percent cytotoxicity of L-929 cells
observed in experiments with monocytes from a total of 24 donors were
compared. Figure 3.4 represents paired differences in L-929 cytotoxicity due
to TNF-a bioactivities caused by different treatments of monocytes
compared with monocytes incubated with medium only. Compared with
supernatants from cells incubated with medium alone (mean cytotoxicity
48%, SE 5.2), supernatants from cells incubated with CSE (mean
cytotoxicity 60%, SE 5.1) had significantly increased TNF-a bioactivities
(95% CI of paired differences 3.7,19.7, t = 3.05, P = 0.006) as did the
supernatants from RSV-infected cells (mean cytotoxicity 68%, SE 4.6)
(95% CI of paired differences 16.4,34.15, t = 5.9, P = 0.000). There was no
correlation between the % cytotoxicity for L-929 cells and proportions of
virus-infected cells in RSV-infected samples.
Compared with TNF-a bioactivities detected in supernatants from cells (15
donors) exposed to medium alone (mean cytotoxicity 38%, SE 5.4), a
significant increase was observed in supernatants from cells incubated with
both CSE and RSV (mean cytotoxicity 71%, SE 6.6) (95% CI of paired




























d- CSE RSV CSE+RSV
Figure 3.4. Paired difference in TNF-a bioactivity expressed as %
cytotoxicity for L-929 cells from monocytes of individual donors
exposed to medium only or to CSE and/or RSV. Error bar represent
standard errors.
Compared with TNF-a bioactivities of monocytes from 15 donors exposed
to CSE alone, the bioactivities observed with the combination of CSE and
RSV infection were significantly higher (paired differences 26%, 95% CI
10.4,41.3, t = 3.58, P = 0.003). Compared with levels of TNF-a found for
cells incubated only with RSV, addition of CSE did not significantly
increase TNF-a bioactivities (95% CI -12.9,21.5). This indicates that the
main contribution to increased levels of TNF-a was due to the virus
infection.
Compared with TNF-a bioactivity of monocytes from 6 donors exposed to
medium only (mean cytotoxicity 32%, SE 7.5), there was no significant




cytotoxicity 34%, SE 8.7) (95% CI of paired differences -14.2,15.4) or
cotinine (mean cytotoxicity 39%, SE 7.2) (95% CI of paired differences -
1.6,15.2). Incubation with IFN-y did, however, result in significantly
increased TNF-a bioactivity (mean cytotoxicity 51%, SE 3.0) (95% CI of
paired differences 6.2,31.7, t = 3.83, P = 0.012) (Figure 3.5).
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Figure 3.5. Paired difference in TNF-a bioactivity expressed as %
cytotoxicity for L-929 cells from monocytes of individual donors
exposed to medium only or IFN-y, nicotine or cotinine.
3. 3. 4 The effect of CSE and RSV infection on NO release from
monocytes
Since exposure to cigarette smoke can be considered to be a common or




in relation to CSE as control. The supernatants from cells in the same
experiments were examined for nitrite levels. Paired differences between
nitrite levels resulting from different treatments of monocytes compared
with those incubated with medium alone are given in Figure 3.6.
Figure 3.6. Paired difference sodium nitrite production from
monocytes of individual donors exposed to medium only or CSE
and/or RSV.
Compared with supernatants from cells incubated with medium only (mean
0.41 nM, SE 0.09), supernatants from cells incubated with CSE (mean 0.34
nM, SE 0.08) had significantly lower levels of nitrite (95% CI of paired
differences -0.14,-0.008, t = 2.3, P = 0.031) as did RSV-infected cells (mean
0.35 nM, SE 0.05), but the results were not significant (95% CI of paired




nitrite detected and ratios of RSV-infected cells in the samples. Compared
with cells incubated with medium only, cells incubated with both CSE and
RSV showed a significant decrease in nitrite production (mean 0.25 nM, SE
0.06) (95% CI of paired differences -0.4,-0.01, t = 2.26, P = 0.04).
In experiments with monocytes from 15 donors, there was no significant
difference between nitrite levels found for cells incubated with CSE alone
compared with those incubated with both CSE and RSV. In comparison
with nitrite detected in supernatants from cells incubated with RSV only,
supernatants from RSV-infected cultures containing CSE had lower levels
of nitrite with marginal significance (paired difference -0.098 nM, SE 0.048,
95% CI -0.006,-0.2, t = 2.02, P=0.063). This indicated that the main
decrease in nitrite levels was caused by CSE.
Experiments with cells from 6 individual donors showed that, compared
with nitrite levels observed with cells incubated with medium only (mean
0.10 nM, SE 0.03), addition of INF-y (mean 0.15 nM, SE 0.03) (95% CI
0,0.057) or nicotine (mean 0.13 nM, SE 0.03) (95% CI 0,0.03) to cells did
not result in significant changes in nitrite release, but addition of cotinine
significantly increased release of nitrite from cells (mean 0.26 nM, SE 0.03)
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Figure 3.9. Paired difference sodium nitrite production from
monocytes of individual donors exposed to medium only or IFN-y,
nicotine or cotinine.
3. 3. 5 Variability of TNF-a and NO responses of individual
donors
Each set of experiments was carried out with cells from different donors.
Individual TNF-a and NO responses to CSE, RSV infection, separately and
in combination, are summarised in Table 3.2. TNF-a and NO responses of
the test samples were arbitrarily classified as very high if the levels of
cytotoxicity for L-929 cells or levels of nitrites were more than twice the
value for the controls in which monocytes were cultured with medium
alone. Responses were classified as very low if the levels of test samples
were less than half the control. The most common pattern observed was




controls in which cells were incubated with medium only. The proportions
of extreme responses in the presence of CSE (4%) or RSV (4%) increased in
the presence of CSE and RSV (20%).
Cells from two individuals showed extreme responses (very high TNF-a
and very low NO) to RSV or RSV+CSE and one individual showed very
high response to RSV+CSE only.
Table 3.2. Individual responses to CSE and/or RSV.














CSE TNF 75 25 42 12 0 4
(n = 24) Nitrit
e
33 63 0 12
RSV TNF 92 8 33 25 4 4
(n = 24) Nitrit
e
50 46 21 25
CSE+RS
V
TNF 87 13 67 48 7 20
(n = 15) Nitrit
e
13 87 7 48





3. 4.1 The model system
RSV is a common pathogen affecting infants and the elderly [Hall, 1980].
Complete immunity does not follow exposure to RSV, hence reinfections
are not uncommon [Hall et al., 1991]. Significant numbers of patients with
COPD or bronchial asthma suffer bouts of exacerbation and possible
residual effects due to RSV infection in the course of their disease [Philit et
al., 1992], Cigarette smoking is a major cause of COPD [Silverman &
Spezier, 1996]. Both viral infection and cigarette smoking enhance bacterial
binding to epithelial cells in model systems [Raza et al., 1993; El-Ahmer et
al., 1994; Saadi et al., 1993, 1997] and cause immunosuppression [Babiuk
et al., 1988; Philips et al., 1985]. Since TNF-a and NO are important
mediators of inflammation in the respiratory tract, TNF-a and NO responses
of blood monocytes to RSV infection and CSE were assessed.
Peripheral blood monocytes were used in the study for four reasons, 1) their
ready availability in sufficient numbers; 2) alveolar macrophages in the
lungs are derived from monocytes; 3) they were less likely to have been




be in an unstimulated state. Some stimulation ofmonocytes due to the use of
histopaque for isolation of monocytes could not be ruled out. There is
evidence that genetic factors contribute to levels of TNF-a in response to
endotoxins and the toxic shock syndrome toxin [Westendorp et al., 1997;
Blackwell et al., 2002;D'Aiuto et al,. 2004], The variable spontaneous TNF-
a and NO release from monocytes could be attributed to the individual
donor's genetic make up or condition at the time of blood donation, recent
virus infection, active smoking, passive exposure to cigarette smoke, or
variable responses of monocytes to histopaque. The assays examined the
responses to various agents in relation to background levels of each
individual donor.
The dose of CSE (0.001 cigarettes mH) used in the assays was similar to
dilutions of smoke extract used in experiments with alveolar macrophages
[Higashomoto et al., 1992], It was based on the range of numbers of
cigarettes an average person can smoke and the water soluble components of
the inhaled smoke that cross the mucosal lining and are diluted in the body
fluids..
Bioactivity of TNF-a in samples can differ from total TNF-a detected by
ELISA because of the soluble TNF-a receptors produced by monocytes that
block the functions of the cytokine. We found no correlation between the
data from the bioassay and the ELISA with 200 samples (data not shown).




supernatant and partly to variable rate of degradation of TNF-a by the
monocytes. The bioassay was selected for this study because it measures the
levels of TNF-a activity in the solution at a given time.
3. 4. 2 TNF-a responses
RSV infection elicited variable TNF-a responses from alveolar
macrophages from individual donors and in different patients [Midulla et
al., 1989; Rutigliano & Grham 2004; McNamara et al,. 2004; Gentile et al,.
2003]. Cells from most of the donors in the present study showed increased
TNF-a responses to RSV infection or exposure to CSE. A minority
exhibited very high responses to either of the agents. TNF-a is thought to
play a protective role in RSV infection. Prior incubation with TNF-a has
been shown to reduce the replication of RSV in alveolar macrophages by
about half [Girino et al., 1993]. Cells from 8% of donors in this study
exhibited a decreased TNF-a response to RSV infection. Individuals with
this response might be particularly susceptible to severe infection RSV.
Persistence of RSV infection rendered murine macrophages dysfunctional
and low in TNF-a [Guerrero et al,. 2001].
3. 4. 3 NO responses
The beneficial pulmonary vasodilatory, possible bronchodilatory, and




by its induction of exudate formation, inflammation, DNA-toxicity and
cytotoxicity. It is generally agreed that mild NO induction is protective in
the respiratory tract while higher levels might be associated with deleterious
consequences [Barnes & Bevisi, 1993; Nussler & Billiar, 1993], Two
distinct populations of donors based on the level of NO production have
been recognised [Mautino et al., 1994], The assay for nitrite used in this
study was sensitive down to NaN02 concentrations of approximately 1 pM.
Results presented here indicate that increased responses of TNF-a are not,
in most donors, accompanied by increased NO responses to RSV or CSE.
TNF-a reduced the half life of mRNA encoding NO synthase in human
umblical vein endothelial cells [Yoshizumi et al., 1993]. The results indicate
that TNF-a activity might also affect the production of this enzyme in
monocytes.
3. 4. 4 The role of IFN-y, cotinine or nicotine
Some of the effects of virus infections are mediated through release of TNF-
a from monocytes [Sodhi & Basu, 1992]. The present data found that
stimulatory effects of RSV infection on TNF-a bioactivity could be due in
part to IFN-y. Significant increases in TNF-a and significant decreases in
NO response in the presence of CSE did not match with the observed slight
increase in both responses mediated by nicotine alone. This suggests other




significant increase of NO from cells treated with cotinine indicated that
some of the effects of cigarette smoking on inflammatory mediators in vivo
might be mediated by this metabolite of nicotine. Cotinine was not expected
to be present in the CSE as it is produced from metabolism of nicotine in the
liver.
The results presented here examined some of the effects of two
environmental factors that exacerbate COPD and asthma. Smoking or
passive exposure to cigarette smoke and virus infections of the respiratory
tract do not always lead to similar degrees of acute or chronic illness. This
could reflect the individual differences in responses observed in the model
system examined in this study. In addition to enhancing bacterial
colonisation of the respiratory mucosa and immunosupression, these agents
appear generally to enhance TNF-a response and reduce NO levels. The
extreme responses noted with cells from a minority of subjects might
contribute to increased susceptibility to chronic inflammatory disease of the
respiratory tract or exacerbations. Comparison of monocytes from healthy
donors with those from patients with these conditions for production of





Effect of infection with respiratory
syncytial virus on expression of
potential bacterial receptors native to
THP-1 and HEp-2 cells
4.1 Introduction
Viral infections are known to increase susceptibility of host to bacterial
infections [Babiuk et al., 1988; Stock et al., 1999; Levine et al., 2004;
Peltola & McCullers, 2004; Beadling & Slifka, 2004; Ogra, 2004]. Host
antibacterial mechanisms including phagocytic activity of monocytes
provide defence against bacterial infections. Bacterial binding to the surface
of monocytes is an essential pre-requisite to phagocytosis. Viral infections
might alter proficiency of monocytes to bind bacteria, among other factors
involved in monocyte-related bactericidal mechanisms (Chapter 5).
Native cell surface molecules such as integrins play a fundamental role in
adhesion, differentiation and inter-cellular interactions; however, they might
also be used by microbial pathogens, such as CD 18 used by meningococci,




[Miyamoto et al., 2003; Weineisen et al., 2004] as a means of entry to the
host's cells. Numerous studies have examined these surface antigens on
cells ofmyeloid origin. Lymphocyte function-associated antigen-1 (LFA-1)
expression was increased on monocytes infected with rhinovirus that
resulted in their increased adherence to endothelial cells [Hummel et al.,
1998]. Expression of surface antigens, e.g., CDllc, CD14, CD15, on
monocyte cells lines including THP-1 cells was altered due to acute or
chronic infection with Human Immunodeficiency virus-1 [Ushijima et al.,
1993],
RSV is an important agent of respiratory tract infections in older age groups
[Hall et al., 1991; Walsh & Falsey, 2004], Alveolar macrophages play an
important role in killing and inhibition of replication of inhaled
microorganisms and in inflammation in the respiratory tract due to these
agents [Nelson & Summer, 1998; Van Reeth & Adair 1997]. A human
monocytic leukaemia cell line, THP-1 [Tsuchiya et al., 1980], possesses the
properties of alveolar macrophages [Chen et al., 1996; Kurosaka et al.,
2001; Li et al., 2001] and was adopted as a relevant model to study
interaction between RSV and bacterial species commonly isolated from
patients with COPD.
Density of colonisation of epithelial surfaces is an important factor in the
pathogenesis of many infectious diseases [Beachey 1988; Beachey et al.,




was shown that one of the surface proteins, glycoprotein G, of RSV
expressed on the surface of infected cells contributed to enhanced binding of
bacteria to cells [Raza et al., 1994], Reports on expression of surface
antigens native to epithelial cells are emerging. Murine CD14 gene
expression was demonstrated on epithelial cells in response to TNF secreted
in the presence of bacterial lipopolysaccharide (LPS) [Fearns, 1997].
CD1 la (a chain of LFA-1) was demonstrated on epithelial cells of rat lungs
exposed to high oxygen pressure [Barquin et al., 1996]. CDllb/CD18,
components of complement receptor 3 (CR3) were detected on rectal and
cervico-vaginal epithelial cells in patients with HIV [Hussain et al., 1995].
HEp-2 cells provided a suitable model to perform studies on the effect of
RSV-infection on expression of native surface antigens on epithelial cells.
The objective of this part of the study was to compare the effects of RSV
infection on binding of monoclonal antibodies (MAbs) to the following
antigens on THP-1, human peripheral blood monocytes (PBM) and HEp-2
cells: the two components of LFA-1, CDlla and CD18; the Lewis" antigen,
CD15; CD14, the cell surface receptor for LPS; and CD29, an antigen




4. 2 Materials and methods
4. 2. 1 Cells cultures and RSV-infected cell cultures
4. 2. 1. 1 RSV
The flow cytometry method described previously to detect host cell antigens
on buccal epithelial cells [Ziegler & Ulevitch, 1993] was used in these
experiments to measure cells surface antigens. The Edinburgh strain ofRSV
(subgroup A) harvested from HEp-2 cells maintained as described in Section
2.5 was used to infect the cells.
4. 2. 1. 2 THP-1 cells
THP-1 cells were grown as described in section 2.5.2. Fresh cultures of
cells were infected with RSV at a multiplicity of infection of two. Overnight
cultures of uninfected and RSV-infected cells were washed with MM
without antibiotics by centrifugation at 300 x g for 7 min and the counts
adjusted to 1 x 106 ml"1 in this medium for use in the experiments.
4. 2. 1. 3 HEp-2 cells
HEp-2 cells (Flow Lab) were grown in 25 cm2 tissue culture flasks (Costar)
in GM. Monolayers grown for 24 hrs were infected with RSV at a
multiplicity of infection of 1.0 and cultured overnight in MM. RSV-infected




(w/v) ethylenediaminetetraactetic disodium acid (EDTA) (Sigma) was
applied, 1 ml per 25cm2 flask at 37°C for 5-10 min, to suspend the cells.
MM (10 ml) was added to the cells to terminate EDTA activity. After
centrifugation at 460 g for 7 min, the cells were resuspended in MM without
antibiotics, counted and adjusted to 1 x 106 cells ml"1 for use in the assay.
4. 2. 1. 4 Peripheral bloodmonocytes (PBM)
PBM obtained using methods described in section 3.2.2 were infected with
RSV at a multiplicity of infection of two. Overnight cultures of uninfected
and RSV-infected cells from two donors were washed with MM without
antibiotics by centrifugation at 300 x g for 7 min. The cells were adjusted to
1 x 106 ml"1 in this medium for use in the experiments.
4. 2. 1. 5 RSV-infected cells
The proportions of monocytes infected with RSV in the samples were
determined by flow cytometry and by indirect immunofluorescence (Section
2.6). Fluorescent cells were detected by flow cytometry (See below).
Viability of RSV-infected and uninfected THP-1 cells was determined by
trypan blue exclusion.
4. 2. 2 Binding of anti-CD monoclonals to cells
Uninfected and RSV-infected cell suspensions (Section 2.5) at I x IO6 ml"1




against the following human cell surface antigens: CDlla, CD18, CD15,
CD14 and CD29 (Table 4.1).
Table 4.1. Anti-CD monoclonals used in the assays with THP-1 and
HEp-2 cells.
THP-1 cells HEP-2 cells
Antibody Source Isotype Dilution Source Isotype Dilution
CDlla DAKO IgGl 1/20 Serotec IgGl 1/20
CD18 DAKO IgG2b 1/20 Serotec IgG2b 1/20
CD14 DAKO IgM 1/10 SAPU IgM 1/2
CD15 SAPU* IgGl 1/20 SAPU IgGl 1/20
CD29 Sertoec IgGl 1/20 Serotec IgGl 1/20






♦Scottish Antibody Production Unit
All the antibodies were produced in mice except anti-CD 18 and IgG2b which were of rat
origin and FITC-labelled antibodies of rabbit origin.
The samples were incubated for 30 min with gentle rotation (60 rpm) in an
orbital incubator (Gallenkamp) and were washed 3 times with PBS. The
appropriate fluorescein isothiocyanate (FITC)-labelled immunoglobulin
antibody was mixed with the cells and incubated with gentle rotation for 30
min to detect binding of the primary antibodies to cells. The cells were




binding of the FITC-labelled antibodies was determined in parallel samples
to which the first antibody was not added. Cells with fluorescence greater
than the control were assessed for mean fluorescence and binding index
calculated. The assays with THP-1 were performed at 4°C to prevent
ingestion of the antibodies and those with HEp-2 cells at 37°C.
Non-specific binding of antibodies to the cells was assessed by isotype
control antibodies directed to irrelevant antigens. Cell samples were
incubated as above with mouse isotype control (IgG2a) MAb to Aspergillus
niger (DAKO) or rat isotype control (IgG2b) MAb to kappa chain myeloma
protein (Serotec) (both diluted 1 in 20). Binding of the isotype controls was
detected with FITC-labelled rabbit anti-mouse Ig (Sigma) or FITC-labelled
rabbit anti-rat Ig (Serotec). As both uninfected and infected cells appeared
to bind the isotype controls at low levels, a second experiment was carried
out to determine if these control antibodies had any effect on binding of the
anti-CD antibodies. After incubation with the isotype control, the cells were
washed 3 times and incubated with unlabelled rabbit anti-mouse or rabbit
anti-rat Ig (Sigma) (both diluted 1 in 20) to block the isotype control
antibodies. The experiment to assess binding of anti-CD 18, anti-CD 14 and
anti-CD29 to cells was then carried out as described above.
The samples were washed 3 times with PBS, suspended in 200 pi volumes




(Sigma). Dulbecco's phosphate buffered saline solution A (DPBS) was used
for washing.
4. 2. 3 Flow cytometric analysis
The samples containing THP-1 cells and PBM were analysed with an XL flow
cytometer (Coulter Electronics, Luton, UK) and samples with HEp-2 cells with
EPICS-C flow cytometer (Coulter Electronics, Luton, UK) for the percentage
and the mean fluorescence above the background. The main cell population
was gated by forward and side light scatter to exclude debris and cell
aggregates. The percentage of cells with fluorescence greater than the
background was determined on a histogram produced by log-amplified
fluorescence signals and mean fluorescence of the positive population on a
histogram produced by linear signals. The values were multiplied to obtain a
binding index (Bind) for each sample.
4. 2. 4 Statistical analysis
Paired t tests were employed to analyse the logarithms of Bi„d of replicate
experiments for the flow cytometry studies to detect binding of antibodies or





4. 3. 1 RSV-infected cells
At 24 hours post-infection 40-50 % of THP-1 cells, 20-30% of PBM and
more than 80% ofHEp-2 cells were infected with RSV. RSV infection did
not affect the viability of cells at 24 hr post-infection.
4. 3. 2 Effect of RSV infection on binding of anti-CD MAbs to
cells
4. 3. 2. 1 THP-1 cells
Background binding of FITC-labelled rabbit anti-mouse/rat Ig (second
antibody) to HEp-2 cells was negligible. Mean Bind for the MAbs directed
towards the cell surface antigens of THP-1 cells are summarised in Table
4.2. In 7 experiments, RSV infection resulted in significant decreases in
binding anti-CDlla by 35%, anti-CD18 by 24%, anti-CD14 by 28% and
anti-CD 15 by 30%. There was an increase of 9% in binding of anti-CD29 to




4. 3. 2. 2 HEp-2 cells
Background binding of FITC-labelled rabbit anti-mouse/rat Ig (second
antibody) to HEp-2 cells was negligible. Data from 7 experiments to assess
binding of MAbs to HEp-2 cells and the effect of RSV infection on their
binding are summarised in Table 4.3. Traces of the histograms from flow
cytometric analysis of fluorescence obtained with MAbs to CD 14, CD 18
and CD29 are compared in Fig 4.1.
Antibodies to CD 11a, CD14, CD 15, CD 18 and CD29 bound to uninfected
HEp-2 cells. Approximately half the cells bound anti-CD 18 and
anti-CDlla, 40% bound anti-CD15, 15-25% bound anti-CD14 and over
90% bound anti-CD29. Infection of cells with RSV increased Bis
significantly for anti-CD 18, anti-CD 14 and anti-CD 15. The Bis for
anti-CD 1 la and anti-CD29 were also increased for RSV-infected cells by a
mean of 62% and 41% respectively above that observed for uninfected cells,
but these varied between experiments and the effects were not statistically
significant. Binding of the antibodies to cells was similar with slightly older











Figure 4.3. Traces of histograms from flow cytometeric analysis of green
fluorescence on cells treated with antibodies to (A) CD18, (B) CD14 and (3)
CD29. The darker curves in the tracings represent fluorescence obtained with
uninfected HEp-2 cells and the lighter curves with RSV-infected HEp-2 cells.




Table 4.3. Mean binding indices (Binci) of monoclonal antibodies to
HEp-2 cells and RSV-infected HEp-2 cells. (Standard error of mean
in the parenthesis) (Results from 7 experiments)
HEp-2 cells
Anti-CD RSV- RSV+
% Mean BI(SE) % Mean BI(SE) %RSV+/RSV- 95%CI P value
11a 44 8 352(127) 57 10 570(86) 162 73-365 NS
18 55 4 219(15) 60 5.8 348(60) 159 123-204 <0.01
15 40 7 280(18) 64 8 512(88) 183 111-302 <0.05
14 17 4 68(8) 23 5.6 129(8) 190 152-238 <0.001
29 90 13.6 1224(244) 96 18 1725(249) 141 92-214 NS
4. 3. 2. 3 PBM
As the THP-1 cell line was to be used in further studies on the effect ofRSV
infection on monocyte function, two experiments with PBM were carried
out to compare their expression of the CD antigens with those identified on
THP-1 cells. Data from antibody binding to PBM were similar to those
obtained for THP-1 cells except the expression of CD 15 on the PBM was
lower compared with THP-1 cells (Figure 4.2). There were insufficient




CDlla CD18 CD14 CD29 CS15
4.2. Binding of anti-CD monoclonals to uninfected and RSV-infected
PBM. (Means of two experiments)
4. 3. 3 Binding of control MAbs to cells
Since MAbs used to detect CD lib and CD 11c were of IgGl isotype, and as
these antigens were not detected on HEp-2 cells, a further control for this
isotype was not included in the assays. In two experiments, the two isotype
control antibodies directed against irrelevant antigens bound to HEp-2 cells:
IgG2a on average bound to 20% uninfected and 23% RSV-infected cells;
and IgG2b to 26% uninfected cells and 32% RSV-infected cells. These
antibodies, however, did not alter the binding of the same subclass isotype





Previous studies have shown that RSV infection increases bacterial binding
to epithelial cells [Raza et al., 1993; El Ahmer et al., 1996; Saadi et al.,
1993 & 1996; Jiang et al., 1999]. Since monocytes play an important role
in bactericidal activity in the respiratory tract and epithelial cells act as
initial binding sites, this study used THP-1 cells and HEp-2 cells as models
to examine the effect of RSV infection on bacterial binding, their ingestion
and killing (presented in Chapter 5). Changes in the surface receptors due to
RSV-infection, some of which could be involved in bacterial binding, were
examined.
Flow cytometry has recently been used extensively to detect
fluorochrome-labelled particles. Because large populations can be
examined, it is consistently more accurate and sensitive than direct
microscopy.
The objective of this study was to determine if RSV infection enhanced the
native surface components THP-1 and HEp-2 cells that might act as
receptors for bacteria. Binding of antibodies to CD 11a, CD14, CD 18 and
CD 15 to THP-1 cells was decreased as a result of RSV-infection. In
contrast, antibodies to CD14, CD15, CD18 and CD29 showed increased
binding to RSV-infected HEp-2 cells. Prior treatment of cells with isotype




indicating that the isotype control MAbs were binding to epitopes different
from CD molecules and/or bacterial receptors.
The enhancement of surface antigens on HEp-2 cells infected with RSV
observed in the present study might be due to a direct effect of virus on cells
or mediated through cytokines secreted by the infected cells. Virus
infections have been shown to alter surface expression ofmolecules.
The results for the THP-1 cells agreed with previously published results for
human mononuclear cells. RSV infection of human mononuclear leukocytes
has been shown to suppress LFA-1 (CD 18/CDlla) [Salkind et al., 1991;
Koga et al., 2000]. Rhinovirus decreased expression of CD 14 on peripheral
blood mononuclear cells [Papadopoulos et al., 2002].
The results obtained with HEp-2 cells agreed with the previous studies on
resected human tissue. RSV infection of the middle ear was shown to induce
or enhance mRNAs for ICAM-1, VCAM-1, and ELAM (a selectin
molecule). Cultures of resected tissue from the middle ear infected in vitro
with RSV were positive for the mRNAs for ELAM and for the cytokines
IL6 and TNF [Okamoto et al., 1993],
The changes in expression of cell surface antigens might be mediated by
cytokines produced in response to the RSV infection. Cytokines have been
shown to alter expression of CD 14 on blood monocytes: IL-4 decreases its




expression [Ziegler & Ulevitch, 1993]. Cytokine production from PBM in
the presence or absence of RSV infection was examined in experiments
summarised in Chapter 3. The effects of RSV infection on cytokine
production from THP-1 cells were examined in Chapter 5 as a part of the
study of their bactericidal functions.
CD 14, CD1 la, CD18 and CD15 have been identified as receptors for several
bacterial species [van t'Wout et al., 1992; Wright and Jong, 1986; Wright et
al., 1989; Espinoza et al., 2002; El-Azami et al., 2003; Weineisen et al.,
2004], Enhanced production of these antigens on HEp-2 cells might result
in increased bacterial binding to epithelial cells which would contribute to
increased density of colonisation by potential pathogens. Lower levels of
these antigens on THP-1 cells associated with RSV infection might
contribute to decreased bacterial binding and consequently ingestion and





The effect of RSV infection on binding
of H. influenzae, S. pneumoniae and M.
catarrhalis to HEP-2 and THP-1 cells
5.1 Introduction
Non-typeable H. influenzae, S. pneumoniae and M. catarrhalis are
bacterial species commonly isolated from patients during episodes of
COPD and asthma [Calder & Schonel, 1971; Smith et al., 1976; Nicotra et
al., 1986; Seddon et al., 1992], RSV is an important viral pathogen in
older age groups because complete immunity does not follow RSV disease
and reinfections are not uncommon [Hall et al., 1991; Hashem & Hall,
2003],
Results presented in Chapter 4 indicated that infection with RSV might





The objective of this part of study was to examine the changes associated
with RSV infection in binding of strains of H. influenzae, S. pneumoniae
and M. catarrhalis to HEp-2 cells and THP-1 cells. Uptake of bacteria into
phagocytic cells and non-professional phagocytic cells, e.g., cultured
epithelial cells, could be mechanistically similar [Falkow, 1991]. The
HEp-2 epithelial cell line model was used to compare the effects of RSV-
infection on bacterial binding to these two types of cells. Alveolar
macrophages play an important role in bacterial binding and further
antibacterial functions. THP-1 cells that possess the properties of alveolar
macrophages [Tsuchiya et al., 1980; Chen et al., 1996] were used to study
the effect ofRSV on intracellular bactericidal activity and cytokine release.
5. 2 Materials and methods
5. 2. 1 Respiratory Syncytial Virus
The Edinburgh strain of RSV (subgroup A) (Section 2.5) was used in these
experiments.
5. 2. 2 THP-1 cells
THP-1 cells were grown as described in section 2.5.2. Fresh cultures of
cells were infected with RSV at a multiplicity of infection of 2. Overnight
cultures of uninfected and RSV-infected cells were washed with MM




population adjusted to lxl06mr1 in this medium for use in the
experiments.
The proportions of monocytes infected with RSV in the samples were
determined by flow cytometry by indirect immunofluorescence (Section
2.6) with a convalescent serum from a patient with RSV infection
previously absorbed with THP-1 cells and appropriately diluted in PBS
(Section 2.6). Viability of RSV-infected and uninfected THP-1 cells was
determined by trypan blue exclusion.
5. 2. 3 HEp-2 cells
HEp-2 cells were grown, maintained and infected with RSV for use in
assays with bacterial binding as described in section 4.2.1.3.
5. 2. 4 Flow cytometric analysis
The main cell population was gated by forward and side light scatter to
exclude debris and cell aggregates and analysed as described in section 4.3.
A binding index (Bind) was obtained by multiplying the percentage of




5. 2. 5 Bacteria
The method described previously for bacterial binding [Raza et al., 1993]
was used in this study. Dulbecco's phosphate buffered saline solution A
(DPBS) was used for washing.
Isolates of non-typeable H. influenzae (HI1 and HI2), M. catarrhalis (MCI
and MC2) and S. pneumoniae (serotype 3, 6 and 23) were used in the assays
(Section 2.2.1). The bacterial preparations were made as described in
Section 2.2.3. The bacteria were washed twice with PBS and fixed with 1%
buffered paraformaldehyde (Sigma) for 30 min in a water bath at 37°C. The
bacteria were labelled with ethidium bromide (EB) according to the methods
described in section 2.3.2. The bacteria were washed twice and the total
count was adjusted to 4 x 108 m"1 in PBS by direct microscopy. Aliquots of
the labelled bacteria were kept at -20°C for up to 3 months for use in
experiments.
In some of the assays with HEp-2 cells, bacteria were labelled with





5. 2. 6 Bacterial binding
5. 2. 6.1 THP-1 cells
Uninfected and RSV-infected THP-1 cells (2 x 105) in capped plastic tubes
were mixed with EB-labelled bacteria to provide a ratio of 10 bacteriaxell
and incubated at 37°C in an orbital incubator (40 rpm). Samples were
removed after 0 or 30 min incubation and washed 3 times with ice-cold PBS
by centrifugation at 300 x g for 7 min to remove unbound bacteria from the
pellet. The cells were suspended in 1 ml of PBS and stored in the dark at
4°C until analysed within 24 hours by flow cytometry.
5. 2. 6. 2 HEp-2 cells
Samples (200 pi) ofHEp-2 cells, RSV-infected HEp-2 cells were suspended
in maintenance medium MM. An equal volume of FITC-labelled bacterial
suspension was added to the cells to provide a ratio of 200 bacteriaicell.
After incubation for 30 min at 37°C with gentle rotation in an orbital
incubator, the samples were washed 3 times in PBS by centrifugation at 480
x g for 7 min, resuspended in 200 pi PBS. The cells were fixed with 100 pi
of 1% (v/v) buffered paraformaldehyde and stored in the dark at 4°C until




5. 2. 7 Statistical analysis
Paired t tests were on the logarithms of the binding indices were used to
analyse data obtained from binding and ingestion of bacteria.
5. 3 Results
At 24 hours post-infection 40-50 % of THP-1 cells and more than 80% of
HEp-2 cells were infected with RSV. RSV infection did not affect the
viability of cells at 24 hr post-infection.
5. 3. 1 Bacterial binding to THP-1 cells
Figure 5.1 summarises data from bacterial binding to THP-1 cells. The
binding observed for isolate HI1 to uninfected THP-1 cells was about half of
that observed for isolate HI2 (P <0.05). HI1 also bound significantly less to
RSV-infected cells compared with HI2 (P <0.01). Compared with
uninfected cells, binding of both the isolates to cells infected with RSV was
significantly reduced: HI1, P <0.01, 95%CI -5520,-18141; HI2, P <0.02,
95%CI-1588,-25237.
Compared with MC2, MCI bound in higher numbers to uninfected THP-1
cells (P <0.001) and to RSV-infected cells (P <0.005). Both MCI and MC2
isolates bound significantly less to RSV-infected cells compared with





Compared with SP6, SP3 bound significantly more to uninfected cells (P
<0.05) and to RSV-infected cells (P <0.05). Compared with uninfected
cells, fewer SP3 bound to RSV-infected cells (P = 0.051, 95%CI 55,-23737).
There was no significant difference in binding of SP6 to uninfected or RSV-
infected cells. A decrease in ingestion of SP3 by RSV infected cells was
observed (P = 0.059, 95%CI 1212,-45717).
Figure 5.1. Binding indices of H. influenzae isolates (HI and H2), M.
catarrhalis (Mland M2) and S. pneumoniae type 3 and 6 (SP3 and
SP6) to THP-1 and RSV-infected THP-1 cells (mean of nine





5. 3. 2 Bacterial binding to HEp-2 cells
Figure 5.2 summarises the data from binding of FITC-labelled bacteria to
HEp-2 cells. Binding of all the strains except one of the two strains of
Moraxella catarrhalis was increased due to infection of cells with RSV.
Compared with uninfected cells, RSV-infected cells bound about twice as
many bacteria giving the following p values: HI1, < 0.001; MCI, <0.001,
SP6, <0.001; and SP23, <0.05. The effect of RSV infection on binding to
MC2 was opposite: RSV-infected cells bound significantly lower numbers
of bacteria compared with uninfected cells (p<0.05). Similar pattern of
results were obtained with the cells infected with group B RSV in few
experiments (results not shown).
The type 6 pneumococcal strain was used in these experiments to
demonstrate the effect ofRSV-infection ofHEp-2 cells. Infection with RSV
increased the mean binding index for pneumococci in 7 experiments from




Figure 5.2. Binding indices of H. influenzae isolates (HI and H2), M.
catarrhalis (Mland M2) and S. pneumoniae type 3 and 6 (SP6 and
SP23) to HEp-2 and RSV-infected HEp-2 cells.
5. 4 Discussion
Exacerbations in the course of COPD and asthma are usually attributed to
infection. Non-typeable H. influenzae, S. pneumoniae and M. catarrhalis are
common bacterial species isolated from these patients [Calder & Schonel,
1971; Smith et al., 1976; Nicotra et al., 1986; Seddon et al., 1999]. Fagon
and Chastre [1996] reviewed studies comparing the tracheobronchial
microflora during acute exacerbations and stable periods in the course of
COPD; significant differences in isolation rates in these studies were found
only for viruses, influenza virus and RSV. These studies did not measure




compared with uninfected HEp-2 cells, HEp-2 cells infected with RSV
exhibited enhanced binding of several species of bacteria: N. meningitidis',
H. influenzae type b; S. aureus and B. pertussis, pneumococci [Raza et al,
1993; El Ahmer et al., 1996; Saadi et al., 1993, 1996; Hament et al., 2004],
Patients with RSV infections showed a significant rise of antibodies to
H. influenzae, S. pneumoniae and M. catarrhalis [Korppi et al., 1989].
Although significant differences in rates of isolation of bacterial species
during exacerbation and stable periods were not found in patients with
COPD, the density of bacterial colonisation of the respiratory tract might
contribute to exacerbation. Secondary bacterial infections following virus
infections are thought to be associated with enhanced bacterial binding, and
suppression of host immune responses and bactericidal functions associated
with viral infections [de Graaf-Miltenburg et al., 1994].
Virus infections might predispose individuals to secondary bacterial
infections due to suppression of host immune responses and impairment of
bactericidal functions among other factors [de Graaf-Miltenburg et al.,
1994], Influenza virus modified monocytic antigen presentation, and
cytokine production [Louie et al., 1995]. RSV infection of a murine
macrophage cell line P388D1 resulted in an increase in their phagocytic
activity and a decrease TNF-a production [Guerrero-Plata et al., 2001].
Murine alveolar macrophages when infected with RSV, however, produced




Ullmann et al., 1995]. RSV infection induced production of pro¬
inflammatory cytokines in human neonatal macrophages and milk
macrophages [Matsuda et al., 1996; Sone et al., 1997], RSV replication
triggered chemokine production in epithelial cells and macrophages in
vitro and in murine model [Miller et al., 2004], Since monocytes play an
important role in bactericidal activity in the respiratory tract, this study
used THP-1 cells as model to compare the differences in binding of H.
influenzae, M. catarrhalis, and S. pneumoniae.
5. 4. 1 Bacterial staining and use of flow cytometry
Flow cytometry has recently been used extensively to detect
fluorochrome-labelled particles. Because large populations can be
examined, it is consistently more accurate and sensitive than direct
microscopy [Cunningham, 1994a&b]. Flow cytometric analysis in bacterial
binding studies cannot provide an absolute measure of the mean number of
bacteria attached to individual cells, but the mean fluorescence values
obtained by this method can reliably compare the binding between samples
[Loken and Stall, 1982; Rohde & Dyer, 2004],
Direct labelling of bacteria with fluorescein derivatives can affect the protein
moieties on the surface. Compared with unlabelled bacteria, FITC-labelled
E. coli and Salmonella typhimurium bound in higher numbers to mouse




bacteria were labelled with EB that binds to nucleic acid within the cells.
EB enters through the pores in bacterial cells wall produced by fixation with
paraformaldehyde. Any possible effects of bacterial fixation on surface
molecules and on binding were not studied in these experiments but were
not expected to alter the results of experiments that compared the binding
between uninfected and RSV-infected cells.
An attempt was made to differentiate between FITC-labelled antibodies and
EB-labelled bacteria in two-coloured histograms in flow cytometeric
analysis. The analysis, however, did not produce conclusive results due to
technical difficulties with the flow cytometer, which had settings for only
low discrimination between the two colours. As a result, any direct evidence
to associate the cellular surface antigens studies with bacterial binding could
not be provided in this study.
5. 4. 2 Effect of RSV infection of cells on bacterial binding to
THP-1 cells
It has been suggested that cellular antigens normally involved in cell-to-cell
recognition might be 'hijacked' by bacteria [Isberg et al., 1994; Rozdzinski &
Tuomanen, 1995]. There are reports that complement receptors, CR3 (CD 1
lb/CD 18) and CR4 (CD1 lc/CD18), are receptors for E. coli [Wright & Jong,
1986] and for Mycobacterium leprae [Schlesinger et al., 1991] on human




macrophages was inhibited by capping with anti-Lewis® and anti-Lewisx
(CD15) [van't Wout et al., 1992], The antibodies to Lewis® and Lewis"
antigens also inhibited binding of S. aureus and B. pertussis to buccal
epithelial cells [Saadi et al., 1993, 1996]. Helicobacter pylori bound to
Leweis® and Leweisb antigens on cells [Alkout et al., 1997]. CD14 and
LFA-1 function as receptors for bacterial lipopolysaccharides [Schumann et
al., 1994; Wright et al., 1989], Collagen receptors on CD4+ cells, ofwhich
CD29 is a common (3 chain, are involved in binding of Yersinia
pseudotuberculosis [Ennis et al., 1993], Reduction in meningococcal
binding and reduction in attachment of meningococcal LOS-coated sheep
erythrocytes to HEp-2 cells pretreated with anti-CD 14 or anti-CD18 indicate
that these antigens are involved in meningococcal binding [Raza et al.,
1999],
Decreased bacterial binding to RSV-infected THP-1 cells might be
explained by decreased expression of certain surface antigens on these cells
(Chapter 4).
5. 4. 3 Effect of RSV infection on binding of bacteria to HEp-2 cells
Increase in binding H. influenzae, S. pneumoniae and M. catarrhalis to HEp-
2 cells due to RSV infection found in this work was consistent with previous
studies by our group and others [Raza et al., 1993; Patel et al., 1992; Jiang et




up with increased expression of surface antigens measured on HEp-2 cells
that are considered as potential receptors on epithelial cells for bacteria
(Chapter 4).
5. 4. 4 Comparison of effects of RSV infection in relation to host defence
RSV infection of the respiratory tract might increase density of colonisation
due to increase in number of potential receptors for bacterial binding, among
other factors promoting increased bacterial load, e.g., local oedema
formation, tissue injury, decreased bacterial clearance associated with loss of
mucocilliary function and formation of exudate that increases bacterial
growth (Section 1.5.3).
It might also increase frequency of colonisation due to spread of bacteria in
aerosols due to hyperirritability of the respiratory tract and heavy bacterial
load. There is epidemiological evidence to suggest viral infection enhances
colonisation by M. catarrhalis. In a study in Denmark, significantly more
children in the 1-48 month age range with upper or lower respiratory tract
infections were colonised with M. catarrhalis (68%) compared with children
without such infections (36%, P < 0.001). After recovery, the isolation rate





RSV infected phagocytic cells in the lungs might have decreased capacity to
deal with the bacteria due to decreased capacity to bind, which can become
more important on relation to increased bacterial load in the respiratory tract.
The next part of the study examined phagocytic and bactericidal functions of
THP-1 cells when challenged with H. influenzae, S. pneumoniae and M.





Bactericidal activity of a monocytic
cell line (THP-1) against H. influenzae,
S. pneumoniae and M. catarrhalis is
depressed after infection with
respiratory syncytial virus
6.1 Introduction
Previous results indicated that infection with RSV might decrease
expression of potential bacterial receptors on monocytes (Chapter 4) and,
compared with uninfected monocytes, RSV-infected monocytes bound
fewer numbers of H. influenzae, S. pneumoniae and M. catarrhalis
(Chapter 5). Chapters 4 and 5 also showed that RSV-infected HE-p2 cells
might bind more of these bacterial species compared with uninfected
cells. The decreased capacity of monocytes to deal with bacterial load
might not be limited to decreased binding but other antibacterial
functions might also be deranged due to virus infection.
THP-1 possesses the properties of alveolar macrophages that play an
essential role in bactericidal functions against inhaled and ingested




agents. [Tsuchiya et al., 1980; Chen et al., 1996] were used for this part
of the study. The first objective was to examine the effect of RSV
infection on phagocytic and intracellular bactericidal activities of THP-1
cells.
Tumour necrosis factora (TNF-a) plays a role in defence against viral
[Neuzil et al., 1996; Cirino, et al., 1993; Minagawas et al., 2004] and
bacterial infection [von der Mohlen et al., 1996; Westendorp et al., 1997;
Ehlers, 2003], but has been considered responsible for full-blown
infection in rhinovirus infection by down-regulating IFN-y response
[Berg et al., 2004], Its release, however, also results in inflammation in
the respiratory tract and contributes to the systemic symptoms in patients
with COPD [Keatings et al., 1996; de Godoy et al, 1996]. The second
objective was to investigate the effect ofRSV infection and the presence
of intracellular bacteria on TNF-a release from THP-1 cells.
6. 2 Materials and methods
The Edinburgh strain of RSV (subgroup A) (Section 2.5) was used to
infect THP-1 cells (5.2.2). Two isolates each of non-typeable H.
influenzae (HI1 and HI2), M. catarrhalis (MCI and MC2) and S.
pneumoniae (serotype 3 and 6) were used in the assays (Section 2.2.1)




6. 2.1 Ingestion of bacteria
Bacterial preparations were incubated with cells at appropriate ratios as
described for bacterial binding studies (5.2.7). To measure the
fluorescence from bacteria ingested by cells, fluorescence from
extracellular bacteria was quenched in each sample (1 ml) with 20 pi of
0.05% crystal violet (BDH) in 0.15 N sodium chloride. Since the optical
density of the soluble dye and its quenching effect increased with time,
the flow cytometric analysis was carried at 500-600 nm. In this range
more than 90% of the EB-labelled bacteria outside the cells were
completely quenched. Crystal violet at higher optical densities is
membrane permeable and can quench intracellular bacteria. The laser
power for these samples was adjusted to compensate for the decrease in
background autofluorescence of the control samples due to quenching
and the percentage of fluorescent cells and the mean fluorescence were
measured to obtain an Iind-
6. 2. 2 Intracellular survival of bacteria
Uninfected and RSV-infected THP-1 cells were incubated with live
unlabelled bacteria under the above conditions for 30 min. Extracellular
bacteria were killed by adding gentamicin (30 pg ml"1) and ampicillin (50
pg ml"1) for 15 min at 37°C. After 3 washes with PBS, the cells were
resuspended in 100 pi of PBS and lysed with an equal volume of 0.05%




immediately plated in triplicate for determination of cfii as described
above. For a time course study of intracellular survival and growth of
bacteria, cells were incubated for different periods before lysing and
plating.
6. 2. 3 TNF-a bioactivity
Uninfected and RSV-infected THP-1 cells were incubated in 5% CO2 at
37°C with unlabelled live or EB-labelled fixed bacteria at a ratio of 10
bacteria:cell in 24-well tissue culture plates (Costar). After 24 hr of
incubation, supernatants from individual wells were collected for
determination of TNF-a. The bioassay described in section 3.2.4 was
used to determine TNF-a activity.
6. 2. 4 Statistical analysis
Paired t tests were used to analyse data from ingestion of bacteria.
Wilcoxon's test for matched-pairs was applied to the data on experiments
measuring intracellular survival of bacteria. The data for TNF-a
production by uninfected or RSV-infected THP-1 cells under various
conditions were analysed also by paired t tests.
6. 3 Results
6. 3. 1 Bacterial ingestion and survival
As described previously, at 24 hours post-infection 40-50 % of THP-1
cells were infected with RSV. RSV infection did not affect the viability




Bacteria bound to cells at 0 min (data not shown), but intracellular
bacteria were not detected at this time either by quenching the external
bacteria or by determination of intracellular survival. Data from 9
experiments on ingestion of H. influenzae, M. catarrhalis and
pneumococci are presented in Figure 6.1.
MCI MC2
Bacterial strain
6.1. Ingestion indices (SE) of H. influenzae isolates (HI and H2),
M. catarrhalis (Mland M2) and S. pneumoniae type 3 and 6 (SP3
and SP6) to THP-1 and RSV-infected THP-1 ceils (mean of nine
experiments). Error bars represent SEM.
RSV infection of cells reduced the ingestion of both the H. influenzae
strains, but this was significant only for HI1 (P <0.05, 95%CI -791,-




with uninfected cells (P <0.02, HI1, Z = -2.366; P <0.05, HI2, Z = -
2.1974). RSV infection of cells reduced the ingestion of both the M.
catarrhalis strains (MCI, NS; MC2, P <0.05, 95%CI -335,-31328).
Neither of the isolates survived in uninfected or RSV-infected THP-1
cells in the conditions used in the study. A decrease in ingestion of S.
pneumoniae SP3 by RSV infected cells was observed (P = 0.059, 95%CI
1212,-45717). There was no significant difference for SP6 in ingestion
by uninfected or RSV-infected THP-1 cells. Significantly more SP3
survived in RSV-infected cells compared with uninfected cells (P <0.05,
Z = -2.0226). SP6 showed evidence of only occasional survival in
uninfected cells, which was twice as high in RSV-infected cells. Data for





Figure 6.2. Survival of H. influenzae isolates (HI1 and HI2) and S.
pneumoniae type 3 (SP3) in uninfected and RSV_infected THP-1




6. 3. 2 Effect of RSV infection and bacteria on TNF-a
bioactivity of cells
TNF-a bioactivity in supernatants of uninfected or RSV-infected THP-1
cells incubated with either live unlabelled or fixed EB-labelled bacteria
was determined (Figure 6.3).
In 7 experiments, compared with THP-1 cells to which no bacteria were
added, the bioactivity was increased by incubation of THP-1 cells with
live strains: HI1, P <0.01 (95%CI 11.5,45.9); HI2, P <0.001 (95%CI
24.3,50.6); MCI P <0.05 (95%CI 8.5,59.2); MC2, P <0.05 (95%CI
5.1,47.2); SP3, P <0.001 (95%CI 48.6,65.9); or SP6, P <0.005 (95%CI
15.5,44.5). Differences in the levels of TNF-a induced were not
statistically significant between strains of the same species. Compared
with THP-1 cells to which no bacteria were added, the TNF-a bioactivity
was increased by incubation of THP-1 cells with EB-labelled fixed
strains: HI1, P <0.05 (95%CI 4.1,31.9); HI2, P <0.001 (95%CI 19,42.4);
MCI, P<0.002 (95%CI 23.1,63.2); MC2, P<0.001 (95%CI 38.9,59); SP3,
P <0.02 (95%CI 5.9,29.5); or SP6, NS. Compared with fixed HI1, fixed
HI2 elicited significantly more TNF-a bioactivity (P <0.005, 95% CI
6,19.3). Fixed MC2 and SP3 elicited higher TNF-a bioactivity compared





Figure 6.3. Percentage of cytotoxicity for L-929 cells caused by
TNF-p in supernates from uninfected or RSV-infected THP-1
cells incubated with live or fixed H influenzae (HI1 & 2), M.
catarrhalis (MCI & 2) and S. pneumoniae (SP3 & 6) obtained from
7 Experiments.
RSV infection increased TNF-a bioactivity from THP-1 cells incubated
with live HI1, HI2 or MC2 but the differences were not statistically
significant. Compared with uninfected cells, TNF-a bioactivity was
decreased for RSV-infected cells incubated with live MCI, P <0.002





RSY infection increased TNF-a bioactivity from THP-1 cells incubated
with fixed HI1 or HI2 but the differences were not statistically
significant. Compared with uninfected cells, there was decreased TNF-a
bioactivity observed with RSV-infected cells incubated with fixed MC1,
MC2, SP3 or SP6, but the results were significant only for SP3 (P <0.01,
95%CI -25.5,-5.2).
6. 4 Discussion
Decreased bacterial binding to and ingestion by THP-1 monocytes and
their impaired ability to kill bacteria suggest a role of virus infection in
pathogenesis of bacterial disease at multiple levels. While persistent RSV
infection did not derange antigen presenting function of a monocyte cell
line [Guerrero-Plata et al., 2004], it increased phagocytic activity and
expression of Fc receptors and decreased TNF-a production from a murine
macrophage cell line, P388D1 [Guerrero-Plata et al., 2001]. Infection with
RSV, however, induces release of TNF-a from human alveolar
macrophages and a murine monocyte cell line [Panuska et al., 1994; Frank
et al., 1994]. Decreased ingestion of bacteria by THP-1 cells infected with
RSV might be due to the lower levels of initial bacterial binding observed
with these cells.
The differences in binding of different isolates of each strain of bacteria
(Chapter 5) and their killing by the phagocytes found in this work might




less to uninfected THP-1 cells, were ingested at lower levels and survived
better in the cells might be more virulent than the others.
Heavy growths of bacteria over prolonged periods in the respiratory tract
in COPD due to inefficient bactericidal mechanisms might cause further
damage to the tract due to release of inflammatory cytokines. Increased
TNF-a bioactivity contributes to inflammation while a marked decrease
can jeopardise mucosal protection against bacteria and bactericidal
activity [Degre et al., 1989; von der Mohlen et al,. 1996]. With this in
view, this study examined the levels of TNF-a elicited from THP-1 cells
in response to bacteria. TNF-a produced by uninfected and RSV-
infected THP-1 cells in response to bacteria were also compared. While
various degrees of increased TNF-a bioactivity were observed with all
the bacterial isolates tested, the responses were reduced by concurrent
RSV infection in some cases indicating different isolates can elicit
different responses. RSV infection in human alveolar macrophages can
persist for at least 25 days after in vitro infection [Panuska et al., 1990]
and in a significant number of patients with COPD [Mikhalchenkova et
al., 1987]. Persistently lower TNF-a responses to the bacteria observed
with RSV infection combined with decreased intracellular bactericidal
activity might prolong bacterial disease in patients with COPD and cause




In conclusion, the differences observed between uninfected and RSV-
infected THP-1 cells in the pattern of binding, intracellular killing of
bacteria and TNF-a production in response to bacteria can help to explain
increased susceptibility of virus-infected patients to secondary bacterial
infections. Bacteria that escape virus-infected monocytes might have a








Although the precise sequence of events in COPD leading to airway
obstruction is not completely understood, inflammation in the airways has
been unanimously seen by researchers as a pivotal factor. Understanding
the role and pathophysiological and molecular mechanisms of
inflammation in the lungs holds the key to the development of effective
intervention strategies. The studies on inflammation in COPD might also
enhance the insight into proposed mechanisms of cytokine upsurge in
infants with sudden infant death syndrome (SIDS) [Raza & Blackwell,
1999] and of chronic damage to the respiratory tract due to presence of
exceptional microflora in the respiratory tract in patients with cystic
fibrosis.
7. 2 Role of microorganisms in COPD
Only a small proportion of smokers progress to COPD (Section 1.5.1).
The effect of cigarette smoke on responses associated with different




determinant of the outcome. Cessation of smoking is the chief measure
that can slow down the decline in lung functions in COPD [Anthonisen et
al., 1994], Microbial pathogens in COPD as agents boosting inflammation
and inflicting tissue damage have been considered as additional important
deleterious factors (1.5.5.1).
Chronic lower respiratory tract bacterial colonisation is a hallmark of
COPD (Section 1.5.2) [Hill et al., 2000]. Persistence of bacteria e.g., H.
influenzae in the respiratory tract, which is kept relatively sterile in healthy
individuals, can be facilitated by intracellular niches in the mucosal
epithelial cells [Wilson et al., 1986]. The evidence that latent [Hogg,
2001] or persistent [Krivitskaia et al., 1996] viral infections can establish
in the respiratory tract in these patients also supports the hypothesis for a
role ofmicrobial pathogens in COPD.
7. 3 Exacerbations in COPD
Acute exacerbation in the course of COPD entails significant morbidity
and mortality. In addition to the role ofmicrobial pathogens in the chronic
setting, the course of illness is marked with frequent exacerbations in the
symptoms due to acute bacterial infections. Compared with 'mucoid' non¬
infectious exacerbations, 'purulent' exacerbations exhibit increased levels
of myeloperoxidase, neutrophil elastase IL-8 and C-reactive proteins




2001]. Antibiotics are typically prescribed to treat purulent exacerbations
and usually this treatment benefit the patient. Pathophysiologic studies of
exacerbation reveal the role of infection in COPD more clearly. Recurrent
infections in patients with COPD enhance the progression of the
underlying process. There is evidence that not all COPD exacerbation
recover to baseline with respect to symptoms and lung functions
[Seemungal et al., 2000], A proposed course of COPD highlighting the






Figure 7.1. Decline in respiratory functions over the years
expected in healthy individuals or patients with COPD with or





7. 4 Combined effects of cigarette smoke and
infectious agents
Combining the deleterious agents in in vitro assays could be useful method
in depicting the in vivo scheme of events. Infectious agents and cigarette
smoke incite numerous responses in the respiratory tract: cellular
infiltration, e.g., neutorphils [Aaron et al., 2001], lymphocytes [Hogg,
2001] or monocytes [Ofulue et al., 1998]; alter intercellular interactions
resulting from change in the expression of surface antigens and/or cellular
functions, e.g., phagocytosis, or defective natural killer cells [Priet et al.,
2001] (Section 1.5.1.1).
Release of proinflammatory cytokines by cells is facilitated and anti¬
inflammatory cytokines impeded by bacteria or their products.
Inflammation is initiated in bronchoalveolar epithelium, which also
becomes its first main target [Takizawa et al., 1998; Khair et al., 1994],
Antibodies to various pathogens in COPD patients might be increased
[Bakri et al, 2002; Lieberman et al., 2001] although their role in
inflammation is less well explained.
Remodelling, parenchymal destruction, mucosal changes occur due to
inflammatory cytokines and direct effects of deleterious agents [Jeffery,




7. 5 Models used in the present study
Commonly described pathogens in COPD, H. influenzae, S. pneumoniae
and M. catarrhalis, and RSV were tested in these studies. The system using
human peripheral blood monocytes [Gordon & Read, 2002] obtained from
blood donors indicate individual differences in inflammatory responses to
these common bacterial pathogens and cigarette smoke (Chapter3). Use of
the monocyte cell line provided consistent genetic background to assess the
effects of the individual bacterial strains and the effects of cigarette smoke
[Guerrero-Plata et al., 2001], It provided a model to examine the difference
in expression of cell surface antigens due to viral infection (Chapter 4) and
inflammatory and other responses to these agents (Chapter 6). Comparison
of bacterial binding to monocytes and epithelial cells not only informed a
more inclusive understanding of the effects of concurrent viral infection,
but also improved the validity of the model due to the contrasting results of
binding obtained with the two cell types (Chapter 5).
7. 6 Main conclusions
There is ample epidemiologic and clinical evidence to indicate the role of
microbial pathogens in COPD (Section 1.5.2.1). Numerous experimental
studies have examined their role using in vitro models [Inoue et al., 2003;
O'Rielly, 1995]. The major conclusions of the current study can be




peripheral blood monocytes exposed to cigarette smoke extract. There was
evidence in the data pointing to extreme responses in some (blood) donor
ofmonocytes; 2) RSY infection increased expression of potential bacterial
receptor molecules on epithelial cells, while decreased their expression on
monocytes. This finding implied that RSV infection resulted in higher
bacterial load whereas reduced the proficiency of the system to deal with
that load; 3) Not only that monocytes did not bind bacteria as well due to
RSV-infection but also they did not perform as well in internalising and
killing them.
7. 6. 1 Immunomodulatory effects of Virus infection
Viruses influence the host in various ways. They modify immune system
with consequential higher susceptibility to infections and immune-
mediated diseases. Human immunodeficiency virus, Epstein Bar virus
[Hillary et al., 1999; Porcu & Caligiuri, 2000] and cytomegalovirus
(CMV) [Mocarski, 2004; Boeckh & Nichols, 2003] are well recognized
immunomodulatory agents predisposing individuals to secondary
bacterial, fungal and protozoal infections. Myxoma viruses release
immunologically active proteins that simulate complement and
chemokines [Barrett et al., 2001; Kotwal, 2000]. Varicella Zoster Virus
demonstrates immunomodulatory effects during the primary infection, and
during persistence and reactivation phases through interference with CD4




virus-6 and -7 might predispose the individuals to infection with CMV
[Singh, 2000]. Genomic sequences for immunomodulatory proteins, e.g.,
complement control proteins, have been mapped in herpesviruses and
poxvirus [McFadden & Murphy, 2000].
Respiratory tract viruses usually cause acute infection involving cell
surface changes, cytokine production and tissue damage; this phase is
followed by clearance of pathogens and repair of tissue. Their persistence
in the respiratory tract in certain patients groups might provide an ongoing
source of injury and alteration in inflammatory and immune mechanisms.'
mechanism leading to persistent infection with adenovirus are mediated by
interference with antigen presentation on the surface of cells. Endogenous
virus proteins resist presentation with MHC-1 and impede apoptosis of
infected cells by TNF [Burgert & Blusch, 2000]. Persistence of RSV [
Krivitskaia, et al., 1996] compounded by chronic colonisation with
respiratory tract bacterial pathogens in COPD might provide sufficient
stimulus to cause injury and alteration in the inflammatory and immune
mechanisms.
Immunomodulatory effects of respiratory viruses are not, however, well
described except for influenza virus. Secondary pneumonia with S. aureus
following influenza virus infection in the elderly is a widely documented
complication. This effect results from numerous factors including lung




findings of the present study identify RSV as disabling monocytes in the
multitude of their functions: bacterial binding, internalisation, bacterial
killing and inadequate production of cytokines. These findings might be
more significant in the light of evidence of persistence ofRSV infection in
the lungs in patients with COPD and colonisation with bacteria.
7. 6. 2 Smoking and infection
Sexually transmitted human papillomavirus is more likely to cause cervical
carcinoma in female patients who also smoke cigarettes [Severson et al.,
2001; Castellsague & Munoz, 2003], although the pathogenesis is not clear.
Epidemiological studies indicate smoking a risk factor for severe pneumonitis
and admission to ITU due to Varicella Zoster virus infection [Frangides &
Pneumatikos, 2004; Harger et al., 2002; Jones et al., 2001]. Interaction of
effects of smoking and infections has been described in Section 1.5.4.
7. 7 Implications of the conclusions
7. 7. 1 Individual variations in inflammations response
Individual genetic polymorphisms are a primary source of variations
among individuals' inflammatory responses to cigarette smoke and
infections (Section 1.1.5). Cytokine profiles are also determined by inter¬
species variations and those between the members of the same species of
pathogens. Complexity is further increased by the presence of both virus




might induce inflammatory responses with qualitative and quantitative
differences, but also they might also be differently affected by
antibacterial or antiviral activity of cytokines induced. Some of the
cytokines have simultaneous anti-pathogen activity and potential to cause
tissue injury. On experimental level, there were contrasting differences
among various monocyte cell lines in their cytokine profiles and
phagocytic functions [Guerrero-Plata et al., 2001; Panuska et al., 1994;
Frank et al., 1994], These factors make difficult any attempt of
generalising the pathophysiological changes in the respiratory tract during
cigarette smoking and concurrent infections. In spite of these complexities,
the course of clinical illness in COPD is relatively well defined, and might
allow selection of appropriate management strategies. The following areas
of interest could be a focus for further development.
7. 7. 2 Further research
There are three areas of investigation into the role of infection in COPD
need further work:
1) Isolation of bacterial species from routine respiratory specimens
from patients with COPD does not necessarily indicate infection.
This necessitates investigation into methods to determine densities
and extents of colonisation by bacterial flora during exacerbations
and stable periods "in the course of COPD. Results of such studies




2) The presence of bacteria in the normally sterile lower respiratory
tract whether during stable COPD or acute exacerbation warrants
investigation into their role in inflammation;
3) Possible changes in the growth patterns of bacteria might be due to
the appearance of as yet unrecognised host factor(s) in the
respiratory tract, changes in the bacterial phenotype {van Alphen,
Jansen, et al. 1995 194 /id} or virus infections. Viral infection can
increase bacterial load and possibly the extent of bacterial
colonisation in the respiratory tract. The changes in the milieu of
the lungs during exacerbation, modified by the genetic factors,
disturb the fine-tuning of the cytokine production contributing to
chronic inflammation (Figure 7.2). Interactions between virus and
bacterial pathogens, cytokines and chemokines leading to
inflammation and tissue damage are illustrated in Figure 7.3;
4) The model used in these studies could be extended to examine the
effects of adenovirus, influenza virus and other respiratory tract
viruses;
5) A population-based longitudinal study to examine the combined
effects of smoking and infectious agents on cytokine production,
lung functions and clinical features would be complementary to the
observations made by this study;
6) It might be also pertinent to compare model of pathogenesis in
COPD with other models of chronic respiratory inflammatory


























Figure 7.2. Schematic representation of events leading to chronic
obstructive pulmonary disease (COPD) and episodes of




Figure 7.3. Schematic diagram of interactions between various
components of inflammatory cascade leading to tissue damage.
7. 7. 3 Future Strategies
Cessation of smoking is, of course, the most important single step to
prevent, and arrest progression in, COPD. Viral infections in COPD
usually do not get treated. Their persistence makes appropriate treatment
even more important to prevent secondary bacterial disease, cytokine over¬




consistent in application of policies of using available vaccinations and
treatment in the log term care plans in these patients. Although sterility of
the respiratory tract might be a difficult goal to achieve, keeping a low
bacterial load with prophylactic antibiotics might be beneficial in term of
preventing chronic injury by pouring of cytokines. Anti-cytokine therapy,
unless profoundly fine-tuned, might predispose individuals to infections,
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Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity
and mortality world-wide. The precise sequence of events in COPD is not
completely understood. Inflammation in the airways has been unanimously
seen by researchers as a pivotal factor, and cigarette smoking is, without doubt,
the main cause. A large proportion of heavy smokers, however, does not suffer
with COPD, suggesting a role of additional risk factors in pathogenesis. The
inflammatory response to cigarette smoke and infectious agents is determined
by the host's genetic composition. Cigarette smoking, by altering the surface
milieu of respiratory mucosa and by causing immunosuppression, increases the
susceptibility of individuals to infection with respiratory viral and bacterial
pathogens. Virus infection has also been recognised as a susceptibility factor for
secondary bacterial infection. An investigation into the role of individual
genetic variations in inflammatory cell and cytokine production and non-host
factors involved in COPD forms the basis of the development of more effective
strategies to intervene in pathogenesis, progression and exacerbation of COPD.
The aims of this article are to review the evidence for predisposing factors for
COPD, with a particular emphasis on respiratory tract infections, and to
examine those findings in relation to individual genetic variations and their
interactions for induction of pro-inflammatory cytokine production in the
respiratory tract.
© 2001 Lippincott Williams & Wilkins
Keywords: chronic obstructive pulmonary disease, COPD, infection, cigarette
smoking, genetic polymorphism, pathogenesis.
CHRONIC OBSTRUCTIVE flow that do not improve markedly over several
PULMONARY DISEASE (COPD): months of observation. Emphysema is a form of
, DEFINITIONS restrictive lung disease caused by an irreversible
distension of lung acini distal to the terminal
COPD affects 16 million people in the USA alone bronchioles. There is destruction of alveolar[1], and is the fourth leading cause of death [2]. septa but no fibrosis [3]. Chronic bronchitis is
Clinically, COPD presents heterogeneously with characterised by inflammation of large airways,
' atures of emphysema and chronic bronchitis. It and clinicallyJt is characterised by a chronic
Is confirmed by abnormal tests of expiratory productive cough for more than 3 months for at
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least 2 consecutive years in patients in whom
other causes of chronic cough have been ex¬
cluded [4]. Changes of varying severity in the
peripheral airways determine the degree of
airflow obstruction which often accompanies
chronic bronchitis [5]. Airflow obstruction is
common between emphysema, chronic bronchi¬
tis and bronchial asthma, and their relationship
based on this feature is illustrated in Fig. 1.
INFLAMMATION AND COPD
Inflammatory cells
COPD shares many histopathological features
with bronchial asthma [61 but differs from
asthma by the presence of infiltration of inflam¬
matory cells and cytokines [7,8]. Compared with
healthy smokers or non-smokers, smokers with
chronic bronchitis have increased numbers of
macrophages, neutrophils and T cells. Non-
Bronchial
asthma
Fig. 1. Schematic non-proportional representa¬
tion showing subsets of chronic obstructive
pulmonary disease (COPD) patients with em¬
physema, chronic bronchitis and/or bronchial
asthma with features of airflow obstruction
(shaded areas in the box). The patients without
airflow obstruction are not classified as COPD
(areas of circles outside the box). Some bron¬
chial asthmatic patients have reversible airflow
obstruction and are not classified as COPD
(represented by non-shaded area of circle within
the box). Airflow obstruction can be due to
causes other than COPD, e.g. cystic fibrosis
(represented by the area in the box outside the
circles). (Adapted from Am J Respir Crit Care
Med 1995, 152:578-583 with permission from
American Thoracic Society).
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smokers with asthmatic bronchitis show more
eosinophils and mast cells in their bronchoalveo-
lar lavage (BAL) [9]. BAL specimens and
collagenase-dissociated lung tissue from rats
exposed for 6 months to cigarette smoke ex¬
hibited at 1 month a wave of infiltration with
neutrophils which were replaced by macro¬
phages that persisted until the end of observa¬
tion period [10],
Cytokines
Cytokines are present as an intricate network of
soluble signalling substances that elicit and
control inflammation, immune responses, cellu¬
lar growth and fibrosis. Cytokines in the lungs
can be divided into three categories: pro-inflam¬
matory; anti-inflammatory; and growth-stimula¬
tory (Table 1).
Pro-inflammatory cytokines are essential to
combat infections [11—13], but their secretion
in excessive quantities for prolonged periods
can become detrimental to the tissue. Over¬
production of anti-inflammatory cytokines may
hamper the protective role played by pro¬
inflammatory cytokines against noxious agents
[14]. Overproduction of tissue growth factors in
the lungs is often associated with chronic
inflammation and fibrosis.
Tumour necrosis factor (TNF), interleukin (IL)-6
and IL-8 are involved in inflammation in COPD
[15]. Patients who have asthmatic bronchitis but
do not smoke show IL-5 in their BAL speci¬
mens, whereas patients who smoke and have
chronic bronchitis show IL-2, TNF-a and IL-8 in
their BAL specimens [9]. There are conflicting
reports on IL-8 production in COPD [16,17].
TNF-a has a central role in inflammation; it is a
potent inducer of endothelial cells for the
production of intercellular adhesion molecule-1,
which is critical for the recruitment of phago¬
cytes [18]. It activates macrophages and neutro¬
phils, increases cytotoxicity, releases oxygen and
nitrogen radicals [19], IL-6 and IL-8 [20,21] from
inflammatory cells.
Nitric oxide (NO)
NO in human airway tissue is localised to the
airway epithelium, sensory nerves, endothelium,
vascular and airway smooth muscles, and
inflammatory cells [22]. It is thought that, at
moderate concentrations, NO is protective and
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regulatory in function; at higher concentrations,
it acts as a toxic factor. The beneficial pulmonary
vasodilatory, bronchodilatory, and bactericidal
effects are lost in cases where NO production is
low. Higher levels might induce exudate forma¬
tion, DNA-toxicity and cytotoxicity [23].
NO production from alveolar macrophages is
enhanced by virus infection [24] whereas it is
reduced by episodic or habitual smoking [25],




COPD is associated with the total numbers of
cigarettes smoked per year, current smoking
status, smoking at an early age and duration of
smoking [27], More than 80% of smokers, how¬
ever, do not suffer with COPD [28]. The factors
that determine whether the disease is mild and
short-lived or severe and chronic are not clear. In
some individuals, smoking causes well described
histopathological [29], cellular [30] and biochem¬
ical [31] abnormalities in the airways without
causing COPD. These observations indicate the
existence of additional host and environmental
factors that might determine the outcome of the
injury caused by smoking.
Smoking causes mucus gland hypertrophy with
mucus hypersecretion in the proximal airways,
mucous hyperplasia, metaplasia, smooth muscle
hypertrophy and fibrosis in the bronchioles; and
j damage to respiratory bronchioles resulting in
emphysema [32]. Differences in inhaling habits,
smoking style, presence and type of the filter
and the kind of the tobacco smoked might have
effects on the lung pathology in response to
smoking [33]. Shallow inhalation of smoke
resulting in high nicotine uptake and smoke
particle deposition in the airways might be
associated with chronic bronchitis. High carbon
monoxide absorption from alveoli exposed to
smoke in deep inhalation might result in
emphysema [34]. Cigarette smoke in vivo and
in vitro has been shown to affect protective
mechanisms, immune function and inflamma¬
tory balance in the respiratory tract (Table 2).
Infection
Respiratory infection has been postulated to have
a role in pathogenesis and progression of COPD
[45-47]. Treating exacerbations of COPD with
antibiotics when bacteria are isolated is a
common practice. There are, however, two
difficulties with this approach to treating exacer¬
bations: (i) although symptoms such as produc¬
tive cough, purulent sputum and dyspnoea
could be due to infection, a non-infectious cause
might be responsible for the underlying inflam¬
matory process in COPD; (ii) the incidence of
microbial isolates from the respiratory tract
during exacerbation is not usually different from
that during remission.
The airways are constantly bombarded with
microbial agents and there are normally efficient
antimicrobial mechanisms keeping the lungs
relatively sterile. It is likely that more bacteria
colonise the lower airways and cause acute-on-
chronic disease in patients with COPD due to
structural derangement and possibly due to
REVIEWS IN MEDICAL MICROBIOLOGY (2001) 12(2)
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Table 2. Effect of cigarette smoking, or cigarette smoke extracts in in-vitro models, on protecti
mechanisms and immune responses against respiratory tract infection




Altered cell surface antigens
on macrophage cell line
Cigarette smoke deposits on
the epithelium




Cytokines and nitric oxide
Protection against bacterial toxins
and microorganisms
Clearance of particles and
microorganisms
Thinning 35
Slowed down, cilia lost 36
Increased bacterial binding 37
Increased bacterial binding 38
Non-specific bactericidal activity Bactericidal and bacterial uptake 39-42
functions deranged
Bactericidal and antiviral mechanisms Altered expression of surface 43
antigens on immune cells
Bactericidal and pro-inflammatory Increased tumour necrosis factor 44
and decreased nitric oxide
interference with the local anti-bacterial and
clearance mechanisms in areas of the lungs.
Non-typeable Haemophilus influenzae, Streptococ¬
cus pneumoniae and Moraxella catarrhalis are
common bacterial species isolated from patients
during episodes of exacerbation in the course of
COPD and asthma [48-50]. Some recent reviews
[47,51] did not find differences in isolation of
bacterial flora, using routine respiratory speci¬
mens, between patients with exacerbation or
with stable COPD. Studies in which samples
were taken from the lower respiratory tract
have, however, demonstrated differences be¬
tween the two groups [52].
Studies comparing the tracheobronchial micro¬
flora during acute exacerbation and stable
periods in the course of COPD showed signifi¬
cant differences in isolation rates of influenza
virus, respiratory syncytial virus (RSV) [53] and
rhinovirus [54]. Evidence of persistent infection
with RSV was found in patients with COPD
[55].
Compared with uninfected human peripheral
blood monocytes (PBM), PBM infected with
RSV exhibited a significant increase in the
production of TNF and a significant decrease
in production of NO [44].
chronic bronchitis have been demonstrated
Repeated childhood respiratory infections wen
shown to have a greater influence than cigarette
smoking in the later life on the subsequent
development of COPD in later life [56]. Because
passive smoking predisposes to respiratory
infection, passive smoking at an earlier stage
combined with repeated infections might be the
underlying factor predisposing to COPD in their
study.
Other risk factors
The incidence and mortality rates of COPD are
higher in heavily industrialised urban areas [57].
Associations have been found between the
amount of sulphur dioxide and particulate
matter in the air and exacerbation of bronchitis
[58].
Men suffer more than women with respiratory
symptoms [27]. Compared with male smokers,
female smokers, however, suffer a higher degree
of morbidity based on degree of airflow
obstruction [59]. Prevalence of airflow obstruc¬
tion among grain workers was greater in groups
of British origin than those of German or
Eastern European origin [60]. Lower socio¬
economic status is associated with higher
morbidity and mortality due to COPD [27].
Recurrent respiratory virus infections during
childhood
Significant associations between childhood re¬
spiratory infections and the later development of
Smoking predisposes to infection
Smoking affects the respiratory tract in many
ways: increased frequency and/or density of
bacterial colonisation; symptomatic viral and
REVIEWS IN MEDICAL MICROBIOLOGY (2001) 12(2)
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bacterial infection. Compared with non-smokers,
buccal epithelial cells of smokers bound higher
numbers of S. pneumoniae, non-typeable H.
influenzae and M. catarrhalis [61,62], Materials in
a water-soluble' extract of cigarette smoke were
shown to enhance binding of major bacterial
respiratory pathogens to cells of non-smokers
[61].
Various mechanisms, including immuno¬
suppression and cell surface alteration have
been described (Table 2).
Virus infection of the respiratory tract
predisposes to bacterial disease
Clinical, epidemiological and experimental evi¬
dence indicates that virus infection of the
respiratory tract can be a predisposing factor
for bacterial disease [63,64]. Infection of epithelial
cells with RSV increases binding of respiratory
bacterial pathogens to epithelial cells or respira¬
tory mucosa [65,66}. Two mechanisms by which
virus infection could increase binding of bacteria
to epithelial cells are: (i) expression of new virus-
induced cell surface antigens; and (ii) upregula-
tion of host cell antigens that act as receptors for
bacteria [67-69]. Patients with RSV infections
showed a significant rise in antibodies to H.
influenzae, S. pneumoniae and M. catarrhalis [70],
and invasive disease due to pneumococci fol¬
lowed infection with RSV [71]. Invasive infec¬
tions due to pneumococci or H. influenzae were
identified in 26 % of children suffering with RSV
[72]. Similarly, 54 % of cases of invasive infection
with H. influenzae and 47% with pneumococci
also had serological evidence of infections with
respiratory syncytial, parainfluenza or influenza
viruses [73], The ways in which viral infection
can predispose individuals to secondary bacterial
disease are given in Table 3.
GENETIC FACTORS IN
INFLAMMATION
Damage to the respiratory tract might be
associated with the magnitude of the inflamma¬
tory response to bacterial infection. Susceptibility
to and progression of inflammatory conditions
have been associated with polymorphisms in
genes encoding cytokines and major histocom¬
patibility antigens [78,79]. Associations have
been found between certain TNF gene poly¬
morphisms and rheumatoid disease [80],
myasthenia gravis [81], cystic fibrosis [82],
primary biliary cirrhosis [83], and ulcerative
colitis [84]. Predominant pro- or anti-inflamma¬
tory cytokine responses to infectious agents
based on the host genetic make up have been
reported [85].
Gene polymorphism in cytokine production
and susceptibility to infections
Variations in individual susceptibility to infec¬
tion have aroused interest in the investigation of
polymorphism of genes coding for cytokine
production. Immune responses and inflamma¬
tory cytokines in response to infectious agents
have been associated with a number of poly¬
morphisms in genes encoding TNF, IL-6 and IL-
10 (Table 4).
Host genetic factors for vulnerability to
cigarette smoking and COPD
The finding that many cigarette smokers do not
progress into COPD might suggest genetic
polymorphism. Alphai-antitrypsin is an acute
phase protein with anti-protease activities and is
produced in many inflammatory conditions [94].
Alphai-antitrypsin is genetically determined and
low levels have been associated with early onset
,69,77
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Table3. Factors in viral infection considered to contribute to secondary bacterial disease
Refer
e suppression 74,75
°ca' oedema formation and tissue injury. Loss of mucociliary function and decreased bacterial 76
France
formation of exudate that enhances bacterial growth 74"ceased bacterial binding to virus infected cells 65,67
leased phagocytosis 37
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Table 4. Polymorphism of genes encoding for TNF, IL-6 and IL-10 associated with increased
susceptibility to infection and inflammation
Cytokine Polymorphism Comments Reference
TNF G to A transition at position -238
G to A transition at position -308
Point mutations in TNF gene
Alleles exhibiting /Vcol-digestion
IL-6 G to C transition at position -174
IL-10 Substitution at -1082, -819 and
-592 positions
Higher inflammatory response in meningitis
Patients more susceptible to cerebral malaria; higher
production of TNF; differences in ethnic groups
Decrease of TNF expression from cell lines
transfected with the altered gene; patients with
sepsis exhibited point mutations more than control
group; resistance to human cytomegalovirus infection
More patients with fatal sepsis exhibited these alleles
than patients with non-fatal sepsis; finding more
significant in homozygous individuals than the
heterozygous; chronicity of hepatitis B and C
infection; can affect the binding of nuclear factors,
e.g. kappa B, to the promoters regions of the gene
Decreased production; altered binding site for NF-1;
-174 C rare in Afro-Caribbean compared with UK
Caucasians
-1082 G protects against Epstein-Barr virus infection;








panacinar emphysema [95]. Compared with
normal controls, lung function abnormalities
were found more commonly in individuals
heterozygous for the ai-antitrypsin gene; 5-
14% of the population were producing subnor¬
mal quantities of this factor [95,96]. Cigarette
smoking has been found particularly deleterious
to individuals homozygous (and possibly hetero¬
zygous) for cii -antitrypsin gene [96].
Analyses of the incidence of COPD in affected
families, twins and first-degree relatives of
patients with COPD indicate the presence of
additional unknown genetic factors [97,98].
Genetic rather than environmental factors corre¬
lated with lung function in families with
members affected by COPD [98]. PBM from
blood donors exhibited various responses of
TNF and NO production when challenged with
cigarette smoke extract, RSV or both; monocytes
from some individuals demonstrated extreme
responses compared with others tested under
the same conditions [37].
CONCLUSION
Although the precise sequence of events in
COPD leading to airway obstruction is not
completely understood, inflammation in the air¬
ways has been seen unanimously by researchers
as a pivotal factor. Understanding the pathophy¬
siological and molecular mechanisms of inflam-
REVIEWS IN MEDICAL MICROBIOLOGY (2001) 12(2)
mation in the lungs holds the key to the
development of effective intervention strategies.
Inflammation is initiated in bronchoalveolar
epithelium which also becomes its first main
target [99]; it is initiated by cigarette smoking but
other genetic and environmental factors seem
needed to promote it. Recurrent infections, to
which patients with COPD are generally highly
susceptible, enhance the progression of the
underlying process and result in exacerbations.
A proposed course of COPD highlighting the
role of respiratory tract infections in pathogen¬
esis is illustrated in Fig. 2.
There are five areas of investigation into the role





Fig. 2. Decline in respiratory functions over the
years expected in.healthy individuals or patients
with chronic obstructive pulmonary disease
(COPD) with or without episodes of infection
(non-proportional representation).
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(i) Isolation of bacterial species from routine
respiratory specimens from patients with COPD
does not necessarily indicate disease. This
necessitates investigation into methods to deter¬
mine density of colonisation and the areas of
the respiratory tract colonised by bacteria dur¬
ing exacerbations and stable periods in the
course of COPD. Results of such studies might
explain episodes of exacerbation in a proportion
of cases, (ii) The presence of bacteria in the
normally sterile lower respiratory tract, whether
during stable COPD or acute exacerbation,
warrants investigation into their role in inflam¬
mation. (iii) Possible changes in the growth
patterns of bacteria might be due to the
appearance of as yet unrecognised host factor(s)
in the respiratory tract, changes in the bacterial
phenotype [100] or viral infections. Viral infec¬
tion can increase bacterial load and possibly the
extent of bacterial colonisation in the respiratory
tract, (iv) The role of virus infection in priming
or enhancing the inflammatory response to
bacterial components or their products also
needs to be investigated in relation to host
genetic factors and cigarette smoking, (v) Gene
polymorphisms and their effects on different
levels of pro- and anti-inflammatory cytokine
production in response to infection or cigarette
smoke might provide additional insights into
the genetic influence in development of COPD.
These changes in the milieu of the lungs during
exacerbation are expected to disturb the fine-
tuning of the cytokine production contributing
to chronic inflammation (Fig. 3).
' Fi9-3. Schematic representation of events leading to chronic Obstructive pulmonary disease (COPD)
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Abstract
Many epidemiological risk factors identified for sudden infant death syndrome (SIDS) suggest a viral aetiology, e.g.
exposure to cigarette smoke and winter peak, mild respiratory symptoms. Virus infections and bacterial toxins induce cytokine
activity and it has been suggested that uncontrolled inflammatory mediators could be involved in some cases of SIDS. The aim
of this review was to assess the evidence for virus infection in SIDS and to examine those findings in relation to individual
variations in cytokine responses and various pathophysiological mechanisms proposed for STDS such as sleep derangement,
hypoxia, cardiac arrhythmia, vascular hypotonicity and hypoglycaemia. © 1999 Federation of European Microbiological
Societies. Published by Elsevier Science B.V. All rights reserved,
Keywords: Virus infection; Cytokine; Sudden infant death syndrome; Sleep; Cardiac arrhythmia; Hypoxia; Apnea; Hypoglycemia;
Orcadian rhythm; Cortisol
E Virus infections and sudden infant death syndrome
(SIDS)
Extensive epidemiological studies in several coun¬
tries have identified the major risk factors for SIDS.
Many developmental and environmental factors sig¬
nificantly associated with these deaths parallel those
associated with susceptibility of infants and young
children to infectious agents, particularly infections
°t the respiratory tract. These include the age range
affected, a winter peak of SIDS in many countries,
exposure to cigarette smoke and poorer socioeco¬
nomic backgrounds. Case histories of SIDS infants
Corresponding author. Tel.: +44 (131) 650 6616;
Jx: +44 (131) 650 6531: E-mail: m.razafoed.ac.uk
often contain references to mild upper respiratory
symptoms prior to death. Major signs of respiratory
illness (wheezing, drowsiness, vomiting and bouts of
coughing) in these infants during the 2 weeks before
death were not significantly different from infants
matched for age and sex who died from other causes.
There were, however, significant differences in inci¬
dence of minor symptoms, snuffles and occasional
cough, in these groups [I], More deaths due to
SIDS occur in winter months (Table 1) when virus
infections are also prevalent [14-17], Outbreaks of
influenza A virus in children were significantly asso¬
ciated with SIDS, and the association was independ¬
ent of effects of lower atmospheric temperature [18],
SIDS mostly affects the poor in prosperous countries
[19-21] in whom infectious diseases are also rela¬
tively more common. Forsyth et al. [22] found higher
levels of IgG and IgM, but not IgA, in the lungs at
'928-8244/99/S20.00 < 1999 Federation ot" European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
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'No association was found.
necropsy of infants who died of SIDS compared with
infants who died of non-respiratory causes.
While no single agent has been clearly identified as
causing SIDS, many different viruses affecting both
respiratory and gastrointestinal tracts have been
identified in these infants [19] (Table 2). Exposure
to cigarette smoke enhances susceptibility to respira¬
tory virus infections [14], possibly by affecting vari¬
ous arms of the host defences against infection: non¬
specific immune responses [41]; humoral [42] and
cellular immunity [43]; and macrophage functions
[44]. Maternal cigarette smoking during pregnancy
and passive exposure to cigarette smoke are signifi¬
cantly associated with SIDS [5,8,45-51]. Cigarette
smoke might also alter pathophysiological sequelae
of virus infections [52],
Early infancy (2-4 months), when most deaths
from SIDS occur, coincides with a period of declin¬
ing levels of maternal antibodies and immature im¬
mune responses in infants. Breast-feeding in many
Table 2
Reports on respiratory symptoms and virus isolates in cases of SIDS
studies has been shown to be protective against
SIDS [45,53,54], The effect of breast-feeding in rela¬
tion to SIDS was significant in infants of mothers
who were non-smokers [55]. If infectious agents are
involved in SIDS, the protection afforded by breast¬
feeding could be due to the anti-viral and anti-bac¬
terial activities of secretory IgG and oligosaccharides
present in human milk. Oligosaccharides in human
milk have been shown to have antiviral activity [56-
58],
While significant necropsy findings are essentially
absent in SIDS, mild inflammatory changes are com¬
monly reported [59]. Epidemiological and autopsy
studies of SIDS or epidemiological studies of near-
miss infants have provided evidence of virus infec¬
tions (Table 2). Some negative reports on association
between virus infections and SIDS might be attrib¬
uted to early virus infection with symptoms not yet
noticed or not taken as significant by the parents.
Failure to isolate or detect viruses might be due to
late or inappropriate microbiological sampling or
lack of facilities to identify viruses. Newer molecular
techniques have been used to screen for viruses, but
they have not significantly increased the identifica¬
tion rate [29,31].
2. Cytokine levels in virus infections and SIDS
Various hypotheses to explain SIDS have been
postulated. Negative findings at necropsy in infants
who died of SIDS suggest a serious physiological
derangement: hypoxia and apnoea; extreme altera¬
tions in body temperature; hypoglycaemia; hypoten-
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Table 3
Significant increase in cytokines in early phase (2-6 h) of virus infection in different models
Virus Cytokine Model Reference
Influenza IL-1 p. TNF-a. Human peripheral blood leukoeytes [68]
RSV IL-2 RSV-specific peripheral blood T ceils [69]
Cord blood monocyte-derived macrophages [70]
IL-6 Cord blood monocyte-derived macrophages [70]
Nasal secretion [71]
IL-8 Human bronchial epithelial cell line [77]
IL-10, IL-12 Peripheral blood mononuclear cells [69,73]
IFN-y RSV-specific peripheral blood T cells [69]
Murine bronchial alveolar lavage [74]
Cord blood monocyte-derived macrophages [70]
TNF-a Peripheral blood mononuclear cells [73]
Nasal secretion [71]
Rhinovirus IL-8 Respiratory epithelial cells [75]
Nasal secretion [76]
sion; cardiac arrhythmia; or combinations of these
factors. It has been suggested that in extreme cases
interleukin 1 (IL-1), interferon (IFN) and tumour
necrosis factor a (TNF-a) elicited by infections
cause somnolence and hypoxia leading to death
[60,61]. Blackwell et al. [62-64] suggested uncon¬
trolled cytokine responses elicited by combinations
of bacterial toxins, virus infection and/or cigarette
smoke might precipitate a series of events leading
to some of these unexplained deaths. Very high tem¬
peratures observed in some SIDS infants was
thought to be the cause of death [65]; these extreme
temperatures could have been induced by cytokines
such as TNF-a and IL-1. A slight initial derange¬
ment of a few cytokines in response to an apparently
trivial challenge is capable of triggering various cy¬
tokine cascades which might prove lethal. In septic
shock, it is not the number of bacteria present but
the body's response to the bacteria that determines
the severity of illness [66],
Viruses might cause minimal clinical symptoms in
infants but trigger cytokine cascades culminating in
sudden death. Bacterial pathogens or their products,
cigarette smoke, or any combination of these might
similarly amplify the production of proinflammatory
cytokines. Whatever the identity of the agents, a final
common pathway in the pathogenesis of SIDS is
suggested by a combination of factors unique to
SIDS; (1) a higher prevalence in the early hours of
•he morning; (2) an association with presumed sleep;
D) peak incidence of SIDS at 2-4 months; (4) and
absence of gross necropsy abnormalities.
Studies of cytokines in SIDS babies are scarce.
Howat et al. [67] used cells obtained from the lungs
to assess IL-4, IL-5 and IL-10. Significantly higher
numbers of cells stained for the cytokines were found
in SIDS babies compared with controls. Table 3
summarises studies of cytokines in virus infections
for both in vivo and in vitro models.
3. Genetic factors: race and gender
The incidence of SIDS varies significantly between
different ethnic groups [77,78]. In Britain, the inci¬
dence of SIDS among Indian, Pakistani and Bangla¬
deshi families is lower than in the white population.
Infant deaths due to respiratory infections are also
lower than in white families [79], Although low so¬
cioeconomic standards have been significantly asso¬
ciated with SIDS in Britain [80], in Hong Kong,
where many families live in suboptimal circumstan¬
ces, there is also a very low incidence of SIDS [81].
On the other hand, some indigenous populations
have high incidences of SIDS, e.g., American Indi¬
ans, Alaskan natives and Australian Aborigines
[82,83], The criticism that the higher incidence of
SIDS in the Aboriginal infants was due to differences
in diagnosis was addressed by re-examination of all
Aboriginal cases of SIDS and sudden unexpected
death in infancy between 1980 and 1988 and a cor¬
responding random sample of non-Aboriginal cases.
There was no evidence of differences in diagnosis of
SIDS in the two populations [84]. Among Native
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Americans, Eskimos and Australian Aborigines, the
incidence of serious respiratory tract and ear infec¬
tions is also higher [85,86].
Environmental and cultural factors are thought to
contribute to some of these differences. Epidemiolog¬
ical studies indicate that in groups in which smoking
is less prevalent among women, deaths due to SIDS
are lower. Studies on American Indians and Alaskan
natives examined the prevalence of risk factors on
populations in which there was a significant differ¬
ence in incidence of SIDS. From 1984 to 1986 the
incidence of SIDS was 4.6 per 1000 live births among
Indians and Alaskan natives in the northern region
of the USA. In contrast, the incidence among south¬
western Indians was 1.4 per 1000 live births. There
was no significant difference between the incidence of
SIDS in white populations in the two regions with
2.1 and 1.6 per 1000 live births in the north and
southwest regions respectively. Socioeconomic sta¬
tus, maternal age, birth weight or prenatal care
were not significantly different among the Indian
populations in the two areas. The prevalence of ma¬
ternal smoking during pregnancy was exceptionally
high among northern Indians and Alaskan natives
but low among the Southwest Indians [82].
In Britain smoking is more prevalent among lower
socioeconomic groups [87], and both smoking and
poorer socioeconomic conditions were found to be
significant risk factors for SIDS [51,80], Among
Asian women of all social classes, smoking is very
rare [77], and we have suggested that this might con¬
tribute to the lower levels of both SIDS and respira¬
tory deaths in these populations. This could be re¬
lated to reduced frequency or density of colonisation
by potential pathogens or to a lower level of absorp¬
tion of water-soluble components of cigarette smoke
that could enhance inflammatory responses to infec¬
tion.
Polymorphism in individual susceptibility to infec¬
tions is expected. Immune responses and proinflam¬
matory cytokines have been reported to differ in sev¬
eral ethnic groups. In white subjects, a TNF2 variant
at locus TNF-308 was shown to be significantly as¬
sociated with HLA-DR3, which also showed a
strong association with white subjects compared
w'th black populations [88], Important ethnic differ¬
ences were found in the genotype of TNF-a and its
linking to MHC alleles [89].
There appears to be a significant genetic compo¬
nent associated with induction of both pro-inflam¬
matory (TNF-a) and anti-inflammatory (IL-10) cy¬
tokines [90,91], Fatal outcome of meningococcal
disease was significantly associated with low TNF-
a responses and/or high IL-10 responses of first-de¬
gree relatives of the patient [91], Studies on differ¬
ences in pro- and anti-inflammatory responses to vi¬
rus infections have not been carried out in different
ethnic groups.
SIDS affects more male than female infants
[7,49,83]. RSV infection was more common in hos¬
pitalised male infants; the ratio of males to females
was 1.44:1 [92]. Compared with female infants, sig¬
nificantly more males suffered with RSV, influenza
and parainfluenza viruses, rhinovirus and adenovirus
[93].
4. SIDS and sleep
Sleep is physiologically very different from wake¬
fulness. Higher neuronal disinhibition in sleep is as¬
sociated with changes in cardiovascular and respira¬
tory systems, as witnessed in adult sleep apnoea
syndrome. Most SIDS cases have been reported in
infants during presumed sleep in the early hours of
the morning [94], IL-1, TNF-a and IFN-y have been
shown to be somnogenic in physiological conditions
and during infections [95]. Since hypoxia has been
proposed as a possible cause of SIDS, the effects of
virus infections and cytokines on hypoxia are re¬
viewed below (Section 8).
Circadian rhythm can affect the numbers of im¬
mune cells in circulation. Compared with wakeful¬
ness, there was an acute reduction of the number
of natural killer cells, monocytes and all subsets of
lymphocytes during nocturnal sleep in healthy men
[96].
5. Cytokines, Cortisol and circadian rhythm
Circadian rhythm is a characteristic of neuroendo¬
crine pathways. Two important neuroendocrine hor¬
mones, Cortisol and melatonin, were suggested to
affect diurnal variations in the levels of IFM-y and
IL-10 observed with an in vitro model in which
V/ W. Ruzu, C.C. Bluckwell/FEMS Immunology unci Medical Microbiology 25 (!')W) 55-% S9
whole blood was challenged with bacterial LPS or
tetanus toxoid. INF-y was highest and IL-10 was
lowest during the early morning hours and corre¬
lated negatively with plasma Cortisol and positively
with melatonin [97], Urinary free Cortisol levels in
subjects between 1.8 and 17 years were found to be
positively correlated with age [98], Impairment in the
ability to control inflammatory mediators resulting
from low night-time Cortisol levels associated with
changes accompanying development of adult-type
night-time temperature rhythm was proposed as a
'window of vulnerability' to SIDS [63], Viral infec¬
tions might hinder Cortisol release from the adrenals
in response to stimulation by corticotrophin releas¬
ing hormone (CRH) from the pituitary gland. Stim¬
ulation by CRH resulted in a reduced or a blunted
Cortisol response in some men with HIV infection
[99].
Sleep was associated with enhanced production of
IL-2 by CD3+ T cells but not of IL-lp, TNF-a or
IL-6, and the effects were independent of Cortisol
levels [96,100], Uthgenannt et al. [101] found similar
effects of sleep on IL-2 production. Monocytes from
subjects obtained during nocturnal sleep were stimu¬
lated in vitro by LPS from Escherichia coli\ they
showed significantly higher TNF-a and IL-1 [3 com¬
pared with monocytes obtained when the subjects
were awake. Association of cytokines and sleep was
further substantiated in patients with obstructive
sleep apnoea syndrome. These patients experience
disturbed sleep patterns, less sleep at night and spells
of sleep during the day. Nocturnal peaks of TNF-a
disappeared in these patients and a daytime peak
had developed [102]. Cortisol was shown to have
damping effect on the somnogenic cytokines, IL-1,
IL-2, TNF-a and IFN. While Cortisol is induced
by virus infections, its production in response to vi¬
rus infections is not as efficient compared with the
response to bacterial infections [98].
h- Infections, cytokines and sleep regulation
Sleep, like fever, is a common manifestation of
infection. Most deaths attributed to SIDS occur dur-
lng presumed sleep between midnight and 8.00 a.m.
when many somnogenic cytokines (IL-1, IL-2, 11-6,
TNF-a, and IFN) are at a peak. Human recombi¬
nant TNF-a and IL-1 were shown to cause or pro¬
long slow-wave sleep and suppress the rapid eye
movement (REM) phase of sleep [103,104], Similar
effects were observed in rabbits with human recombi¬
nant IFN [105]. Immunisation and strain difference
in mice were associated with dissimilar sleep pattern
after challenge with influenza virus; some mice had
deeper, more prolonged sleep than others [106].
Virus-associated double-stranded RNA extracted
from mice infected with influenza virus and a syn¬
thetic double-stranded RNA were shown to cause
flu-like symptoms and non-REM sleep in rabbits
[107]. Serum anti-viral activity, probably due to
IFN, was associated with sleep [107,108]. Bacteria
and their products have similar somnogenic effects
[109,110].
7. Hypoxia, reflex apnoea and SIDS
Airway obstructions, other than suffocation, lead¬
ing to chronic and acute hypoxia have been postu¬
lated as a cause of death in SIDS infants. Profound
hypoxia and infection were necessary experimental
conditions to produce intrathoracic petechiae in
rats, a characteristic of the autopsy changes observed
in SIDS infants [59], Levels of Cortisol in infants who
died of SIDS without petechiae (9 pg per 100 ml)
were lower than that of SIDS infants showing intra¬
thoracic petechiae at necropsy (25 pg per 100 ml).
SIDS infants with petechiae also showed 20% more
muscle mass in pulmonary arteries compared SIDS
infants without petechiae, indicating the existence of
chronic hypoxia/hypoventilation in the first group
[59]. Rognum and Saugstad [111] suggested tissue
hypoxia was a cause of death from comparison of
hypoxanthine levels in vitreous humor from SIDS
and comparison groups included in their study. Mul¬
tiple brief apnoeic attacks were noticed in infants
who eventually died of SIDS [112], Some workers
have, however, argued against hypoxia as a possible
cause of SIDS [113,114],
8. Effects of virus infections and cytokines on hypoxia
and reflex apnoea
Reinforced reflex apnoea was observed in infants









Fig. 1. Schematic representation of events leading to a final common pathway of physiological derangement and sudden death.
with infection due to RSV compared with uninfected
infants [115], and this was suggested to be one of the
mechanisms of sudden death in some infants who
suffered mild respiratory symptoms before death
[116]. Apnoeic attacks can cause near-miss SIDS in
infants with RSV infection [117].
Cytokines and regulation of vascular smooth
muscle cell contractility and vascular tone
Proinflammatory cytokines (TNF-a, IL-1, IFN-y)
released in response to viral infections modulate vas-
Cl|lnr contractility primarily through regulation of
nitric oxide (NO), a potent vasodilatory factor
[118]. Vascular endothelial NO production is consti-
tutively controlled and modulated by bradykinin,
acetylcholine and epinephrine. Baseline vascular
tone is maintained in partial relaxation due to NO
[118,119]. Vascular smooth muscle cells can also re¬
lease vast amounts of NO when stimulated by the
proinflammatory cytokines [120].
10. Cardiac arrhythmia, SIDS and cytokines
Gunteroth reviewed studies on SIDS relating to
possible cardiac causes of death and concluded a
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cardiac theory of SIDS was not sustainable [121],
There is, however, some evidence that arrhythmia
without structural cardiac abnormalities might cause
sudden death in SIDS. REM sleep is a vulnerable
phase for cardiac arrhythmia [113], Abnormally in¬
creased heart rates during sleep were reported in
subsequent siblings of SIDS infants [122] and near-
miss infants [123], Long QT syndrome is character¬
ised by ventricular fibrillation and, sometimes, fatal
syncopal attacks [124], Long QT interval was consid¬
ered to be an important risk factor for SIDS in a
prospective study of a large group of infants [125],
Arrhythmia has been reported as a side effect of
treatment of patients with metastatic cancer with
TNF, IL-2 and IFN-y [126,127], Negative ionotropic
and arrhythmogenic effects were observed in myo¬
cytes cultured in IL-1, IL-2, IL-3 and TNF-a [128],
11. Hypoglycaemia and cytokines
Acute hypoglycaemia has been associated with de¬
ranged cytokine levels. Flypoglycaemia was induced
in rats with TNF-a without changes in the insulin
levels; it was ameliorated with corticosteroid therapy
[129]. Hypoglycaemia in an elderly patient with non-
Hodgkin's lymphoma was associated with normal
insulin and insulin-like hormone levels but with
high TNF-a levels. It was normalised after correct¬
ing TNF-a by cytoreductive therapy [130], TNF-a-
like molecules might be responsible for hypoglycae-
mia observed in cerebral malaria [131]. Staphylococ¬
cal enterotoxin B caused weight loss and hypoglycae¬
mia in rats. This was prevented by antibodies against
IFN-y; levels of TNF-a and IL-6 remained un¬
changed [132],
12. Conclusion
Animal models indicate that the inflammatory re¬
sponse to viral infections could have a priming effect
via INF for induction of high levels of mediators
such as TNF-a or nitric oxide [133]. We proposed
'he hypothesis that virus infection, alone or in con¬
junction with bacteria, their toxins or cigarette
smoke, might induce an uncontrolled cytokine cas¬
cade which could contribute to the events leading to
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sudden deaths in infants. Virus infection has been
demonstrated to enhance bacterial binding to epithe¬
lial cells in vitro [134-136]. Compared with infants
with no signs of respiratory infection, infants with
respiratory viral infections have significantly more
bacteria and more species of bacteria in their nasal
secretions when sleeping in the prone position; and,
the species of bacteria are similar to those isolated
from SIDS infants at autopsy [137], Fever, prone
sleeping and blocking of nasal passages with secre¬
tions could induce a micro-environment in which the
permissive temperature for induction of potent bac¬
terial toxins is obtained. Virus infections have been
demonstrated to enhance the lethality of bacterial
toxins in animal models [138] and to enhance induc¬
tion of inflammatory mediators from human cells in
vitro [139,140],
Physiological systems regulating cytokines, sleep
and body temperature are closely interrelated. In¬
fants develop circadian rhythm during the age range
in which most SIDS cases occur. During the period
following the switch to adult-like temperature
rhythms, the physiological changes that occur in en¬
docrine responses and hormone levels might result in
infants producing lethal amounts of proinflamma¬
tory cytokines in response to infectious agents and/
or exposure to cigarette smoke. The uncontrolled
production of these cytokines could affect any of
the mechanisms proposed as possible causes for
SIDS [133] (Fig. 1).
Acknowledgements
This work was supported by grants from Chest,
Heart and Stroke, Scotland and The Scottish Cot
Death Trust.
References
[1] Gilbert. R.E., Fleming. P.J.. Azaz. Y. and Rudd. P.T. (1990)
Signs of illness preceding sudden and unexpected death in
infant. Br. Med. J. 300. 1237-1239.
[2] Jones, M.E.. Ponsonby. A.L., Dweyer, T. and Gilbert. N.
(1994) Relation between climatic temperature and sudden in¬
fant death syndrome differs among communities: results from
tin ecologic analysis. Epidemiology 5. 332-336.
[3] Douglas, A.S.. Allan, T.M. and Helms, P.J. (1996) Seasonality
92 M. W. Raza. C.C. BlackuvlllFEMS Immunology and Medical Microbiology 25 (IW9) 85-96
and the sudden infant death syndrome during 1987-9 and
1991-3 in Australia and Britain. Br. Med. J. 312. 12SI—1383.
[4] Douglas. A.S.. Gupta. R.. Helms. P.J. and Jollitfe. I.T. (1997)
Month of birth as an independent variable in the sudden in¬
fant death syndrome. Paediatr. Perinatal Epidemiol. II. 57-
66.
[5] Jukious, S.A. (1997) There is still seasonality in sudden infant
death syndrome in England and Wales. J. Epidemiol. 51, 101 —
102.
[6] Gupta. R., Helms. P.J.. JollifTe, l.T. and Douglas. A.S. (1996)
Seasonal variation in sudden infant death syndrome and bron¬
chiolitis - a common mechanism. Am. J. Respir. Crit. Care
Med. 154. 431—435.
[7] Hatton, F„ Bouvir-Colle, M.H., Barois. A., Imbert, M.C.,
Leroyer. A.. Bouvier, S. and Jougla, E. (1995) Autopsies of
sudden infant death syndrome - classification and epidemiol¬
ogy. Acta Paediatr. 84, 1366-1371.
[8] Williams, S.M., Taylor. B.J. and Mitchell, E.A. (1996) Sudden
infant death syndrome: insulation from bedding and clothing
and its etfect modifiers. The National Cot Death Study
Group. Int. J. Epidemiol. 25, 366-375.
[9] Leiss, J.K. and Suchindren. C.N. (1993) Age and season of
birth in sudden infant death syndrome in North Carolina,
1982-1987: no interaction. Am. J. Epidemiol. 137, 207-212.
[10] Milerad, J., Norvenius, G. and Wennergren, G. (1993) SIDS
outdoors and seasonality in Sweden 1975-1987. Acta Pae¬
diatr. 82. 1039-1042.
[11] Beal, S.M. and Porter. C. (1991) Sudden infant death syn¬
drome related to climate. Acta Paediatr. Scand. 80, 278-
287.
[12] Knobel, H.H., Yang, W.S. and Chen, C.J. (1994) Sudden in¬
fant death syndrome among Chinese. Lancet 344 (8925).
820.
[13] Watanabe, N., Yotsukura, M„ Kadoi. N„ Yashiro, K„ Saka-
noue, M. and Nishida. H. (1994) Epidemiology of sudden
infant death syndrome in Japan. Acta Paediatr. Jpn. 36..
329-332.
[14] Omenaass, E., Bakke, P., Haukenes, G.. Hanoa, R. and Guls-
vik, A. (1995) Respiratory virus antibodies in adults of a
Norwegian community: prevalences and risk factors. Int. J.
Epidemiol. 24. 223-231.
[15] Bishop, R.F. (1996) Natural history of human rotavirus in¬
fection. Arch. Virol. 12, 119-128.
[16] Noah. N.D. (1989) Cyclical patterns and predictability of in¬
fection. Epidemiol. Infect. 102, 175-190.
[17] Anonymous (1991) Communicable Disease Report. Surveil¬
lance of respiratory syncytial virus infection: England and
Wales 1988-91. CDR 1. 27.
[18] Nelson, K.E.. Greenberg, M.A.. Mufson. M.A. and Moses,
V.K. (1975) The sudden infant death syndrome and epidemic
viral disease. Am. J. Epidemiol. 101. 423-430.
[19] Fleming. K. (1992) Upper respiratory tract inflammation and
detection of viral nucleic acids. J. Clin. Pathol. Suppl. 45. 17-
19.
PO] Schluter. P.J.. Ford. R.P.. Mitchell. E.A. and Taylor. B.J.
(1997) Housing and sudden infant death syndrome. New Zea¬
land Cot Death Study Group. NZ Med. J. 110. 243-246.
[21] Wolkind. S.. Taylor. E.M.. Waite. A.J.. Dalton. M. and Em¬
ery, J.L. 11993) Recurrence of unexpected infant death. Acta
Paediatr. 82. 873-876.
[22] Forsyth. K.D., Weeks. S.C.. Koh. L„ Skinner. J. and Bradley.
J. (1989) Lung immunoglobulin in the sudden infant death
syndrome. Br. Med. J. 298. 23-26.
[23] Williams, A.L. (1980) Tracheobronchitis and sudden infant
death syndrome. Pathology 12. 73-76.
[24] Czegledy-Nagy, E.N., Cuts. E. and Becker, L.E. (1993) Sud¬
den infant death syndrome under one year of age. Pediatr.
Pathol. 13, 671-684.
[25] HolTman, H.J., Damns. (C., Hilman. L. and Krongrad. E.
(1988) Risk factors for SIDS: results of the National Institute
of Child Health and Human Development SIDS Cooperative
epidemiological study. Ann. NY Acad. Sci. 533. 13-30.
[26] Bentham, G. (1994) Population mixing and sudden infant
death syndrome in England and Wales. Int. J. Epidemiol.
23, 540-544.
[27] Ford, R.P.K., McCormick, H.E. and Jennings, L.C. (1990)
Cot death in Canterbury (NZ): Lack of association with res¬
piratory virus patterns. Aust. NZ J. Med. 20, 798-801.
[28] Zink, P.. Drescher. J., Verhagen, W., Filk, J. and Milbradt. H.
(1987) Serological evidence of recent influenza virus A (H3N2)
infections in forensic cases of the sudden infant death syn¬
drome (SIDS). Arch. Virol. 93, 223-232.
[29] An, S.F.. Gould, S„ Keeling, J.W. and Fleming, K.A. (1993)
Role of respiratory viral infection in SIDS: detection of viral
nucleic acid by in situ hybridization. J. Pathol. 171, 271-
278.
[30] Williams, A.L., Uren, E.C. and Brotherton, L. (1988) Respi¬
ratory viruses and sudden infant death syndrome. Br. Med. J.
288, 1491-1493.
[31] Cubie, H.A., Duncan, L.A., Marshall, L.A. and Smith, N.M.
(1997) Detection of respiratory syncytial virus nucleic acid in
archival post-mortem tissue from infants. Pediatr. Pathol.
Lab. Med. 17, 927-938.
[32] Las Heras. J. and Swanson, V.L. (1983) Sudden death of an
infant with rhinovirus infection complicating bronchial asth¬
ma: case report. Pediatr. Pathol. I. 319-323.
[33] Bajonwoski, T.. Wiegand, P., Pring-Akerblon, P., Adrian, T.,
Jorch, G. and Brinkmann. B. (1996) Detection and signifi¬
cance of adenoviruses in cases of sudden infant death. Virch-
ows Arch. 428. 113-118.
[34] Shimizu. C.. Rambaud, C.. Cheron. G.. Rouzioux, C., Loz-
inski, G.M., Rao, A„ Stanway. G., Krous, H.F. and Burns,
J.C. (1995) Molecular identification of viruses in sudden infant
death associated with myocarditis and pericaridits. Pediatr.
Infect. Dis. J. 14. 584-588.
[35] Bettiol, S.S., Radclilf, F.J.. Hunt, A.L. and Goldsmid. J.M.
(1994) Bacterial flora of Tasmanian SIDS infants with special
reference to pathogenic strains of Escherichia coli. Epidemiol.
Infect. 112, 275-284.
[36] Carpenter. R.G. and Gardner. A. (1990) Environment find¬
ings and sudden infant death syndrome. J. Infect. 18. 125-130.
[37] Uren, E.C.. Williams. A.L., Jack. I. and Rees. J.W. (I9S0)
Association of respiratory virus infections with sudden infant
death syndrome. Med. J. Aust. I. 417-419.
VI. II'. RiUli. C.C. BlackwellI FEMS fmnumoh ">Y ami McJiral Microhiiilogr 25 (IWQ) ,y5-% 93
[38] Brooks. J G. (1993) Unravelling (he mysteries of sudden in¬
fant death syndrome. Curr. Opin. Pediutr. 5, 266-272.
[39] Grangeot-Keros. L.. Braver. M.. Briand. E„ Gut. J.P.. Tur-
koglu. S.. Chretien. P.. Emilie. M„ Dussaiz. E.. Lazizi. Y. and
Dehan. M. (1996) Enterovirus in sudden unexpected death in
infants. Pediatr. Infect. Dis. J. 15, 123-128.
[40] Yolken, R. and Murphy. M. (1982) Sudden infant death syn¬
drome associated with rotavirus infection. J. Med. Virol. 10,
291-296.
[41] Nair. M.D.. Kronfol, Z.A. and Schwartz. S.A. (1990) Effects
of alcohol and nicotine on cytotoxic functions of human lym¬
phocytes. Clin. Immunol, lmmunopathol. 54, 395-409.
[42] Mili. F., Flanders, W.D., Boring, J.R., Anert. J.L. and Des-
tefeno, F. (1991) Association of race, cigarette smoking and
smoking cessation to measures of immune system in middle-
age men. Clin. Immunol. Immunopathol. 59, 187-200.
[43] Ginns. L.C.. Miller, L.G., Doldenheim, P.D., Coldstein, G.
and Bria, W.F. (1984) Alterations in immunoregulatory cells
in the lungs and smoking. J. Clin. Immunol. 25. 905-945.
[44] Cosio, F.G.. Hoidal. J.R., Douglas, S.D. and Michael, A.F.
(1982) Binding of soluble immune complexes by human
monocytes and pulmonary macrophages: effects of cigarette
smoking. J. Lab. Clin. Med. 100, 469-476.
[45] Golding, J. (1993) Breast-feeding and sudden infant death
syndrome. In: Report of the Chief Medical Officer's Expert
Group on the Sleeping Positions of Infant and Cot Death, pp.
77-82. HMSO. London.
[46] Moller, L.F. (1994) Smoking and sudden infant death (Ab¬
stract). Ugeskr. Laeg. 156, 7197-7199.
[47] Ponsonby. A.L., Dwyer, T„ Kasl. S.V. and Cochrane, J.A.
(1995) Tasmanian SIDS case-control study; univariable and
multivariable risk factor analysis. Paediatr. Perinatal. Epide¬
miol. 9, 256-272.
[48] Haglund, B„ Cnattingius, S. and Otterblad-Olausson, P.
(1995) Sudden infant death syndrome in Sweden, 1983—
1990: season at death, age at death, and maternal smoking.
Am. J. Epidemiol. 142, 619-624.
[49] Sanghavi, D.M. (1995) Epidemiology of sudden infant death
syndrome (SIDS) for Kentucky infants born in 1990: mater¬
nal, prenatal, and perinatal risk factors. J. Kentucky Med.
Assoc. 93, 286-290.
[50] Schellscheidt, J., Ott, A. and Jorch, G. (1997) Epdemiological
features of sudden infant death after a German intervention
campaign in 1992. Eur. J. Pediatr. 156, 655-660.
[51] Brooke. H„ Gibson, A„ Tappin. G. and Brown, H. (1997)
Case-control study of sudden infant death syndrome in Scot¬
land, 1992-5. Br. Med. J. 314, 1516-1520.
[52] Raza. M.W., Essery, S.D., Blackwell. C.C., Ogilvie. M.M.,
Elton. R.A. and Weir. D.M. (1999) Infection with respiratory
syncytial virus and water soluble components of cigarette
smoke alter pro-inflaminatory function of human monocytes.
FEMS Immunol. Med. Microbiol. 24. 387-394.
[53] Mitchell, E.A.. Taylor, B.J., Ford. R.P.. Stewart, A.W., Be-
croft, D.M., Thompson. J.M., Scragg. R.. Hassall. I B.. Barry.
D.M. and Allen. E.M. (1992) Four modifiable and other risk
factors for cot death: the New Zealand study. J. Paediatr.
Child Health 28. S3-S8.
[54] Ford. R.P.. Taylor. B.J.. Mitchell. E.A.. Enright. S.A.. Stew¬
art. A.W.. Becroft. D.M.. Scragg, R,. Hassall, I.B.. Barry.
D.M.. Allen. E.M. and Roberts. A.P. (1993) Breast feeding
and the risk of sudden infant death syndrome. Int. J. Epide¬
miol. 22. SS5-890.
[55] KIonolF-Cohen. H.S.. Edelstein, S. L.. Lefkowitz. E.S.. Srini-
vasan. I.P., Kaegi, D.. Chang. J.C. and Wiley. K.J. (1995) The
effect of passive smoking and tobacco exposure through breast
milk on sudden infant death syndrome. J. Am. Med. Assoc.
273. 795-798.
[56] Bauchner. H.. Leventhal, J.M. and Shapiro. E.D. (1986) Stud¬
ies of breast-feeding and infections: how good is the evidence.
J. Am. Med. Assoc. 256, 887-892.
[57] Victora, C.G.. Smith, P.G.. Vaughan, J.P.. Nobre, L.C.. Lom-
bardi. C„ Teixeira. M., Moreira, L.B. and Gigante, S.C.
(1987) Evidence of protection by breast-feeding against infant
deaths from infectious diseases in Brazil. Lancet ii, 319-322.
[58] Peterson, J.A., Patton, S. and Hamosh, M. (1998) Glycopro¬
teins of the human milk fat globules in the protection of
breast-fed infants against infections. Biol. Neonate 74. 143-
162.
[59] Naeye, R.L.. Fisher. R., Rubin, H.R. and Derners. L. (1980)
Selected hormone levels in victims of sudden infant death
syndrome. Paediatrics 65. 1134-1136.
[60] Thrane, P.S., Maehlen, J., Stoltenberg. L. and Brandtzaeg. P.
(1994) Retrograde axonal cytokine transport: a pathway for
immunostimulation in the brain inducing hypoxia and sudden
infant death? Med. Hypotheses 44, 81-84.
[61] Sayers, N.M.. Drucker, D.B. and Grencis. P.K. (1995) Cyto¬
kine may give insight into mechanism of sudden infant death
syndrome. Med. Hypotheses 45, 369-374.
[62] Blackwell, C.C., Weir, D.M., Busuttil, A., Saadi, A.T., Essery,
S.D., Raza, M.W.. James, V.S. and Mackenzie, D.A.C. (1994)
The role of infectious agents in sudden infant death syndrome.
FEMS Immunol. Med. Microbiol. 9, 91-100.
[63] Blackwell, C.C., Weir, D.M. and Busuttil. A. (1995) Infectious
agents, the inflammatory responses of infants and sudden in¬
fant death syndrome (SIDS). Mol. Med. Today 59, 72-78.
[64] Blackwell. C.C.. Weir. D.M. and Busuttil. A. (1997) Infectious
agents and SIDS: analysis of risk factors and preventive meas¬
ures. J. SIDS Infant Mortal. 2, 61-76.
[65] Sunderland, R. and Emery, J.L. (1981) Febrile convulsions
and cot death. Lancet ii. 176-178.
[66] Bone. R.C. (1993) Gram-negative sepsis: a dilemma of mod¬
ern medicine. Clin. Microbiol. Rev. 6, 57-68.
[67] Howat. W.J., Semper. A.E.. Moore. I.E. and Roche. W.R.
(1997) Pulmonary production of cytokines in sudden infant
death syndrome. Biochem. Soc. Trans. 25, S298.
[68] Lundemose. J.B.. Smith. H. and Sweet. C. (1993) Cytokine
release from human peripheral blood leucocytes incubated
with endotoxin with and without prior infection with influenza
virus: relevance to the sudden infant death syndrome. Int. J.
Exp. Pathol. 74. 291-297.
[69] Jackson. M. and Scott. R. (1996) Different patterns of cyto¬
kine induction in cultures of respiratory syncytial (RS) virus-
specific human TH cell lines following stimulation with RS
virus and RS virus proteins. J. Med. Virol. 49. 16-169.
M. IK Rant, C.C. BlacknvlllFEMS Immunology anil Meilical Miirobiulin;y 25 (I'lOO) ,55-%94
[10] Tsutsutni. H.. Matsuda. K.. Sone, S.. Takeuchi, R. and Chiba,
S. (1996) Respiratory syncytial virus-induced cytikine produc¬
tion by neonatal macrophages. Clin. Exp. Immunol. 106. 442-
446.
[71] Matsuda. K.. Tsutsumi, H., Okamoto, Y. and Chiba. C.
(1995) Development of interleukin-6 and tumour necrosis fac¬
tor a activity in nasopharyngeal secretions of infants and chil¬
dren during infection with respiratory syncytial virus. Clin.
Diag. Lab. Immunol. 2, 322-334.
[72] Noah, T.L. and Becker, S. (1993) Respiratory syncytial virus-
induced cytokine produced by a human bronchial epithelial
cell line. Am. J. Physiol. 265, L472^t78.
[73] Konig, B.. Streckert. H.J., Krusat, T. and Konig, W. (1996)
Respiratory syncytial virus G-protein modulates cytokine re¬
lease from human peripheral blood mononuclear cells. J. Leu¬
kocyte Biol. 59, 403-406.
[74] Hessel. T.. Spender, L.C., Georgiou, A., O'Garra, A. and
Openshaw. P.J. (1996) Thl and Th2 cytokine induction in
pulmonary T cells during infection with respiratory syncytial
virus. J. Gen. Virol. 77, 2447-2455.
[75] Subauste, M.C.. Jacoby, D.B.. Richards, S.M. and Proud, D.
(1995) Infection of a human respiratory epithelial cell line with
rhinovirus. Induction of cytokine release and modulation of
susceptibility to infection by cytokine exposure. J. Clin. Invest.
96, 549-557.
[76] Johnston, S.L. (1995) Natural experimental rhinovirus infec¬
tions of the lower respiratory tract. Am. J. Respir. Crit. Care
Med. 152. S46-52.
[77] Hilder, A.S. (1994) Ethnic differences in sudden infant death
syndrome. What we can learn from immigrant in the UK?
Early Hum. Dev. 38, 143-149.
[78] Nelson. E.A.S. (1996) Sudden Infant Death Syndrome and
Childcare Practices, pp. 25-28. E.A.S. Nelson, Hong Kong.
[79] Balarajan, R.. Raleigh, V.S. and Botting, B. (1989) Sudden
infant death syndrome and post neonatal mortality in immi¬
grants in England and Wales. Br. Med. J. 298, 716-720.
[80] Blair, P.S., Fleming, P.J., Bensley. D., Smith, I., Bacon, C.,
Taylor, E., Berry. J.. Golding. J. and Tripp, J. (1996) Smoking
and the sudden infant death syndrome: results from 1993-5
case-control study for confidential inquiry into stillbirths and
deaths in infancy. Confidential Enquiry into Stillbirths and
Deaths Regional Coordinators and Researchers. Br. Med. J.
313. 195-198.
[81] Davies, D.P. (1985) Cot death in Hong Kong: a rare prob¬
lem? Lancet ii. 1346-1349.
[82] Bulterys, M. (1990) High incidence of sudden infant death
syndrome among northern Indians and Alaska natives com¬
pared with southwestern Indians: possible role of smoking.
J. Community Health 15. 185-194.
|83] Alessandri. L.M., Read. A.W.. Stanley. F.J.. Burton. P.R. and
Dawes, V.P. (1994) Sudden infant death syndrome in aborigi¬
nal and non-aboriginal infants. J. Paediatr. Child Health 30,
234-241.
[84] Alessandri, L.M., Read, A.W.. Dawes, V.P.. Cooke. C.T..
Margolius, K.A. and Cadden, G.A. (1995) Pathology review
el sudden and unexpected death in aboriginal and non-abo¬
riginal infants. Pediatr. Perinatal Epidemiol. 9. 406-419.
[85] Leach. A.J.. Boswell. J.B.. Asche. V.. Nienhuys, T.G. and
Mathews, J.D. (1994) Bacterial colonization of the nasophar¬
ynx predicts very early onset and persistence of otitis media in
Australian Aboriginal infants. Pediatr. Infect. Dis. 13. 983—
989.
[86] Homoe. P.. Prag, J., Farholt, S., Henrichsen, J.. Hornsleth,
A.. Killian, M. and Jensen. J.S. (1996) High rate of nasopha¬
ryngeal carriage of potential pathogens among children in
Greenland: results of a clinical survey of middle ear disease.
J. Infect. Dis. 23, 1081-1090.
[87] Wald, N„ Kiryluk, S„ Doll. R. and Peto, R. (1988) UK
Smoking Statistics. Oxford University Press. Oxford.
[S8] Rudwaleit. M.. Tikly. M„ Khamashta, M„ Gibson, K..
Klinke, J„ Hughes, G. and Wordsworth, P. (1996) Interethnic
differences in the association of tumor necrosis factor pro¬
moter polymorphisms with systemic lupus erythmatosis.
J. Rheumatoi. 23. 1725-1728.
[89] Gallagher. G., Eskdale, J., Oh, H.H.. Richards, S.D., Camp¬
bell. D.A. and Field, M. (1997) Polymorphisms in the TNF
gene cluster and MHC serotypes in the West of Scotland.
Immunogenetics 45, 188-194.
[90] Westendorp, R.G.J.. Langermanns, J.A.M., de Bel, C.E.,
Meinders. A.B., Vandenbroucke. J.P.. van Furth, R. and
van Dissel, J.T. (1995) Release of tumor necrosis factor:
an innate host characteristic that may contribute to the out¬
come of meningococcal disease. J. Infect. Dis. 171. 1057—
1060.
[91] Westendorp, R.G.J., Langemans.J.A.M., Huizinga. T.W.J.,
Elouali, A.H., Verweij, C.L., Boomsma, D.I. and Vanden-
brouke, J.P. (1997) Genetic influence on cytokine production
and fatal meningococcal disease. Lancet 349. 170-173.
[92] La Via, W.V., Grant, S.W.. Stutman, H.R. and Marks, M.I.
(1993) Clinical profile of pediatric patients hospitalized with
respiratory syncytial virus infection. Clin. Pediatr. 32, 450-
454.
[93] Winter. G.F.. Hallam. N.F., Hargreaves, F.D., Molyneaux.
P.J., Nurns. S.M. and Inglis, J.M. (1996) Respiratory viruses
in hospitalized paediatric population in Edinburgh 1985-1994.
J. Infect. 33, 207-211.
[94] Bergman. A.B., Ray. C.G., Pomeroty. M.A.. Waltl. P.W. and
Beckwith, T.B. (1972) Studies of the sudden infant death syn¬
drome in King county, Washington: III. Epidemiol. Pediatr.
49. 860-870.
[95] Krueger, J.M., Takahashi. S.. Kapas, L„ Bredow, S., Roky,
R.. Fang. J., Floyd. R.. Reneger. K.B.. Guha-Thakurta, N..
Novitsky. S. and Obal. F.Jr. (1995) Cytokines in sleep regu¬
lation. Adv. Neuroimmunol. 5. 171-188.
[96] Born. J.. Lange, T„ Hansen, K.. Molle. M. and Fehm, H.L.
(1997) Effect of sleep and circadian rhythm on human circu¬
lating immune cells. J. Immunol. 158. 4454-4464.
[97] Petrovsky, N. and Harrison, L.C. (1997) Diurnal rhythmicity
of human cytokine production; a dynamic disequilibrium in
T-helper cell type 1/T helper cell type 2 balance? J. Immunol.
158, 5163-5168.
[98] Levine. A.. Cohen. D. and Zadik. Z. (1994) Urinary free Cor¬
tisol values in children under stress. J. Pediatr. 125. 853-
857.
M IV Ru:a, C.C. BlackwcllIFEMS Immunology ami Medical Microbiology 25 (1090) 85-96 05
[19] Lortholary. O.. Christeff, N.. Casussus, P.. Thobie, N..
Veyssier. P., Trogotf, B.. Torn. 0.. Braunder, M„ Nunez.
E.A. and Guillevin. L. (1996) Hypothalamo-pituitary-adrenal
function in human immunodeficiency virus-infected men.
J. Clin. Endocrinol. Metab. 81, 791-7%.
[100] Young, M.R., Matthews, J.P., Kanabrocki. E.L., Sothern.
R.B., Roitman-johnson, B. and Scheving. L.E. (1995) Orca¬
dian rhythmometry of serum interleukin-2. interleukin-10,
tumor necrosis factor-a. and granulocyte-macrophage col¬
ony-stimulating factor in men. Chronobiol. Int. 12. 19-27.
[1111] Uthgenannt. D„ Schoolmann, D.. Pietrowsky. R„ Fehm,
H.L. and Born, J. (1995) Effects of sleep on the production
of cytokines in humans. Psychosomat. Med. 57, 97-104.
[102] Entizian, P.. Linnemann, K„ Schlaak, M. and Zabel, P.
(1996) Obstructive sleep apnea syndrome and circadian
rhythms of hormones and cytokines. Am. J. Respir. Crit.
Care Med. 153. 1080-1086.
[103] Shoham, S„ Davenne, D., Cady, A.B., Dinarell, C.A. and
Krueger, J.M. (1987) Recombinant tumour necrosis factor
and interleukin 1 enhance slow-wave sleep. Am. J. Physiol.
253, R142-149.
[104] Krueger, J.M., Dinarell, C.A.. Shohan, S., Davenne, D.,
Walter, J. and Kubillus, S. (1987) Interferon oc-2 enhances
slow-wave sleep in rabbits. Int. J. Immunopharmacol. 9, 23-
30.
[105] Toth, L.A., Rehg, J.E. and Webster, R.G. (1995) Strain dif¬
ferences in sleep and other pathophysiological sequelae of
influenza virus infection in naive and immunized mice.
J. Neuroimmunol. 58, 89-99.
[106] Kimura-Tekeuchi, M„ Majde, J.A. and Krueger, J.M. (1992)
The role of double-stranded RNA in induction of the acute-
phase response in an abortive influenza virus infected model.
J. Infect. Dis. 166, 1266-1275.
[107] Kimura-Tekeuchi, M.. Majde. J.A., Toth, L.A. and Krueger,
G.M. (1992) Influenza virus induced changes in rabbit sleep
and acute phase responses. Am. J. Physiol. 263. Rll 15-1121.
[108] Cady, A.B., Brown, P.K., Jones, M.N., Majde, J.A. and
Krueger. J.M. (1989) RNA from influenza-infected lungs in¬
creases slow-wave sleep and body temperature while decreas¬
ing REM sleep. FASEB J. 3. A678.
[109] Toth, L.A. and Krueger, J.M. (1988) Alteration of sleep in
rabbits by Staphylococcus aureus infection. Infect. Immun.
56, 1785-1791.
[HO] Krueger. J.M., Davenne. D.. Walter. J.. Shoham, S.. Kubil¬
lus, S.L., Rosenthal. R.S.. Martin. S.A. and Biemann. K.
(1987) Bacterial peptidoglycans as modulators of sleep. II.
Effect of muramyl peptides on the structure of rabbit sleep.
Brain Res. 403, 258-266.
[HI] Rognum. T.O. and Saugstad. O.D. (1991) Hypoxanthine lev¬
els in vitreous humor; evidence of hypoxia in most infants
who died of sudden infant death syndrome. Pediatrics 87,
306-310.
[112] Steinschneider. A. (1972) Prolonged apnea and the sudden
infant death syndrome: clinical and laboratory observations.
Pediatrics 50. 646-654.
I"3] Schawartz. P.J. (1983) Autonomic nervous system, ventricu¬
lar fibrillation, and SIDS. In: Sudden Infant Death Syn¬
drome (Tyson-Tildon. J. et al„ Eds.), pp. 319-339. Academic
Press, New York.
[114] MacGinty. D.J. and Sternum, M.B. (1980) Sleep physiology,
hypoxemia, and sudden infant death syndrome. Sleep 3. 361 —
373.
[115] Lindgren, C. and Grogaart. J. (1996) Reflex apnoea response
and inflammatory mediators in infants with respiratory tract
infection. Acta Paediatr. 85. 798-803.
[116] Lindgren, C. (1999) Respiratory control during upper airway
infection: Mechanism for prolonged reflex apnea and sudden
infant death with special reference to infant sleep position.
FEMS Immunol. Med. Microbiol. 25. 97-102.
[117] Seto. M„ Shiomi, M„ Togawa, M.. Lee, S.S., Yabiku, M.
and Sugita, T. (1994) Thirty seven cases of respiratory syn¬
cytial virus infection hospitalised and 7 severe cases with
apneic attacks (Abstract). Kensenshogaku Zasshi 68, 226-
233.
[118] Geng, Y.J., Hansson, G.K. and Holme, E. (1992) Interferon
7 and tumour necrosis factor synergise to induce nitric oxide
production and inhibit mitochondrial respiration in vascular
smooth muscle cells. Circ. Res. 71. 1268-1276.
[119] Moncada, S. and Higgs, A. (1993) The L-arginine nitric oxide
pathway. New Engl. J. Med. 329, 2002-2012.
[120] Busse, R. and Mulsch, A. (1991) Induction of nitric oxide
synthase by cytokines in vascular smooth muscle cells. FEBS
Lett. 275, 87-90.
[121] Guntheroth, W.G. (1989) Theories of cardiovascular causes
in sudden infant death syndrome. J. Am. Coll. Cardiol. 14,
443-447.
[122] Harper. R.M., Leake, T., Hopperbrouwers, M.B., Sterman.
D.J., McGinty, D.J. and Hodgeman, J. (1978) Polygraphic
studies of normal infants and infants at risk for the sudden
infant death syndrome: heart rate and variability as a func¬
tion of state. Pediatr. Res. 12, 778-785.
[123] Leistner, H.L., Haddad, G.G., Epstein. R.A.. Lai, T.L., Ep¬
stein, E.P.S. and Mellins, R.B. (1980) Heart rate and heart
rate variability during sleep in aborted sudden infant death
syndrome. J. Pediatr. 97, 51-55.
[124] Park, M.K. and Guntheroth. W.G. (1978) The long Q-T
syndrome: a preventable form of sudden death. J. Fam.
Pract. 7, 945-948.
[125] Schwartz. P.J. (1987) The quest for mechanism of the sudden
infant death syndrome: doubts and progress. Circulation 75,
667-682.
[126] Eskander, E.D., Harvey. H.A., Givant. E. and Liton. A.
(1997) Phase 1 study combining tumour necrosis factor
with interferon a and interleukin 2. Am. J. Clin. Oncol. 20,
511-514.
[127] Muc. M., Baronowski. M.. Braczkowski. R.. Zubelewicz, B.
and Kozowicz, A. (1996) Cardiotoxic effect of the herec-
TNF-a preparation given intravenously to patients with ad¬
vanced neoplasms (Abstract). Prz. Lek. 53, 78-82.
[128] Weisensee, D.. Bereiter-Hahn. J., Schoeppe, W. and Low-
Friedrich. I. (1993) Effects of cytokines on the contractility
of cultured cardiac myocytes. Int. J. Immunopharmacol. 15,
581-587.
[129] Battelino. T.. Goto. M. and Zeller. W.P. (1996) Dexametha-
% M.IV. Ru:it. C.C. Bl.whn.-ll IFEMS liwiwiioh/gy mul Mii/iral A/wrohiiilogv 25 (1999) 4'5-96
sone attenuates hypoglycemia in ten-day-old rats treated
with TNF-a (Abstract). Res. Commun. Mol. Pathol. Phar¬
macol. 92. 149-154.
[1.40] Durig. J.. Fiedler, W.. de Wit. M„ Steffen. M. and Flossfeld.
D.K.. (19%) Lactic acidosis and hypoglycemia in patients
with high-grade non-Flodgkin's lymphoma and elevated cir¬
culating TNF-a.. Ann. Haematol. 72, 97-99.
[131] Jakobsen. P.H.. Bate, C.A.. Taverne. J. and Playfiar. J.H.
(1995) Malaria: toxins, cytokines and disease. Parasite Im¬
munol. 17, 223-231.
[132] Matthys, P., Mitera, T.. Heremans. H„ van Damme. J. and
Billiau. A. (1995) Anti-y-interleron and anti-interIeukin-6
antibodies affect staphylococcal enteroto.xin B-induced
weight loss, hypoglycemia, and cytokines release in ogalac-
tosamine-sensitized and unsensitized mice. Infect. Immun.
63. 1158-1164.
[133] Sarawar, S.R., Blackman. M.A. and Doherty, P.D. (1994)
Superantigen shock in mice with inapparent viral infection.
J. Infect. Dis. 170, 1189-1194.
[134] Saadi, A.T.. Blackwell, C.C., Raza. M.W.. James. V.S.,
Stewart. J., Elton, R.A. and Weir, D.M. (1993) Factors en¬
hancing adherence of toxigenic staphylococci to epithelial
cells and their possible role in sudden infant death syndrome.
Epidemiol. Infect. 110, 507-517.
[135] Saadi. A.T., Blackwell, C.C., Essery, S.D.. Raza, M.W.,
Weir, D.M., Elton, R.A.., Busuttil, A. and Keeling, J.W.
(1996) Developmental and environmental factors that en¬
hance binding of Borilelclla pi'misxix to human epithelial cells
in relation to sudden infant death syndrome. FEMS Immu¬
nol. Vied. Microbiol. 16. 51-59.
[136] El Ahmer. OR. Raza. M.W.. Ogiivie. M.M.. Elton. R.A..
Weir. D.M. and Blackwell, C.C. (1999) Binding of bacteria
to HEp-2 cells infected with influenza A virus. FEMS Im¬
munol. Med. Microbiol. 23. 331-341.
[137] Harrison. L.M., Morris. J.A., Telford. D.R.. Brown, S. and
Jones, K. (1999) Sleeping position in infants over six months
of age: implications for theories of sudden infant death syn¬
drome (SIDS). FEMS Immunol. Med. Microbiol. 25, 29-35.
[138] Jakeman. KJ., Rushton. D.I.. Smith. H. and Sweet, C.
(1991) Exacerbation of bacterial toxicity to infant ferrets
by influenza virus: possible role in sudden infant death syn¬
drome. J. Infect. Dis. 163, 35-40.
[139] Lundemose. J.B., Smith. H. and Sweet, C. (1993) Cytokine
release from human peripheral blood leucocytes incubated
with endotoxin with or without prior infection with influenza
virus: relevance to the sudden infant death syndrome. Int. J.
Exp. Pathol. 74, 291-297.
[140] Raza, M.W., Essery, S.D., Elton. R.A.. Weir. D.M., Busut¬
til. A. and Blackwell. C.C. (1999) Exposure to cigarette
smoke, a major risk factor for SIDS: effects of cigarette
smoke on inflammatory responses to viral infection and bac¬






ELSEVIER FEMS Immunology and Medical Microbiology 24 (1999) 387-394
Infection with respiratory syncytial virus and water-soluble
components of cigarette smoke alter production of tumour
necrosis factor a and nitric oxide by human blood monocytes
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Cigarette smoke and virus infections contribute to the pathogenesis and exacerbation of chronic obstructive pulmonary
disease and asthma. The objective of this study was to examine the effects of a water-soluble cigarette smoke extract (CSE) and/
or respiratory syncytial virus (RSV) infection on release from monocytes of the blood from donors of tumour necrosis factor a
j (TNF-a) and nitric oxide (NO). Both RSV infection and CSE stimulated TNF-a release from monocytes and there was an
additive effect if both the agents were present. There was a decrease in NO release, but the effect was significant only with CSE
or a combination of CSE and RSV infection. Interferon y significantly increased TNF-a release and cotinine significantly
I increased NO release. Nicotine decreased both TNF-a and NO responses. The general pattern observed for individual donors
was increased TNF-a and decreased NO. The proportion of extreme responses with very high TNF-a and very low NO in the
i presence of both RSV and CSE increased to 20% compared with 5% observed with CSE or RSV alone. The results show that
, RSV infection and components of cigarette smoke elicit inflammatory responses that could contribute to damage to the
respiratory tract and these individual factors could be more harmful in combination. © 1999 Federation of European
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Abstract
L Introduction determinants in the pathogenesis of respiratory dis¬
ease. Their influence on the inflammatory and im¬
mune responses underlies the pathological processes
in the respiratory tissues. The factors that determine
whether the disease is mild and short-lived or severe
and chronic are not clear. A number of reports have
examined the release of inflammatory mediators
from alveolar macrophages and there have been clin¬
ical and experimental studies on smoking and virus
Bacterial and viral infections and non-infectious
air pollutants such as cigarette smoke are important
*
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infection as contributory factors to chronic obstruc¬
tive pulmonary disease (COPD) [1,2]. Both tumour
necrosis factor a (TNF-a) and nitric oxide (NO) are
important inflammatory mediators in COPD and
asthma [3-5]. Infection with respiratory syncytial vi¬
rus (RSV) induces release of TNF-a and NO from
human alveolar macrophages, bovine peripheral
blood mononuclear cells and a murine monocyte
cell line [6-8]. There are, however, conflicting reports
on the effect of smoking on TNF-a release [5,9,10].
Both episodic and habitual smoking reduced NO
exhalation [11]; but, in pigs challenged with cigarette
smoke, a vasodilator response due to NO release was
recorded [12].
Both blood monocytes and alveolar macrophages
can be infected with respiratory syncytial virus
(RSV) [13,14], and both cell types are expected to
be exposed to water-soluble components of cigarette
smoke absorbed across mucosal surfaces. The objec¬
tive of the present study was to evaluate release of
TNF-a and NO from human blood monocytes chal¬
lenged with either RSV, a water-soluble cigarette
smoke extract (CSE) or both. Since many virus in¬
fections stimulate release of interferon y (IFN-y)
[15] that might in turn mediate other secretory
functions, the effect of IFN-y on release of TNF-a
and NO in this system was also analysed. Nicotine
is metabolised in the liver to cotinine which is se¬
creted in body fluids including those of the respira¬
tory tract [16]; therefore, the effects of nicotine and
cotinine on TNF-a and NO release were also exam¬
ined.
2. Materials and methods
2.1. Preparation of cigarette smoke extract
A water-soluble extract of cigarette smoke (CSE)
was prepared by the use of a vacuum pump to pass
the smoke of 10 filter-tipped cigarettes (Benson and
Hedges) through 100 ml of Dulbecco's modified
Eagle's medium (DMEM; Gibco) containing 0.45%
(w/v) D-glucose and 4 mg l-1 pyridoxin [17]. To re¬
duce lipopolysaccharide contamination, the glass
bottles were heated at 134°C for 1 h. The CSE was
sterilised by filtration and aliquots were stored at
~20°C.
2.2. Preparation of RSV stock
The Edinburgh strain of RSV (subgroup A) was
grown in HEp-2 cells (an epithelial cell line) as de¬
scribed previously [18] except that the virus was har¬
vested in growth medium (GM) containing DMEM
supplemented with 10% (v/v) foetal calf serum (Gib¬
co), 2 mm r1 L-glutamine (Gibco), 200 pg ml-1
streptomycin (Gibco) and 100 IU ml-1 penicillin
(Gibco). The virus suspension was adjusted to
2x 106 plaque-forming units ml-1.
2.3. Separation and stimulation of monocytes from
blood
One-day-old buffy coats from the blood of group
O, Rh+ donors were obtained from The Scottish
National Blood Transfusion Service (SNBTS), Royal
Infirmary, Edinburgh. Buffy coats were diluted 1 in
4 with sterile phosphate-buffered saline (PBS). The
diluted preparations (40 ml) were layered over 12 ml
of Histopaque 1077 (Sigma) in 50-ml polypropylene
conical tubes (Greiner, Gloucestershire, UK). The
tubes were centrifuged at 400 Xg for 30 min at
25°C. Mononuclear cells, in the opaque band formed
at the interface of serum and Histopaque, were aspi¬
rated carefully. The cells were washed twice in sterile
PBS at 150Xg for 10 min and the supernatant fluid
was discarded. The cells were resuspended in 20 ml
of GM, transferred to a 75-cm2 tissue culture flask
(Greiner) and incubated at 37°C for 30 min to sep¬
arate monocytes from non-adherent cells. The me¬
dium containing non-adherent cells was poured off
and the monocytes harvested by gentle scraping with
a cell scraper in 20 ml of fresh GM. A viable count
was performed by the trypan blue dye exclusion
method and the concentration of monocytes adjusted
to 1X108 ml-1 in GM. The cells (1 ml) were distrib¬
uted in 24-well tissue culture plates (Costar) with
lXlO6 cells in each well. Viability of cells at the
end of each experiment was also assessed by micro¬
scopic examination of cells in the wells for exclusion
of trypan blue.
The cells were cultured at 37°C in 5% C02 in 1 ml
ofGM, GM with CSE at various dilutions, RSV at a
multiplicity of infection (MOI) of 2.0 [6], or with a
combination of RSV and CSE. Some cells were also
exposed to IFN-y (Sigma), nicotine (Sigma) or coti-
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nine (Sigma) ranging from 25 to 400 ng ml-1. Sam¬
ples were collected from each well after 48 h for
determination of TNF-a (100 pi) and after 72 h
for determination of NO (400 pi). Negative control
samples to which no cells were added included cub
ture medium alone, medium with CSE and/or RSV,
or with IFN-y, nicotine or cotinine. The samples
were stored at —20°C until analysed.
The proportion of monocytes infected with RSV
in each sample 24 h post-infection was determined
by an indirect immunofluorescence technique with
monoclonal antibody to glycoprotein G of RSV [18].
2.4. TNF bioassay and detection of NO
L-929 cells (a mouse fibroblast cell line) were used
in a bioassay for TNF-a activity [19] and the results
expressed as per cent cytotoxicity [20]. NO was de¬
tected as nitrites by the spectrophotometry assay
described by Zhang et al. [21]. The samples were
clarified by centrifugation at 12600Xg with a micro¬
centrifuge (Sorval MC 12C, Dupont) for 5 min.
Supernatant fluids (400 pi) were reacted with equal
volumes of Greiss reagent which contained 0.3%
(w/v) naphthylethylenediamine dihydrochloride (Sig¬
ma), and 1% (w/v) sulfanilamide (Sigma) in 5% (v/v)
orthophosphoric acid (BDH), mixed 1:1 immediately
before use. After incubation for 10 min at room
temperature, the absorbance at 540 nm was deter¬
mined in a spectrophotometer (Jeway 6100). Concen¬
trations of nitrites in the samples were derived from
a standard curve for sodium nitrite prepared for each
experiment.
2.5. Statistical methods
The results obtained with buffy coats from 24 do¬
nors are presented here. The results from some sam¬
ples for some treatments could not be presented be¬
cause of contamination in individual wells;
therefore, the mean control values corresponding to
different experiments were not the same. The data
ffom monocytes treated with different agents were
compared with those from the monocytes incubated
with medium only. Comparisons were made also be¬
tween different treatment groups. The significance
values obtained with paired /-tests of the data were
similar to values obtained with a non-parametric test
(Wilcoxon's). The values obtained from /-tests are
presented here.
3. Results
3.1. RSV infection of cells
On average, more than 40% of monocytes from
each individual tested were infected with RSV at
MOI of 2.0 in these assays. One-way 'analysis of
variance' indicated no significant differences in the
proportion of RSV-infected cells among the donors.
3.2. Standardisation of the assay
Ten-fold dilutions of CSE ranging from smoke of
0.1 to 0.0001 cigarette ml-1 were tested with mono¬
cytes from four donors, and a dilution of 0.001 cig¬
arette ml-1 was selected for the assays on the basis
of maximum effects on the production of TNF-a
and NO without killing the monocytes (Fig. 1). Dou¬
bling dilutions of IFN-y, nicotine and cotinine rang¬
ing from 400 ng ml-1 to 6.25 ng ml-1 were tested
[22], A dose of 25 ng ml-1 for these reagents was
used for further study (data not shown). More than
90% of monocytes survived until the end of the ex-
-3 -2
log CSE dilution
Fig. 1. Per cent viability of monocytes (a), per cent cytotoxicity
of L-929 cells due to TNF-a (■) and levels of sodium nitrite
(solid line) produced by monocytes incubated for 24 h with vari¬
ous dilutions of cigarette smoke extract (CSE).
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periments under the conditions selected for the as¬
says.
Time course experiments with monocytes from
four donors (6-72 h) found the maximal TNF-a bio-
activity occurred at 48 h and nitrite accumulation at
72 h in response to CSE or RSY (data not shown).
TNF-a bioactivity was not detected in control sam¬
ples without cells containing culture medium or me¬
dium with CSE, RSV, CSE and RSV, IFN-y, nico¬
tine or cotinine. For the detection of nitrites, the
spectrophotometer was blanked on these individual
controls for assessment of their respective test sam¬
ples. No effect due to presence of these agents was
recorded at the absorbance used to detect sodium
nitrite.
3.3. The effect of CSE and RSV infection on TNF-a
bioactivity
The TNF-a bioactivities expressed as per cent cy¬
totoxicity of L-929 cells observed in experiments
with monocytes from a total of 24 donors were com¬
pared. Fig. 2 represents paired differences in L-929
cytotoxicity due to TNF-a bioactivities caused by
different treatments of monocytes compared with
monocytes incubated with medium only. Compared
with cell culture fluids from cells (24 donors) incu¬
bated with medium alone (mean 48%, S.E.M. 5.2),
















Fig. 2. Paired difference in TNF-a bioactivity expressed as % cy¬
totoxicity for L-929 cells from monocytes of individual donors
exposed to medium only or to CSE and/or RSV. Error bars rep¬
resent S.E.M.
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Fig. 3. Paired difference in sodium nitrite production from mono¬
cytes of individual donors exposed to medium only or to CSE
and/or RSV. Error bars represent S.E.M.
(mean 60%, S.E.M. 5.1) had significantly increased
TNF-a bioactivities (95% CI of paired differences
3.7, 19.7, f = 3.05, F = 0.006) as did the cell culture
fluids from RSV-infected cells (mean 68%, S.E.M.
4.6) (95% CI of paired differences 16.4, 34.15,
t = 5.9, P = 0.000). There was no correlation between
the per cent cytotoxicity for L-929 cells and propor¬
tions of RSV-infected cells in RSV-infected samples.
Compared with TNF-a bioactivities detected in cell
culture fluids from cells (15 donors) exposed to me¬
dium alone (mean 38%, S.E.M. 5.4), a significant
increase was observed in cell culture fluids from cells
incubated with both CSE and RSV (mean 71%,
S.E.M. 6.6) (95% CI of paired differences 15.4,
49.5, f = 4.08, P= 0.002).
Compared with TNF-a bioactivities of monocytes
from 15 donors exposed to CSE alone, the bioactiv¬
ities observed with the combination of CSE and RSV
infection were significantly higher (paired differences
26%, 95% CI 10.4, 41.3, / = 3.58, /> = 0.003). Com¬
pared with TNF-a bioactivity found for cells incu¬
bated only with RSV, addition of CSE did not sig¬
nificantly increase TNF-a bioactivities (95% CI
— 12.9, 21.5). This indicates that the main contribu¬
tion to increased levels of TNF-a was due to the
virus infection.
Compared with TNF-a bioactivity of monocytes
from six donors exposed to medium only (mean
32%, S.E.M. 7.5), there was no significant increase
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observed in cell culture fluids of cells incubated with
nicotine (mean 34%, S.E.M. 8.7) (95% CI of paired
differences —14.2, 15.4) or cotinine (mean 39%,
S.E.M. 7.2) (95% CI of paired differences —1.6,
15.2). Incubation with IFN-y did, however, result
in significantly increased TNF-a bioactivity (mean
51%, S.E.M. 3.0) (95% CI of paired differences 6.2,
31.7, / = 3.83, /" = 0.012).
3.4. The effect of CSE and RSV infection on NO
release from monocytes
The supernatant fluids from cells in the same ex¬
periments were examined for nitrite levels. Paired
differences between nitrite levels resulting from dif¬
ferent treatments of monocytes compared with those
incubated with medium alone are given in Fig. 3.
Compared with supernatant fluids from cells incu¬
bated with medium only (mean 0.41 nM, S.E.M.
0.09), supernatant fluids from cells incubated with
CSE (mean 0.34 nM, S.E.M. 0.08) had significantly
lower levels of nitrite (95% CI of paired differences
-0.14 -0.008, r = 2.3, E = 0.031) as did RSV-in-
fected cells (mean 0.35 nM, S.E.M. 0.05), but the
results were not significant (95% CI of paired differ¬
ences —0.023, 0.099). There was no correlation be¬
tween the levels of nitrite detected and ratios of
RSV-infected cells in the samples. Compared with
cells incubated with medium only, cells incubated
with both CSE and RSV showed a significant de¬
crease in nitrite production (mean 0.25 nM, S.E.M.
0.06) (95% CI of paired differences —0.4, —0.01,
( = 2.26, R = 0.04).
In experiments with monocytes from 15 donors,
there was no significant difference between nitrite
levels found for cells incubated with CSE alone com¬
pared with those incubated with both CSE and RSV.
In comparison with nitrite detected in supernatants
from cells incubated with RSV only, supernatants
from RSV-infected cultures containing CSE had low¬
er levels of nitrite with marginal significance (paired
difference -0.098 nM, S.E.M. 0.048, 95% CI
—0.006, —0.2, / = 2.02, P = 0.063). This indicated
that the main decrease in nitrite levels was caused
by CSE.
Experiments with cells from six individual donors
showed that, compared with nitrite levels observed
with cells incubated with medium only (mean 0.10
nM, S.E.M. 0.03), addition of INF-y (mean 0.15 nM,
S.E.M. 0.03) (95% CI 0, 0.057) or nicotine (mean
0.13 nM, S.E.M. 0.03) (95% CI 0, 0.03) to cells did
not result in significant changes in nitrite release, but
addition of cotinine significantly increased release of
nitrite from cells (mean 0.26 nM, S.E.M. 0.03) (95%
CI of paired differences 0.03, 0.15, f = 3.48,
/* = 0.018).
3.5. Variability of TNF-a and NO response of
individual donors
Each set of experiments was carried out with cells
from different donors. Individual TNF-a and NO
responses to CSE, RSV infection and combinations
of both are summarised in Table 1. TNF-a and NO
responses of the test samples were arbitrarily classi¬
fied as very high if the levels of killing of L-929 cells
or levels of nitrite were more than twice the value of
the controls in which monocytes were cultured with
medium alone. Responses were classified as very low
if the levels of test samples were less than half the
control. The most common pattern observed was
increased TNF-a bioactivity and decreased NO pro-
Table 1
Individual responses to CSE and/or RSV
Response to Per cent of donors Per cent of donors with extreme response"
High Low TTNF+J. Nitrite High Low TTNF+i Nitrite
CSE TNF 75 25 42 12 0 4
(n = 24) Nitrite 33 63 0 12
RSV TNF 92 8 33 25 4 4
in = 24) Nitrite 50 46 21 25
CSE+RSV TNF 87 13 67 48 7 20
f" = 15) Nitrite 13 87 7 48
'High a2 xcontrol; low s 1/2 control.
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duction compared with controls incubated with me¬
dium only. In the presence of CSE or RSV, 4% of
donors exhibited very high TNF-a bioactivity and
very low nitrite levels. In the presence of both CSE
and RSV. this rose to 20%.
4. Discussion
RSV is a common pathogen affecting infants and
the elderly [23]. Complete immunity does not follow
exposure to RSV, hence reinfections are not uncom¬
mon [24]. Significant numbers of patients with
COPD or bronchial asthma suffer bouts of exacer¬
bation and possible residual effects due to RSV in¬
fection in the course of their disease [25 (abstract)].
Cigarette smoking is a major cause of COPD [1],
Both viral infection and cigarette smoking enhance
bacterial binding to epithelial cells in model systems
[18,26,27] and cause immunosuppression [28,29].
Since TNF-a and NO are important mediators of
inflammation in the respiratory tract, TNF-a and
NO responses of blood monocytes to RSV infection
and CSE were assessed.
Peripheral blood monocytes were used in the study
for four reasons: (1) their ready availability in suffi¬
cient numbers; (2) alveolar macrophages in the lungs
are derived from monocytes; (3) they were less likely
to have been exposed to respiratory viruses and air
pollutants; (4) they were more likely to be in an
unstimulated state. Some stimulation of monocytes
due to the use of Histopaque for isolation of mono¬
cytes could not be ruled out. There is evidence that
genetic factors contribute to levels of TNF-a in re¬
sponse to endotoxins [30], The variable spontaneous
TNF-a and NO release from monocytes could be
attributed to the individual donor's genetic make
up or condition at the time of blood donation, their
smoking habits, or variable responses of monocytes
to Histopaque. The assays examined the responses to
various agents in relation to background levels of
each individual donor.
The dose of CSE (0.001 cigarette ml-1) used in the
assays was similar to dilutions of smoke extract used
in experiments with alveolar macrophages by Higa-
shimoto et al. [17], It was based on the range of
numbers of cigarettes an average person can smoke
and the water-soluble components of the inhaled
smoke that cross the mucosal lining and are diluted
in the body fluids.
Bioactivity of TNF-a in samples can differ from
total TNF-a detected by ELISA because of the solu¬
ble TNF-a receptors produced by monocytes that
block the functions of the cytokine. There was no
correlation between the data from the bioassay and
the ELISA with 200 samples (data not shown). This
could partly be due to variable levels of TNF-a re¬
ceptors in the cell culture fluid and partly to variable
rate of degradation of TNF-a by the monocytes. The
bioassay was selected for this study because it meas¬
ures the levels of TNF-a activity in the solution at a
given time.
Midulla et al. found RSV infection elicited varia¬
ble TNF-a responses from alveolar macrophages
from individual donors [31], Cells from most of the
donors in the present study showed increased TNF-a
responses to RSV infection or exposure to CSE. A
minority exhibited very high responses to either of
the agents. TNF-a is thought to play a protective
role in RSV infection. Prior incubation with TNF-
a reduced the replication of RSV in alveolar macro¬
phages by about half [32]. Cells from 8% of donors
in this study exhibited a decreased TNF-a response
to RSV infection. Individuals with this response
might be particularly susceptible to severe infection
RSV.
The beneficial pulmonary vasodilatory, possible
bronchodilatory, and bactericidal effects of NO in
patients with COPD or asthma might be offset by
its induction of exudate formation, inflammation,
DNA toxicity and cytotoxicity. It is generally agreed
that mild NO induction is protective in the respira¬
tory tract while higher levels might be associated
with deleterious consequences [3,33]. Two distinct
populations of donors based on the level of NO pro¬
duction have been recognised [34]. The assay for ni¬
trite used in this study was sensitive down to NaNOj
concentrations of approximately 1 pM. Results pre¬
sented here indicate that increased responses of
TNF-a are not, in most donors, accompanied by
increased NO responses to RSV or CSE. TNF-a
reduced the half-life of mRNA encoding NO syn¬
thase in human umbilical vein endothelial cells [35],
The results indicate that TNF-a activity might also
affect the production of this enzyme in monocytes.
Some of the effects of virus infections are mediated
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through release of IFN-7 from monocytes [36], The
present data indicated that stimulatory effects of
RSV infection on TNF-a bioactivity could be due
in part to IFN-y. Significant increases in TNF-a
and significant decreases in NO response in the pres¬
ence of CSE did not match with the observed slight
increase in both responses mediated by nicotine
alone. This suggests other factors in CSE are respon¬
sible for the effects observed in these assays. The
significant increase of NO from cells treated with
cotinine indicated that some of the effects of ciga¬
rette smoking on inflammatory mediators in vivo
might be mediated by this metabolite of nicotine.
The results presented here examined some of the
effects of two environmental factors that exacerbate
COPD and asthma. Smoking or passive exposure to
dgarette smoke and virus infections of the respira¬
tory tract do not always lead to similar degrees of
acute or chronic illness. This could reflect the indi¬
vidual differences in responses observed in this study.
In addition to enhancing bacterial colonisation of
the respiratory mucosa and immunosuppression,
these agents appear generally to enhance TNF-a re¬
sponse and reduce NO levels. The extreme responses
noted with cells from a minority of subjects might
contribute to increased susceptibility to chronic in¬
flammatory disease of the respiratory tract or exac¬
erbations. Comparison of monocytes from healthy
donors with those from patients with these condi¬
tions for production of inflammatory cytokines is
needed to obtain further evidence for this hypothesis.
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Abstract
Exposure to cigarette smoke is a major risk factor for sudden infant death syndrome and also for respiratory infections in
children. It has been suggested that toxigenic bacteria colonizing the respiratory tract might play a role in some cases of sudden
infant death syndrome and nicotine has been demonstrated to enhance the lethality of bacterial toxins in a model system.
Pyrogenic toxins of Staphylococcus aureus have been identified in tissues of infants who died of sudden infant death syndrome.
It has been suggested that some of these deaths were due to induction of inflammatory mediators by infectious agents during a
period when infants are less able to control these responses. The aim of this study was to assess the effects of a water-soluble
cigarette smoke extract on the production of tumor necrosis factor a and nitric oxide from human monocytes in response to
staphylococcal toxic shock syndrome toxin 1 or infection of the monocytes with respiratory syncytial virus. Cell culture
supernatants were examined by a bioassay using mouse fibroblasts (L-929 cell line) for tumor necrosis factor a activity and by a
spectrophotometric method for nitrite. Compared with monocytes incubated with medium only, monocytes incubated with any
of the factors or their combinations tested in the study released higher levels of tumor necrosis factor a and lower levels of
nitric oxide. Incubation with cigarette smoke extract increased tumor necrosis factor a from respiratory syncytial virus-infected
cells while it decreased tumor necrosis factor a from cells incubated with toxic shock syndrome toxin. Incubation with cigarette
smoke extract decreased the nitric oxide production front respiratory syncytial virus-infected cells while it increased the nitric
oxide production from cells incubated with toxic shock syndrome toxin. Monocytes from a minority of individuals
demonstrated extreme tumor necrosis factor a responses and/or very high or very low nitric oxide. The proportion of samples
in which extreme responses with a very high tumor necrosis factor a and very low nitric oxide were detected was increased in
'he presence of the three agents to 20% compared with 0% observed with toxic shock syndrome toxin 1 or 4% observed with
cigarette smoke extract or respiratory syncytial virus. © 1999 Federation of European Microbiological Societies. Published
hy Elsevier Science B.V. All rights reserved.
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t. Introduction
Exposure to cigarette smoke has been identified as
one of the major risk factors for sudden infant death
syndrome (SIDS) in the majority of epidemiological
studies [1-4]. Parental smoking, especially that of the
mother is also a major risk factor for respiratory
infections in children [5], It has been suggested that
exposure to cigarette smoke and subclinical co-infec¬
tion with viral and/or bacterial pathogens could trig¬
ger the series of events leading to SIDS and that
inflammatory mediators elicited by infection contrib¬
ute to the fatal outcome [6],
Several studies identified respiratory syncytial virus
(RSV) in a substantial proportion of SIDS cases [7,8].
Staphylococcal toxic shock syndrome toxin 1 (TSST-
1) and staphylococcal enterotoxin C (SEC) were iden¬
tified in SIDS infants by immunohistochemical meth¬
ods [9,10] and more recently in over half the SIDS
cases examined by flow cytometric and enzyme-linked
immunosorbent assay (ELISA) methods for the
toxins [11]. Synergy between nicotine and bacterial
toxins has been demonstrated in the chick embryo
model [12]; however, there are many other toxic sub¬
stances in cigarette smoke in addition to nicotine.
Tumor necrosis factor a (TNF-a) and nitric oxide
(NO) are two important mediators of inflammation
and shock in response to microbes and their com¬
ponents or products. Uncontrolled production of
these mediators can lead to death [13,14]. TNF-a
and NO were chosen for investigation in this study
because experiments with mice demonstrated that a
combined challenge with an inapparent virus infec¬
tion and a well-tolerated dose of staphylococcal en¬
terotoxin B (SEB) caused fatal shock. Interferon
(INF) y produced by the viral infection activated
macrophages and subsequent exposure to the toxin
induced TNF-a and NO radicals. The mice were pro¬
tected from the effects of the toxin by TNF receptor-
Fc fusion protein or NO synthase inhibitor [15].
Animal models have been used to examine the
effect of staphylococcal toxins and virus infections
[15,16] but there were no human models in which
the effects of these combinations on the inflamma¬
tory responses were investigated. RSV infection has
been reported to induce release of TNF-a and NO
from human alveolar macrophages [17,18]. There
are, however, conflicting reports on the effect of
smoking on TNF-a [19-21] and NO release [22.23].
Blood monocytes and alveolar macrophages can be
infected with RSV [24,25] and both cell types are
expected to be exposed to water-soluble components
of cigarette smoke or TSST-1 absorbed across mu¬
cous surfaces.
The aim of the present study was to assess the
effect of a water-soluble cigarette smoke extract
(CSE) on the release of TNF-a and NO from periph¬
eral blood monocytes incubated with TSST-1 and/or
infected with RSV. Because there is evidence that
TNF-a responses are under genetic control which
can influence the severity or fatal outcome of infec¬
tion [26,27], the study examined monocytes from dif¬
ferent blood donors to assess individual variations in
TNF-a and NO responses to CSE, TSST-1 and RSV
infection.
2. Materials and methods
2.1. Preparation of CSE
A water-soluble CSE was prepared by using a vac¬
uum pump to pass the smoke of 10 filter-tipped cig¬
arettes (Benson and Hedges) through 100 ml of Dul-
becco's modified Eagle's medium (DMEM) (Gibco,
BRL, Glasgow, UK) containing 0.45% D-glucose
and 4 mg l-1 pyridoxin [28]. To reduce LPS contam¬
ination, the glass bottles used were heated at 134°C
for 1 h. The CSE was filtered with a 0.2 p filter and
aliquots were stored at —20°C.
2.2. RSV stock
The Edinburgh strain of RSV (subgroup A) was
grown in HEp-2 cells (an epithelial cell line) as de¬
scribed previously. The virus was harvested in
growth medium (GM) containing DMEM supple¬
mented with 10% (v/v) fetal calf serum (FCS) (Gib¬
co), 2 pM L-glutamine (Gibco), streptomycin (Gibco)
(200 mg ml-1) and penicillin (Gibco) (100 IU ml-1).
The virus suspension was adjusted to 2X 106 plaque
forming units ml-1.
2.3. Preparation ofmonocytes
One-day old bulfy coats from blood donors of
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group O, Rh+ were obtained from The Scottish Na¬
tional Blood Transfusion Service (SNBTS), Royal
Infirmary, Edinburgh. Buffy coats were diluted 1:4
with sterile phosphate-bufifered saline (PBS). The di¬
luted preparations (40 ml) were layered over 12 ml of
Histopaque 1077 (Sigma, Poole, Dorset, UK) in
50-ml polypropylene conical tubes (Greiner, Glou¬
cestershire, UK). The tubes were centrifuged at
250 Xg for 30 min at 25°C. Mononuclear cells in
the opaque band formed at the interface of serum
and Histopaque were aspirated carefully. The cells
were washed twice in sterile PBS at 150xg for
10 min and the supernatant was discarded. The cells
were resuspended in 20 ml GM, transferred to a
75-cm2 tissue culture flask (Greiner) and incubated
at 37°C for 30 min to separate monocytes from non¬
adherent blood cells. The medium containing non¬
adherent cells was poured off and the monocytes
were harvested by gentle scraping with a cell scraper
in 20 ml fresh GM. A viable count was performed
using the trypan blue dye exclusion method and the
concentration of monocytes was adjusted to 1X108
ml-1 in GM. The cells were distributed in 24-well
tissue culture plates (Costar) with 1X 106 cells in
each well. The viability of the cells at the end of
each experiment was also assessed by microscopic
examination of cells in the wells for exclusion of
trypan blue.
2.4. Stimulation of monocytes
The cells were cultured at 37°C in 5% COt for
24 h in 1 ml GM, CSE, RSV at a multiplicity of
infection of 2.0 [30] or TSST-1 (Toxin Technology,
Sarasota, FL, USA). TSST-1 was added to cells by
first diluting the toxin in supernatant (200 pi) ob¬
tained from each well to avoid abrupt contact of
concentrated toxin with the cells. Samples were col¬
lected from each well after 48 h for determination of
TNF-a (100 pi) and after 72 h for determination of
NO (400 pi). Negative control samples to which no
cells were added included culture medium alone, me¬
dium with CSE, RSV and/or TSST-1. The samples
were kept at —20°C until analyzed.
The proportion of monocytes infected with RSV
in each sample 24 h post-infection was determined
by an indirect immunofluorescence technique with
monoclonal antibody against the glycoprotein G of
RSV.
2.5. TNF bioassay and detection of NO
L-929 cells (a mouse fibroblast cell line) were used
in a bioassay for TNF-oe activity [31]. NO was de¬
tected as nitrites by the spectrophotometric assay
described by Zhang et al. [32], Concentrations of
nitrites in the samples were derived from a standard
curve for sodium nitrite prepared for each experi¬
ment.
2.6. Statistical methods
The results obtained with buffy coats from 31 do¬
nors were assessed. The results from some samples
for some treatments could not be included due to
contamination of individual wells. Therefore, the
mean control values corresponding to different ex¬
periments were not all the same. The data from
monocytes incubated with different agents were com¬
pared with those from monocytes incubated with
medium only. Comparisons were made also between
different treatment groups. The significance values
obtained with paired t tests of the data were similar
to values obtained with a non-parametric test (Wil-
coxon's). The values obtained from t tests are pre¬
sented here.
3. Results
3:1. RSV infection of cells
On average, at 24 h post-infection, more than 40%
of the monocytes from each individual tested were
infected with RSV. One way 'analysis of variance'
indicated no significant differences among the donors
in the proportion of RSV-infected cells.
3.2. Optimization of CSE and TSST-1 concentrations
and time of incubation
Ten-fold dilutions of CSE ranging from 0.1 to
0.0001 cigarette ml-1 and TSST-1 ranging from 0.5
to 0.005 |ig ml-1 were incubated for 24 h with mono¬
cytes from four donors. Dilutions of 0.001 ml-' for
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Fig. 1. Percent viability of monocytes (-A-), cytotoxicity for L-
929 (-■-) due to TNF-a bioactivity and nitrite (nM) (-O-) pro¬




Fig. 2. Percent viability of monocytes (-A-), cytotoxicity for L-
929 cells (-■-) due to TNF-a bioactivity and nitrite (nM) (-O-)
produced by monocytes from lour donors incubated with various
dilutions of TSST-1.
CSE and 0.05 |dg ml-1 for TSST-1 were selected
for the assays on the basis of maximum effects (in¬
crease or decrease) on the production of TNF-a or
NO without killing the monocytes (Figs. 1 and 2).
More than 90% of the monocytes survived until
the end of the experiments with the treatments se¬
lected.
Time course experiments with monocytes from
four donors ranging from 6 to 72 h found that the
maximum TNF-a bioactivity was detected at 48 h
and release of NO at 72 h in response to CSE,
RSV or TSST-1 at the selected concentrations
(data not shown). TNF-a bioactivity was not de¬
tected in culture medium or medium with CSE,
RSV and/or TSST-1 used as negative controls. For
detection of nitrites, the spectrophotometer was
blanked on these controls for the assessment of their
respective test samples. No effect of these agents was











Medium CSE Medium CSE
% 3. Moan and S.E.M. of TNF-a bioactivities of monocytes expressed as % cytotoxicity for L-929 cells (A) and nitrite (nM) (B) of in-
ilividual donors (// = 31) exposed to CSE.
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.IS. The effect of CSE on TNF-a and NO production
from monocytes
The TNF-a bioactivities expressed as percentage
killing of L-929 cells observed for monocytes from
a total of 31 donors are shown in Fig. 3. Compared
with controls (mean 38, S.E.M. 4.2), supernatants
from cells incubated with CSE had a significantly
increased TNF-a bioactivity (mean 47, S.E.M. 4.2)
(95% confidence interval (CI) of the paired difference
3, 15.7, P<0.01). Compared with nitrite concentra¬
tions of supernatants from cells incubated with me¬
dium only (mean 0.41 nM, S.E.M. 0.076), superna¬
tants from cells incubated with CSE had significantly
lower levels of nitrites (mean 0.34 nM, S.E.M. 0.09)
(95% CI of the paired differences -0.14, -0.008,
T<0.05) (Fig. 3A, B).
S.4. The effect of CSE on levels of TNF-a and NO
produced by RSV-infected monocytes
Compared with supernatants from cells incubated
with medium alone, supernatants from RSV-infec-
ted samples had significantly increased levels of
TNF-a (mean 61, S.E.M. 4.1) (95% CI of the paired
differences 14.8, 30.9, P< 0.005) (Fig. 4A). Com¬
pared with the TNF-a bioactivity detected in
supernatants from cells exposed to RSV alone, an
increase was observed in supernatants from cells
incubated with CSE and RSV, but this was not sig¬
nificant.
Compared with supernatants from cells of 20 do¬
nors incubated with medium only (mean 0.41,
S.E.M. 0.09), RSV-infected cells had lower levels of
nitrite (mean 0.35 nM, S.E.M. 0.05) but the effect
was not significant. There was no correlation be¬
tween the levels of nitrite detected and ratios of
RSV-infected cells in individual samples. Compared
with nitrite levels in supernatants of RSV-infected
cells, there was a decrease in nitrite observed with
cells incubated with CSE and RSV (mean 0.25 nM,
S.E.M. 0.055) (95% CI of the paired differences
—0.25, —0.07, P< 0.005) (Fig. 4B). Compared with
nitrite levels with cells incubated with RSV alone, a
decrease was observed in supernatants from cells in¬





























































Pig. 4. Mean and S E.M. of TNF-a bioactivitics of monocytes expressed as % cytotoxicity for L-929 cells (A) and nitrite (nM) (B) of in¬
dividual donors (/I = 31) exposed to CSE and RSV.








































Fig. 5. Mean and S.E.M. of TNF-a bioactivities of monocytes expressed as % cytotoxicity for L-929 ceils (A) and nitrite (nM) (B) of in¬
dividual donors 0i = 31) exposed to CSE and TSST-1.
3.5. The effect of CSE on levels of TNF-a and NO
produced by monocytes exposed to TSST-1
Monocytes from 31 donors incubated with TSST-1
produced significantly higher levels of TNF-a bioac-
tivity (mean 47, S.E.M. 3.9) (95% CI of the paired
differences 4.9, 19.2, P< 0.005) compared with the
controls incubated with GM only (mean 38, S.E.M.
5.4). In experiments with monocytes from 20 donors
incubated with TSST-1 and CSE, the levels of TNF-
a bioactivity were increased (mean 44, S.E.M. 6.4)
but this was not significantly different from the ef¬
fects observed for TSST-1 (Fig. 5A).
Supernatants from cells incubated with TSST-1
alone or in combination with CSE did not have ni¬
trite levels significantly different from the controls
(Fig. 5B).
Table I
Individual responses to CSE, RSV and/or TSST-1





CSE TNF-a 75 25 42 12 0 4
(« = 24) Nitrite 33 63 0 12
RSV TNF-a 92 8 33 25 4 8
(« = 24) Nitrite 50 46 21 25
TSST TNF-a 81 19 29 26 3 0
(u = 31) Nitrite 58 42 6 12
CSE+TSST TNF-a 65 35 40 30 5 0
Or~iII Nitrite 45 50 0 20
CSE+RSV TNF-a 87 13 67 48 7 20
(n = 20) Nitrite 13 87 7 48
RSV+TSST TNF-a 95 5 50 40 0 20
(» = 20) Nitrite 30 60 20 30
RSV+CSE+TSST TNF-a 95 5 55 60 5 20
oriII Nitrite 35 60 5 25
high a2Xcontrol; lows 1/2 control.




































































Fig. 6. Mean and S.E.M. of TNF-a bioactivities of monocytes expressed as % cytotoxicity for L-929 cells (A) and nitrite (nM) (B) of in¬
dividual donors (/7 = 31) exposed to CSE, RSV and TSST-1.
3.6. The effect of CSE on levels of TNF-a bioactivity
production by RSV-infected cells stimulated by
TSST-1
Compared with controls, a significant increase was
observed in supernatants from cells incubated with
RSV and TSST-1 (mean 69, S.E.M. 3.2) (95% CI of
the paired differences 23.4, 38.4, P< 0.001) and in
supernatants incubated with RSV, CSE and TSST-
1 (mean 71, S.E.M. 6.6, 95% CI 15.4, 49.5, P = 0.000)
(Fig. 6A). The increase in TNF-a bioactivity caused
by CSE with RSV-infected cells stimulated by TSST-
1 was not significant. Compared with the control, a
decrease in NO levels was observed but was not sig¬
nificant (Fig. 6B).
3.7. Comparison of the TNF-a bioactivity in relation
to CSE
Since exposure to cigarette smoke can be consid¬
ered to be a common or constant risk factor for
children of smokers, the interactions between RSV
or TSST were assessed in relation to CSE as the
control. Compared with TNF-a bioactivities found
in .supernatants from cells exposed to CSE alone, the
levels observed in supernatants of cells incubated
with a combination of CSE and TSST-1 were not
significantly different, but the bioactivities observed
for a combination of CSE, RSV and TSST-1 were
significantly higher (P < 0.001). Compared with the
TNF-a bioactivity found in supernatants from cells
incubated with CSE alone, supernatants from cells
incubated with CSE and RSV had an increased
TNF-a bioactivity (P< 0.001).
3.8. Variability of TNF-a and NO responses of
individual donors
Each set of experiments was carried out with cells
from different donors. Individual TNF-a and NO
responses to CSE, RSV infection and TSST-1, sepa¬
rately and in combination, are summarized in Table
1. TNF-a and NO responses of the test samples were
arbitrarily classified as very high if the levels of cy¬
totoxicity for L-929 cells or levels of nitrite were
more than twice the value for the controls in which
monocytes were cultured with medium alone. Re¬
sponses were classified as very low if the levels of
test samples were less than half the control. The
most common pattern observed was increased
TNF-a bioactivities and a decreased NO production
compared with controls in which cells were incu¬
bated with medium only. The proportions of extreme
responses in the presence of CSE (4%), RSV (8%) or
TSST-1 (0%) increased in the presence of CSE and
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RSV (20°/,). TSST-! and RSV (20%) or all the three
agents (20%).
Cells from two individuals showed extreme re¬
sponses (very high TNF and very low NO) to
RSV, RSV+TSST and CSE+RSV. Cells from one
of these individuals also showed these extreme re¬
sponses to CSE+RSV+TSST. Cells from another do¬
nor showed extreme responses to CSE, RSV+TSST
and CSE+RSV.
4. Discussion
Epidemiological studies have consistently shown
an association between passive exposure to cigarette
smoke and SIDS [1,4]. It has previously been dem¬
onstrated that both smoking and RSV infection en¬
hance bacterial binding to epithelial cells by Staphy¬
lococcus aureus and some of the Gram-negative
bacteria isolated from SIDS infants [30,33,34], In
this study, we examined the hypothesis that water-
soluble components of cigarette smoke might signifi¬
cantly enhance the levels of potent mediators of in¬
flammation and circulatory shock, TNF-a and NO
[35] elicited by RSV and TSST-1.
4.1. The method for assessing the effects of CSE and
other agents on inflammatory responses
Although animal models such as the chick embryo
assay have been used successfully to examine the
interactions between bacterial toxins and single com¬
ponents of cigarette smoke [12], we developed a
model using human cells and CSE to attempt to
simulate more closely the conditions in the human
infant. We did not observe the synergistic effects
noted for nicotine with the bacterial toxins in the
chick embryo assay. This might be due to differences
in the sensitivity of the chick embryo to the toxins
compared with the human monocyte model. The
current study used purified TSST-1 in contrast to
the toxins used by Sayers et al. which were a crude
extract from the bacteria and might have contained
fragments of endotoxin or peptidoglycan which
could enhance inflammatory reactions. A third fac¬
tor could be that Sayers et al. used purified nicotine
and the CSE used in these studies might have been
more toxic to the cells due to the presence of other
compounds.
Peripheral blood monocytes were used in the study
because of their ready availability in sufficient num¬
bers and compared with alveolar macrophages,
phagocytic cells in the lungs derived from mono¬
cytes, they were less likely to have been exposed to
pathogens or other agents and were more likely to be
in an unstimulated state. Some stimulation of mono¬
cytes due to the use of Histopaque for isolation of
monocytes could not be ruled out. There is evidence
that genetic factors contribute to the levels of TNF-a
produced in response to endotoxins [27]. The varia¬
ble spontaneous TNF-a and NO release from mono¬
cytes could be attributed to the individual donor's
genetic make up, conditions at the time of blood
donation or their smoking habits. For each donor,
the results obtained in the various experimental con¬
ditions were compared with the background levels of
their unstimulated cells.
The dose of CSE (0.001 cigarette ml-1) used in the
assays was similar to dilutions of smoke extract used
in the experiments with alveolar macrophages by Hi-
gashimoto et al. [28], It was based on the average
level of cigarette smoke to which an infant might be
exposed and the water-soluble components of the
inhaled smoke that cross the mucous membranes
and diluted in the body fluids.
The bioavailability of TNF-a in samples can differ
from the total TNF-a detected by ELISA because of
soluble TNF-a receptors produced by monocytes
that block its functions. We found no correlation
between the data from the bioassays and ELISA of
200 samples (data not shown). This could partly be
due to variable levels of TNF-a receptors in the
supernatant and partly due to variable rates of deg¬
radation of TNF-a by the monocytes. The bioassay
was selected in this study because it measures the
effective levels of TNF-a bioactivity at any given
time. The TNF-a bioactivity was expressed as meas¬
ure of cytotoxicity for L-929 cells [36].
4.2. The effects of CSE on production of TNF-a
The increase in TNF-a production from RSV-in-
fected monocytes [37] due to exposure from CSE
indicated enhanced pro-inflammatory effects of these
factors. This was further supported by the observa¬
tion that monocytes from more donors showed a
high level of TNF-a bioactivity with both CSE and
RSV compared with either agent alone. An increased
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TNF bioactivity in most cases was not accompanied
by similar increases in the NO production. However,
in a small subset of the donors tested, both TNF-a
and NO were increased. In another small subset of
subjects, a high TNF production associated with a
very low NO production was observed. These sub¬
jects might have higher inflammatory responses
with a reduced protection by optimum levels of
NO [14],
4.3. The effects of CSE on production of TNF-a and
NO by TSST-1 -stimulated monocytes
CSE did not produce significant differences in
TNF-a or NO from cells exposed to TSST-1. The
concentration of TSST-1 used was optimal for elicit¬
ing inflammatory responses from the monocytes
without killing the cells. Future studies in this area
should examine the effects of cigarette smoke on
suboptimal levels of the toxin.
4.4. The effects of CSE on production of TNF-a and
NO by RSV-infected monocytes stimulated with
TSST-1
Although CSE did not significantly affect the
mean levels of TNF-a or NO production from
RSV-infected monocytes incubated with TSST, the
number of donors showing heightened TNF-a re¬
sponses and very low NO responses due to CSE,
RSV or TSST alone increased from 0-4% to 20%
with the combination of the three agents. Our hy¬
pothesis suggested that it is a combination of infec¬
tious insults and exposure to cigarette smoke that
leads to induction of exaggerated inflammatory re¬
sponses that cannot be controlled by the infant's
physiological reaction to these mediators [6,38].
Most SIDS deaths occur at night. It has been dem¬
onstrated that the night time Cortisol levels (0.5-5 pg
dl-') observed in infants following the development
of circadian rhythm between 7 weeks and 4 months
were not sufficient to control the production of
TNF-a and IL-6 responses to TSST-1 [39]. Infants
who have low levels of antibodies to viruses, bacteria
or their products could be at an increased risk of
SIDS if they are exposed to combinations of infec¬
tious agents and cigarette smoke during this period
of vulnerability.
We conclude that products of cigarette smoke
could influence inflammatory mediators which can
cause fatal shock. However, the genetic and physio¬
logical background of the individual also plays an
important part in these responses. There was a mi¬
nority of individuals in which the experimental con¬
ditions tested in this study induced a very high TNF-
a bioactivity and a marked decrease in NO levels.
Studies on the genetic control of inflammatory re¬
sponses in SIDS and non-SIDS families are the sub¬
ject of our future investigations.
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Abstract
Respiratory virus infections have been suggested to be predisposing factors for meningococcal disease. Respiratory syncytial
virus (RSV) affects young children in the age range at greatest risk of disease caused by Neisseria meningitidis. It has been
previously shown that glycoprotein G expressed on the surface of RSV-infected HEp-2 cells (a human epithelial cell line)
contributed to higher levels of binding of meningococci compared with uninfected cells. The aim of the present study was to
examine the effect of RSV infection on expression of surface molecules native to HEp-2 cells and their role in bacterial binding.
Flow cytometry and fluorescence microscopy were used to assess bacterial binding and expression of host cell antigens. Some
molecules analysed in this study have not been reported previously on epithelial cells. RSV infection significantly enhanced the
expression of CD15 (P<0.05), CD14 (P< 0.001) and CD 18 (P < 0.01), and the latter two contributed to increased binding of
meningococci to cells but not the Gram-positive Streptococcus pneumoniae. © 1999 Federation of European Microbiological
Societies. Published by Elsevier Science B.V. All rights reserved.
Keywords: Respiratory syncytial virus; Neisseria meningitidis: Endotoxin CDI5: CDI1: CD18: CD14; CD29
1. Introduction
Density of colonisation of epithelial surfaces is an
important factor in the pathogenesis of many infec¬
tious diseases [1,2]. Our previous studies found that
compared with uninfected HEp-2 Cells, HEp-2 cells
* Corresponding author. Tel.: +44 (131) 650 3170:
Fax: +44 (131) 650 6531; E-mail: caroline.blackwellfeed.ac.uk
infected with respiratory syncytial virus (RSV) exhib¬
it enhanced binding of several species of bacteria
that cause disease in young children: Neisseria
meningitidis, Haemophilus influenzae type b [3],
Staphylococcus aureus [4], BordeteUa pertussis [5]
and Streptococcus pneumoniae [6].
Two hypotheses were proposed to explain the find¬
ings: (I) RSV-infected cells bear glycoproteins of
viral origin that might act as additional receptors
for bacteria; (2) virus infection might enhance ex-
992S-S244/99/SI9.00 'O 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
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pression of existing cellular molecules that act as
receptors for bacteria. Among the viral glycopro¬
teins, glycoprotein G (attachment) and glycoprotein
F (fusion) are expressed on the surface of RSV-in-
fected cells. In a previous study, we found that gly¬
coprotein G contributed to enhanced binding of N.
meningitidis to RSV-infected cells while glycoprotein
F did not [7].
In the present study, we tested the second hypoth¬
esis. Surface molecules such as integrins play a fun¬
damental role in adhesion and other functions of
cells; however, they might also be used by microbial
pathogens, such as CD 18 used by meningococci, as a
means of entry to the host's cells [8,9], Studies on
expression of these surface antigens on epithelial cells
are emerging; most studies have, however, examined
these antigens on cells of myeloid origin to analyse
their adhesion and homing functions. Murine CD14
gene expression was demonstrated on epithelial cells
elicited by tumour necrosis factor (TNF) secreted in
response to bacterial lipopolysaccharide (LPS) [10].
CDlla (a chain of LFA-1) was demonstrated on
epithelial cells of rat lungs exposed to high oxygen
pressure [11]. CD1 lb/CD 18, components of comple¬
ment receptor 3 (CR3), were detected on rectal and
cervico-vaginal epithelial cells in patients with HIV
[12], We investigated binding of monoclonal anti¬
bodies (mAbs) to the following antigens on an epi¬
thelial cell line (HEp-2) and RSV-infected HEp-2
cells; CDlla, CD lib, CD 11c and CD18; the Lewis*
antigen (CD 15); CD 14; and CD29, an antigen com¬
mon to the P chains of pi integrins. Uptake of bac¬
teria into phagocytic cells and non-professional
phagocytic cells, e.g., cultured epithelial cells, could
be mechanistically similar [13]. The role of these anti¬
gens in binding of N. meningitidis and S. pneumoniae
was assessed by inhibition studies with the mAbs
specific for the host cell antigens.
2. Materials and methods
2.1. HEp-2 cells and RSV
The methods described previously [3] for bacterial
binding were used in this study. Dulbecco's phos¬
phate-buffered saline solution A (DPBS) was used
for washing. HEp-2 cells (Flow Lab) were grown
in 25-cm2 tissue culture flasks (Costar) containing
growth medium (GM). GM was composed of
Eagle's minimal essential medium (Gibco) supple¬
mented with 5% (v/v) foetal calf serum (FCS) (Gib¬
co), 0.85 g l_l sodium bicarbonate, 2 mmol
L-glutamine, 200 pg ml~' streptomycin and 100 IU
ml-1 penicillin (pH 7.4). Monolayers grown for 24 h
were infected with the Edinburgh strain of RSV (a
subgroup A strain) at a multiplicity of infection
(MOI) of 1.0. The infected cells were cultured over¬
night in maintenance medium (MM) which had the
same constituents as GM except the quantity of FCS
was reduced to 1% (v/v). RSV-infected monolayers
and uninfected HEp-2 monolayers were rinsed twice
with DPBS and 0.05% (w/v) ethylenediaminetetra-
acetic disodium acid (EDTA) (Sigma) was applied,
1 ml per 25-cm2 flask at 37°C for 5-10 min to sus¬
pend the cells. MM (10 ml) was added to the cells to
counteract EDTA activity. After centrifugation at
460 Xg for 7 min, the cells were resuspended in
MM without antibiotics, counted and adjusted to
1X10° cells ml-1 for use in the assay.
2.2. Bacteria
The meningococcal isolates used are listed in Table
1. C:2b:P1.2 and C:2a:NT were provided by Dr
R.J. Fallon (Scottish Meningococcal Reference Lab¬
oratory, Glasgow). The standard immunotype
strains L1-L12, which differed in their lipooligosac-
charide (LOS) structure, and the information on se-
rogroup, serotype and subtype were provided by Dr
W.D. Zollinger (Walter Reed Army Medical Insti¬
tute, USA) (Table 1). S. pneumoniae type 6, a sero¬
type associated with meningitis, was used as the
Gram-positive control.
Overnight cultures of meningococci grown on
boiled blood agar and pneumococci grown on blood
agar were used. Bacteria were harvested and washed
twice with DPBS by centrifugation at 2500Xg for
10 min for use in the assay. The bacteria were la¬
belled with fluorescein isothiocyanate (FITC) (Sig¬
ma) freshly prepared as a 0.4% (w/v) solution in
NaH2CO., (0.05 M) and NaCl (0.1 M). FITC-la-
belled bacteria were washed three times with DPBS
and resuspended in MM without antibiotics. The
bacterial concentration was determined by optical
density (OD) at 540 nin [3].
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Table 1
Strains of N. meningitidis
Strain Serogroup Serotype Subtype Imm linotype
C 2b PI .2 L( 3,7.9)
C 2a NT L13.7.9)
LI C NT PI .2 LI,8
12 C 2c Pl.l L2
L3 B 2a PI.5.2 L(3.7.9)
L4 C 11 PI.16 L4
L5 B 4 PI.NT L5
L6 B 5 PI .7,1 L6
L7 B 9 PI.7,1 L13.7.9)
L8 B 8,19 PI .7,1 L<3,7,9).8
L9 A 21 PI.10 L( 3,7.9)
L10 A 21 PI.? LI0
Lit A 21 PI.10 LI 1
L12 A 21 PI.NT LI2
2.3. Antibody binding to cell surface antigens
2.3.1. Flow cytometry
Details of the mAbs, their isotype and working
dilutions are listed in Table 2. Samples of cell sus¬
pensions at 1 X 10s ml-1 (200 pi) were incubated with
each of the mAbs for 30 min at 37°C with gentle
rotation (60 rpm) in an orbital incubator (Gallen-
kamp). After washing three times with DPBS at
480Xg for 7 min, the samples were incubated with
FITC-labelled rabbit anti-mouse immunoglobulin
(Ig) (Sigma) or FITC-labelled rabbit anti-rat Ig (Se-
rotec) (both diluted 1 in 100) at 37°C for 30 min.
Background binding of the fluorochrome-labelled
antibodies was determined in parallel samples to
which the first antibody was not added. The samples
were washed three times with DPBS, suspended in
200 pi of DPBS and fixed with 100 pi of 1% (v/v)
buffered paraformaldehyde. The samples were ana¬
lysed with an EPICS-C flow cytometer (Coulter Elec¬
tronics, Luton, UK) for the percentage of fluorescent
cells on a log scale and the mean fluorescence on a
linear scale. The percentages obtained were further
analysed by the 'immunoanalysis programme'
(Coulter) that compares the fluorescence of the test
samples with that of the control samples at each of
the corresponding channels of the two histograms. A
binding index (BI) for each sample was calculated by
multiplying the values of the percentage from immu¬
noanalysis by the mean fluorescence of the positive
cells converted from the log scale.
Non-specific binding of antibodies to the cells was
assessed by isotype control antibodies directed to
irrelevant antigens. Cell samples were incubated as
Table 2
Monoclonal antibodies
Antibody" Source 1 Isotype Source 2 Isotype Dilution
CD! la Serotec IgGl DAKO IgGl 1/20
CDIlb Serotec IgGl 1/20
CDllc Serotec IgGl 1/20
CD 18 Serotec IgG2b DAKO IgGl 1/20
CD 15 SAPU1' IgM 1/20
CD 14 SAPU IgGl DAKO lgG2a 1/2. 1/5
CD29 Scrotec IgGl DAKO IgG2a 1/20
Control DAKO lgG2a 1/20
Control Serotec IgG2b 1/20
"All the monoclones were produced in mice except anti-CD 18 and IgG2b
''Scottish Antibody Production Unit, Carluke, Lanarkshire. UK.
control which were of rat origin.
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above with mouse isotype control (IgG2a) mAb to
Aspergillus niger (DAKO) or rat isotype control
(IgG2b) mAb to kappa chain myeloma protein (Se¬
rotec) (both diluted 1 in 20). Binding of the isotype
controls was detected with FITC-labelled rabbit anti-
mouse Ig (Sigma) or FITC-labelled rabbit anti-rat Ig
(Serotec). As both uninfected and infected cells ap¬
peared to bind the isotype controls at low levels, a
second experiment was carried out to determine if
these control antibodies had any effect on binding
of the anti-CD antibodies. After incubation with
the isotype control, the cells were washed three times
and incubated with unlabelled rabbit anti-mouse or
rabbit anti-rat Ig (Sigma) (both diluted 1 in 20) to
block the isotype control antibodies. The experiment
to assess binding of anti-CD 18, anti-CD 14 and anti-
CD29 to cells was then carried out as described
above.
2.3.2. Fluorescence microscopy
The percentages of cells in monolayers, which
bound the above antibodies, were also determined
by fluorescence microscopy. Glass coverslips with
monolayers of HEp-2 cells or HEp-2 cells 24 h
post infection with RSV at an MOI of 1.0 were
treated with chilled acetone for 7 min and mounted
on glass slides. The monolayers were incubated
with 20 pi of the first antibody at dilutions listed
in Table 2 for 30 min at room temperature. The
slides were washed three times with PBS and 20 pi
of FITC-labelled second antibody (1/50) was added
for 30 min at room temperature. The slides were
washed three times with DPBS and the mono¬
layers examined by ultraviolet microscopy (Leitz,
Wetzler).
2.4. Bacterial binding and inhibition ofbinding
Bacterial binding studies were carried out as de¬
scribed previously [3]. Samples (200 pi) of HEp-2
cells, RSV-infected HEp-2 cells and aliquots of un¬
infected or RSV-infected cells treated with individual
mAbs were suspended in MM without antibiotics.
An equal volume of FITC-labelled bacteria was
added to the cells to provide a ratio of 200 bacter¬
ia :cell. After incubation for 30 min at 37°C with
gentle rotation in an orbital incubator, the samples
were washed three times in DPBS by centrifugation
at 480 Xg for 7 min, resuspended in 200 pi DPBS.
The cells were fixed with 100 pi of 1% (v/v) buffered
paraformaldehyde and stored in the dark at 4°C un¬
til analysed by flow cytometry within 3 days of the
experiment. The samples from the experiments for
comparison of LOS-immunotype strains were ana¬
lysed with an XL flow cytometer (Coulter Elec¬
tronics, Luton, UK).
2.5. Binding of LOS-coated erythrocytes to HEp-2
cells
The method described by Wright and Jong [14]
was used to coat sheep erythrocytes (Scottish Anti¬
body Production Unit) (1X108 ml-1) with 1 ml of
freshly sonicated LOS (5 mg ml-1) from the
C:2a:NT strain of N. meningitidis (a gift from R.
Brown of this department), which was of the same
LOS-immunotype as the C:2b:P1.2 strain (Table 1).
Erythrocytes were kept at 4°C until used in the assay
within 24 h of coating with LOS.
Erythrocytes or LOS-coated erythrocytes (1X107
ml-1) in 2 ml volumes were incubated for 2 h with 48
h old monolayers of HEp-2 cells or RSV-infected
HEp-2 cells (5 X 105) on coverslips in 24-well tissue
culture plates (Costar). Some monolayers were incu¬
bated with 100 pi volumes of monoclonal anti-CD 14
(1/2) (SAPU), anti-CD18 (1/10) (Serotec) or anti-
CD29 (1/10) (Serotec) for 30 min at 37°C and
washed three times prior to incubation with un-
coated or LOS-coated erythrocytes. The coverslips
were retrieved from the wells and dipped in three
samples of veronal-EDTA buffer [14], 25 times for
each sample. The number of HEp-2 cells with at¬
tached erythrocytes in a total of 100 cells was
counted microscopically. The numbers of erythro¬
cytes attached to individual cells were recorded for
each coverslip and an attachment index for each
coverslip was calculated by multiplying the percent¬
age of cells in a population with erythrocytes at¬
tached by the mean number of erythrocytes for
100 cells counted per coverslip.
2.6. Statistical analysis
Paired /-tests were employed to analyse the loga¬
rithms of Bis of replicate experiments for the flow
cytometry studies to detect binding of antibodies or
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bacteria to the cells and to analyse the data from
experiments to compare the erythrocyte attachment
to cells infected with RSV and/or treated with mAbs.
The data from experiments with different LOS-im-
munotypes of N. meningitidis to compare the binding
of strains were analysed with the Kruskal-Wallis and
Mann-Whitney tests.
3. Results
3.1. RSV infection of HEp-2 cells
More than 80% of HEp-2 cells infected with RSV
at MOI 1.0 had detectable glycoprotein G at 24 h
post infection detected by flow cytometry or fluores¬
cence microscopy.
3.2. Effect of RSV infection on expression of surface
antigens
3.2.1. Flow cytometry
Background binding of fluorochrome-labelled rab¬
bit anti-mouse/rat Ig (second antibody) to HEp-2
cells was negligible. Data from seven experiments
to assess binding of mAbs to HEp-2 cells and the
effect of RSV infection on their binding are summa¬
rised in Table 3. Traces of the histograms from flow
cytometric analysis of fluorescence obtained with
mAbs to CD 14, CD 18 and CD29 are compared in
Fig. 1.
Binding of mAbs to CD lib or CD 11c was not
detected on HEp-2 cells or RSV-infected HEp-2
cells. Antibodies to CDlla, CD14, CD15, CD18
and CD29 bound to uninfected HEp-2 cells. Approx¬
imately half the cells bound anti-CD 18 and anti-
CDlla, 40% bound anti-CD15, 15-25% bound
anti-CD 14 and over 90% bound anti-CD29. Infec¬
tion of cells with RSV increased Bis significantly
for anti-CD18, anti-CD14 and anti-CD15 (Table
3). The Bis for anti-CD 11a and anti-CD29 were
also increased for RSV-infected cells by a mean of
62% and 41% respectively above that observed for
uninfected cells, but these varied between experi¬
ments and the effects were not statistically signifi¬
cant. Binding of the antibodies to cells was similar
with slightly older cells (28 h post infection) or when
the assay was performed at 4°C (data not given). The
green fluorescence on cells treated with antibodies to (A) CDI8,
(B) CD 14 and (C) CD29. The darker curves in the tracings rep¬
resent fluorescence obtained with uninfected HEp-2 cells and the
lighter curves with RSV-infected HEp-2 cells.
results were confirmed in two experiments with
mAbs from a second source (Table 2).
Since mAbs used to detect CDllb and CDllc
were of the IgGl isotype, and as these antigens
were not detected on HEp-2 cells, a further control
for this isotype was not included in the assays. In
two experiments, the two isotype control antibodies
directed against irrelevant antigens bound to HEp-2
cells: IgG2a on average bound to 20% uninfected
and 23% RSV-infected cells: and IgG2b to 26% un¬
infected cells and 32% RSV-infected cells. These anti¬
bodies, however, did not alter the binding of the
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Table 3
Mean binding indices (Bl) from seven experiments on attachment of monoclonal antibodies to HEp-2 cells and RSV-infected HEp-2 cells
Anti-CD HEp-2 cells % RSV+/RSV— 95% CI P value
RSV - RSV+
% Mean Bl % Mean Bl
1 la 44 8 352 (127) 57 10 570 (86) 162 73-365
18 55 4 219 (15) 60 5.8 348 (60) 159 123-204 **
15 40 7 280 (18) 64 8 512 (88) 183 111-302 *
14 17 4 68 (8) 23 5.6 129 (8) 190 152-238 *+*
29 90 13.6 1224 (244) 96 18 1725 (249) 141 92-214
Figures in parentheses are S.E.M. */><0.05. **/><0.0l, ***P<0.001.
same subclass isotype anti-CD antibodies to unin¬
fected and RSV-infected cells.
3.2.2. Fluorescence microscopy
Binding of antibodies to uninfected and infected
cells in monolayers was analysed by fluorescence mi¬
croscopy in four experiments. The proportions of
cells positive for these surface molecules were similar
to those obtained with flow cytometry (data not
shown).
3.3. Inhibition of bacterial binding
In seven experiments, meningococcal strain
C:2b:PI.2 bound in higher numbers to RSV-infected
cells compared with uninfected cells (P = 0.001) (Fig.
2). Treatment of uninfected and RSV-infected HEp-2
cells with isotype controls IgG2a, IgG2b or anti-
CD 15 did not affect the binding of meningococcal
strain C:2b:P1.2. The data from the experiments
with anti-CDlla and anti-CD29 were variable and
non-significant. A summary of the results for binding
of meningococci to cells pretreated with antibodies
to CD18, CD14 and CD29 is given in Fig. 2. A
significant reduction in bacterial binding was ob¬
served with uninfected HEp-2 cells treated with
anti-CD18 (/> = 0.05, 95% confidence interval (CI)
56-100) and with RSV-infected cells treated with
this mAb (P<0.01, 95% CI 57-81). A non-signifi¬
cant decrease in bacterial binding to uninfected
HEp-2 cells treated with anti-CD 14 was observed;
however, the effect of this antibody on inhibition
of bacterial binding to HEp-2 cells infected with
RSV was significant (P< 0.001, 95% CI 48-73)
(Fig. 2).
The type 6 pneumococcal strain was used as a
Table 4
Mean binding indices (Bl) of six experiments on binding of FlTC-labelled LOS-immunotype strains of N. meningitidis to FtEp-2 cells and
HEp-2 cells infected with RSV
Immunotype strain Bl uninfected cells Bl RSV-infected cells Percent increase (95% CI)
LI 2835 (174) 4083 (165) 145 (133-156)'**
L2 2598 (196) 3675 (149) 143 (124-164)**
L3 2684 (87) 3830 (123) 143 (125-164)***
L4 2596 (92) 3739 (78) 149 (114-164)***
L5 2375 (115) 3562 (72) 151 (136-167)***
L6 2823 (81) 3878 (98) 137 (127-149)***
L7 2835 (153) 3937 (50) 140 (123-159)**
L8 3157 (216) 4784 (186) 153 (132-177)***
L9 3627 (162) 4969 (150) 137 (119-159)**
LI0 2948 (98) 3804 (III) 129 (123-136)***
LI 1 2958 (216) 4763 (173) 163 (138-192)***
L12 2806 (171) 3709 (88) 134 (117-152)**
Figures in parentheses are S.E.M. **P< 0.01. ***/><0.001.





ence in binding to RSV-infected cells associated with
serogroup, serotype or subtype [3], 12 immunotype
strains of meningococci were used in bacterial bind¬
ing studies with uninfected or RSV-infected HEp-2
cells to determine if there were differences in binding
associated with LOS structures. Table 4 summarises
the results of six experiments. The results showed
that meningococci added at a ratio of 400 bacteria:
cell bound in higher numbers to RSV-infected cells








Fig. 2. Binding of FITC-labelled N. meningitidis C:2b:PI.2, to
HEp-2 cells (RS—) and RSV-infected HEp-2 cells (RS+) treated
with different mAbs (AB+).
Gram-positive control in these experiments. Infec¬
tion with RSV increased the mean binding index
for pneumococci in seven experiments from 2199
(S.E.M. 73) to 3035 (S.E.M. 102) (138%, 95% CI
129-147, P< 0.001). Treatment of uninfected and
RSV-infected cells with anti-CD18, anti-CD14 or
anti-CD 15 did not alter binding of pneumococci.
3.4. Binding of different LOS-inmnmotype
meningococcal strains to cells
Because our previous studies had found no differ¬
3.5. Binding of LOS-coated sheep erythrocytes to
HEp-2 cells
Sheep erythrocytes coated with meningococcal
LOS were incubated with uninfected and RSV-in¬
fected HEp-2 cells to determine if LOS was a bacte¬
rial adhesin. In three experiments, untreated eryth¬
rocytes did not attach to cells but erythrocytes
coated with LOS did. RSV-infected cells attached
significantly more of the LOS-coated erythrocytes.
HEp-2 cells were pre-incubated with the mAbs to
determine if these altered the attachment of erythro¬
cytes to cells. Pretreatment with anti-CD14 and anti-
CD29 decreased significantly erythrocyte attachment
to uninfected cells; attachment of erythrocytes to
RSV-infected cells was inhibited significantly by
anti-CD14, anti-CD18 and anti-CD29 (Table 5).
4. Discussion
Carriage of bacteria in general does not lead to
Table 5
Attachment of sheep erythrocytes coated with meningococcal (C:2a:NT) lipooligosaccharide to uninfected or RSV-infecled HEp-2 cells or
cells pre-treatcd with mAbs
Untreated HEp-2 cells HEp-2 cells treated with mAB
RSV- RSV+ anti-CD14 anti-CDIS anti-CD29
RSV- RSV+ RSV- RSV+ RSV- RSV+
Cells with erythrocytes (%) 64 72 35 55 58 48 62 65
Mean number of 18 21 13 14 19 18 11 16
erythrocytes per cell
Attachment index (S.E.M.) 1152 (50)1512 (112) 455 (60) 770 (46) 1102 (116) S64 (68) 682 (68) 1040 (7
Paired difference 360 -697 -742 -50 -648 -470 -472
95% CI 204.516 -667.-727 -1953.-431 -232,132 -743.-553 -532,-403 -609.-
P value <0.05 <0.001 <0.01 NS <0.01 <0.01 <0.01
Results are means of three experiments.
122 M. IV. Ra:a el ill. IFEMS Immunology ami Medical Microbiology 23 (190VI 115-124
disease. Changes in the nature of the mucosal surfa¬
ces such as those caused by virus infection might
predispose the individual to bacterial invasion.
Beachey [1] suggested a correlation between in vitro
adhesion and in vivo infectivity for a variety of bac¬
terial pathogens. In our previous studies, in vitro
assays with human cell cultures demonstrated en¬
hanced bacterial binding associated with RSV infec¬
tion [3-5].
Binding of capsulate strains of N. meningitidis to
cells by means of non-pilate adhesins was examined
throughout. The strains were potentially pilate but
the preparative methods used involved washing the
bacteria which removed the bacterial pili. There are
numerous reports indicating that factors other than
pili are important in meningococcal carriage and dis¬
ease [15-17]. While meningococcal pili have been
shown to mediate in vitro binding to epithelial and
endothelial cells [18], pili had been shown not to be
involved in binding of meningococci to monocytes
[19], cells which express the surface antigens under
examination in the present studies.
FITC used to label bacteria in this study is a
monovalent molecule widely used to label biological
reagents without affecting their activity or reactivity.
Previous work found that FITC did not interfere
with or mediate binding of meningococci [20], S.
aureus or B. pertussis to epithelial or HEp-2 cells
[5], Flow cytometry has recently been used exten¬
sively to detect fluorochrome-labelled particles. Be¬
cause large populations can be examined, it is con¬
sistently more accurate and sensitive than direct
microscopy. Flow cytometric analysis in bacterial
binding studies cannot provide an absolute measure
of the mean number of bacteria attached to individ¬
ual cells, but the mean fluorescence values obtained
by this method can reliably compare the binding
between samples [21].
The first objective of this study was to determine if
RSV infection enhanced the native surface com¬
ponents on HEp-2 cells that might act as receptors
for bacteria. Antibodies to CD14, CD15, CD18 or
CD29 of different isotypes from different sources
showed similar increased binding to RSV-intected
cells. Prior treatment of cells with the isotype control
mAbs did not block the binding of specific antibod¬
ies or bacteria indicating that the isotype control
mAbs were binding to epitopes different from CD
molecules and/or bacterial receptors.
The enhancement of surface antigens on HEp-2
cells infected with RSV observed in the present study
might be due to a direct effect of virus on cells or
mediated through cytokines secreted by the infected
cells. Virus infections have been shown to alter sur¬
face expression of molecules. RSV infection of hu¬
man mononuclear leukocytes has been shown to sup¬
press LFA-1 (CD18/CDlla) [22], RSV infection of
the middle ear was shown to induce or enhance
mRNAs for ICAM-1, VCAM-1, and ELAM (a se-
lectin molecule). Cultures of resected tissue from the
middle ear infected in vitro with RSV were positive
for the mRNAs for ELAM and for the cytokines
interleukin (IL) 6 and TNF [23], Cytokines have
been shown to alter expression of CD14 on blood
monocytes: IL-4 decreases its expression, while TNF
and IL-6 induce a moderate increase in the expres¬
sion [24],
It has been suggested that cellular antigens nor¬
mally involved in cell to cell recognition might be
'hijacked' by bacteria [8]. There are reports that
complement receptors, CR3 (CDllb/CD18) and
CR4 (CDllc/CD18), are receptors for Escherichia
coli [14] and a number of intracellular microorgan¬
isms that infect myeloid cells [25], Binding of eryth¬
rocytes coated with pertussis toxin to macrophages
was inhibited by capping with anti-Lewis" and anti-
Lewis'' (CD 15) [26], The antibodies to Lewis" and
Lewis* antigens also inhibited binding of S. aureus
and B. pertussis to buccal epithelial cells [4,5]. CD14
and LFA-1 function as receptors for bacterial lipo-
polysaccharides [27,28], Collagen receptors on CD4+
cells, of which CD29 is a common (3 chain, are in¬
volved in binding of Yersinia pseudotuberculosis [29].
In the present study, reduction in meningococcal
binding and reduction in attachment of meningococ¬
cal LOS-coated sheep erythrocytes to HEp-2 cells
pretreated with anti-CD 14 or anti-CD 18 indicate
that these antigens are involved in meningococcal
binding mediated through the LOS. Pneumococci
which lack endotoxin bound in higher numbers to
RSV-infected HEp-2 cells; however, their binding
was not inhibited by pre-treatment of the uninfected
or RSV-infected cells with anti-CD!4 or anti-CDI8.
These results indicate that other changes in the sur-
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face antigens of the RSV-infected HEp-2 cells con¬
tribute to increased binding of Gram-positive spe¬
cies.
In conclusion, the data presented here indicate
that infection with RSV enhanced expression of anti¬
gens native to HEp-2 cells and that CD 18 and CD 14
are involved in binding of non-pilate N. meningitidis
to these cells. The data also indicate the role for
meningococcal LOS in binding to HEp-2 cells.
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MICROBIAL PATHOGENESIS
Bactericidal activity of a monocytic cell line (THP-1)
against common respiratory tract bacterial
pathogens is depressed after infection with
respiratory syncytial virus
M. W. RAZA, C. C. BLACKWELL, R. A. ELTON* and D. M. WEIR
Department of Medical Microbiology and *Medical Statistics Unit, University of Edinburgh, Teviot Place,
Edinburgh EH8 9AG
Non-typable Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis
and respiratory syncytial virus (RSV) are commonly isolated from patients during the
course of chronic obstructive pulmonary disease (COPD). Earlier studies found that
virus infection enhanced binding of bacterial respiratory pathogens to epithelial cells in
vitro. The objective of the present study was to assess the effect of RSV infection of a
human monocytic cell line on bactericidal activity and cytokine production in response
to these bacterial respiratory pathogens. The effect of RSV infection on binding, uptake
and intracellular killing of bacteria by a human monocytic leukaemia cell line, THP-1,
was assessed. Cell culture supernates were examined with a mouse fibroblast cell assay
for tumour necrosis factor-c (TNF-a) bioactivity. Expression of CD14, CDlla, CD18,
CD15 and CD29 on uninfected and RSV-infected THP-1 cells was assessed by flow
cytometry in relation to differences in bacterial binding. RSV infection of THP-1 cells
significantly decreased their ability to bind and kill bacteria. Compared with uninfected
cells, fewer bacteria bound to RSV-infected THP-1 cells and the surface antigens that
have been reported to bind bacteria were expressed at lower levels on RSV-infected cells.
RSV-infected cells incubated with bacteria exhibited less TNF-a bioactivity than
uninfected cell incubated with bacteria. The results elucidate some of the mechanisms
involved in the increased susceptibility of virus-infected patients to secondary bacterial
infection. Reduced bacterial killing by virus-infected monocytes might contribute to
reduced clearance of bacteria from the respiratory tract and damage elicited by the
bacteria or cytokine response in COPD patients.
Introduction
Chronic obstructive pulmonary disease (COPD), which
deludes chronic bronchitis and emphysema, is an
!™P°rtant cause of ill health in older age groups,"foist cigarette smoking is a major risk factor for the
Condition [1], the precise role ofmicrobial infections in
jls development and progress has yet to be elucidated
I > 3],
^'on-typable Haemophilus influenzae, Streptococcus
Pneumoniae and Moraxella catarrhalis are common
terial species isolated from patients during episodes
exacerbation in the course of COPD and asthma
C]- Respiratory syncytial virus (RSV) is an
-sived 19 April 1999, accepted 11 August 1999.
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important viral pathogen in older groups, because
^ complete immunity does not follow RSV disease and
re-infections are not uncommon [8]. Fagon and
Chastre [9] reviewed studies comparing the tracheo¬
bronchial microflora of patients during acute exacer¬
bations and stable periods in the course of COPD;
significant differences in isolation rates in these
studies were found only for viruses (influenza virus
and RSV). These studies did not measure the bacterial
flora of the respiratory tract or the effect of acute viral
infections on inflammation due to the resident flora.
Infection of epithelial cells with RSV increased
binding of respiratory bacterial pathogens [10-12].
Patients with RSV infections showed a significant rise
of antibodies to H. influenzae, S. pneumoniae and M.
catarrhalis [13].
Viral infections might also alter the bactericidal
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mechanisms in the respiratory tract. Alveolar macro¬
phages play an important role in killing and inhibition
of replication of inhaled micro-organisms and in
inflammation in the respiratory tract due to these
agents. A human monocytic leukaemia cell line, THP-1
[14], possesses the properties of alveolar macrophages
[15] and was adopted as an appropriate model to study
interaction between RSV and bacterial species isolated
from patients with COPD.
The first objective of this study was to examine the
effect of RSV infection of THP-1 cells on binding,
ingestion and intracellular survival of strains of H.
influenzae, S. pneumoniae and M. catarrhalis. Surface
antigens on monocytes, CD14, CDlla, CD18, CD15
and CD29 - some of which act as bacterial receptors
[16, 17] - can be modified during inflammation [18].
RSV infection suppressed the expression of LFA-1*
(CDlla + CD 18) on human monocytes [19]. The
second objective of this study was to examine the
changes in the cell-surface antigens associated with
RSV infection in relation to the ability of monocytes to
bind and ingest bacterial isolates. Hunour necrosis
factor-a (TNF-a) plays a role in defence against viral
[20, 21] and bacterial infection [22,23], but its release
also results in inflammation in the respiratory tract and
contributes to the systemic symptoms in patients with
COPD [24, 25], The third objective was to examine the
effect of RSV infection and different strains of bacteria,
or both, on TNF-a release from THP-1 cells.
Materials and methods
RSV
The Edinburgh strain of RSV (subgroup A) was
harvested from HEp-2 cells maintained in maintenance
medium (MM) which consisted of RPMI-1640 supple¬
mented with fetal calf serum (FCS) 1% and 2 mM L-
glutamine, penicillin 100 IU/ml and streptomycin
200 /rg/ml. The suspension was tested by immuno¬
fluorescence for presence of mycoplasma. The con¬
centration was adjusted to 2 X 106 plaque forming
units/ml [10].
Bacteria
There were two isolates each of nontypable H.
influenzae (HI1 and HI2), M. catarrhalis (MCI and
MC2) and S. pneumoniae (types 3 and 6) from patients
with exacerbation of COPD obtained from the Clinical
Bacteriology Laboratory of the department. H. influ¬
enzae and pneumococcal isolates were sensitive to
ampicillin. M. catarrhalis strain MCI grew on New
York City medium with antibiotics selective for the
pathogenic neisseria: lincomycin 1 ng/ml, colistin
6/rg/ml, amphotericin 1 ttg/ml and trimethoprim
lactate 6.5 ag/ml. M. catarrhalis MC2 did not grow-
on this medium. Overnight growths of H. influenzae
and M. catarrhalis on boiled blood asar and S.
pneumoniae on blood agar were collected in ph(|
phate-buffered saline (PBS) and washed twice .
centrifugation at 2500 g for lOmin. Heavy bacter'
suspensions in MM without antibiotics were stored ,
small volumes at -20°C for up to 3 months for use '
the assays. Concentrations of live bacteria in the frozij
samples were determined by plating triplicate samp!
(5 ,«1) of appropriate dilutions in PBS on appropria
media for determination of colony forming units (cf j
after overnight growth in air with CO2 5% at 37°C.
1
Ethidium bromide-labelling of bacteria >
The bacterial suspensions were washed with PBS, an
fixed with buffered paraformaldehyde (Sigma) 1% fc
30min in a water bath at 37°C. The bacteria wet
washed twice with PBS and incubated with ethidiur
bromide (EB; Sigma) 50 /rg/ml for 20 min in a wate
bath at 37°C. The bacteria were washed twice and th
total count was adjusted to 4 X 108/ml in PBS b;
direct microscopy. The labelled bacteria were held it
small volumes at —20°C for up to 3 months.
THP-1 cells
THP-1 cells (European Collection of Animal Cell:
Cultures, Salisbury, Wilts) were cultured in growth
medium (GM) which contained the same components
as MM except for the higher concentration of FCS
(10%) and the presence of mercapto-ethanol
(2 X 10-5 M). The suspension was tested as described
earlier for presence of mycoplasma. The cells were
kept at 37°C in CO2 5%. Fresh cultures of cells were
infected with RSV at a multiplicity of infection of 2.
Overnight cultures of uninfected and RSV-infected
cells were washed with MM without antibiotics by
centrifiigation at 300 g for 7 min and the counts were ;
adjusted to 1 X 106/ml in this medium by microscopy,
for use in the experiments. !
The proportions of monocytes infected with RSV in the
samples were determined by flow cytometry by indirect
immunofluorescence. The proportions were compared
in one experiment with a mouse monoclonal antibody
(MAb) to a viral surface glycoprotein G [10] or a
convalescent serum from a patient with RSV infection
previously absorbed with THP-1 cells and appropriately
diluted in PBS. FITC-conjugated anti-mouse immuno¬
globulin or anti-human immunoglobulin antibodies
(Sigma) were used to detect primary antibodies on
cells. The convalescent serum was used to detect RSV-
infected cells in subsequent experiments. The viability
of RSV-infected and uninfected THP-1 cells was
determined by trypan blue exclusion.
Bacterial binding
Uninfected and RSV-infected THP-1 cells (2 X 103) in
capped plastic tubes were mixed with EB-labelled
bacteria to orovido a ratio .-f !n Wt?ria per eel! ?.r. i
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mechanisms in fee respiratory tract. Alveolar macro¬
phages play as important role in killing and inhibition
of replication of inhaled micro-organisms and in
inflammation in the respiratory tract due to these
agents. A human monocytic leukaemia cell line, THP-1
[14], possesses the properties of alveolar macrophages
[15] and was adopted as an appropriate model to study
interaction between RSY and bacteria! species isolated
from patients with COPD.
The first objective of this study was to examine the
effect of RSV infection of THP-1 cells on binding,
ingestion and intracellular survival of strains of H.
influenzae, S. pneumoniae and M. catarrhalis. Surface
antigens on monocytes, CD14, CDlla, CD18, CD15
and CD29 - some of which act as bacterial receptors
[16,17] — can be modified during inflammation [18],
RSV infection suppressed the expression of LFA-K
(CDlla + CD18) on human monocytes [19]. The
second objective of this study was to examine the
changes in the cell-surface antigens associated with
RSV infection in relation to the ability ofmonocytes to
bind and ingest bacterial isolates. Tumour necrosis
factor-a (TNF-a) plays a role in defence against viral
[20, 21] and bacterial infection [22, 23], but its release
also results in inflammation in the respiratory tract and
contributes to the systemic symptoms in patients with
COPD [24, 25], The third objective was to examine the
effect of RSV infection and different strains of bacteria,
or both, on TNF-a release from THP-1 cells.
Materials and methods
RSV
The Edinburgh strain of RSV (subgroup A) was
harvested from HEp-2 cells maintained in maintenance
medium (MM) which consisted of RPMI-1640 supple¬
mented with fetal calf serum (FCS) 1% and 2 mM L-
glutamine, penicillin 100 IU/ml and streptomycin
200 fig/ml. The suspension was tested by immuno¬
fluorescence for presence of mycoplasma. The con¬
centration was adjusted to 2 X 106 plaque forming
units/ml [10],
Bacteria
There were two isolates each of nontypable H.
influenzae (HI1 and HI2), M. catarrhalis (MCI and
MC2) and S. pneumoniae (types 3 and 6) from patients
with exacerbation of COPD obtained from the Clinical
Bacteriology Laboratory of the department. H. influ¬
enzae and pneumococcal isolates were sensitive to
ampicillin. M. catarrhalis strain MCI grew on New
York City medium with antibiotics selective for the
pathogenic neisseria: lincomycin 1 ug/ml, colistin
6 «g/ml, amphotericin 1 «g/ml and trimethoprim
lactate 6.5 wg/ml. M. catarrhalis MC2 did not grow-
on this medium. Overnight growths of H. influenzae
and M. catarrhalis on boiled blood near and S.
pneumoniae on blood agar were collected in phtj
phate-buffered saline (PBS) and washed twice -
centrifiigation at 2500 g for lOtnin. Heavy baetcr
suspensions in MM without antibiotics were stored ,
small volumes at —20®C for up to 3 months for use 1
the assays. Concentrations of live bacteria in the fro.\
samples were determined by plating triplicate sairtpl"
(5 ,«1) of appropriate dilutions in PBS on appropria
media for determination of colony forming units (cf.
after overnight growth in air with COj 5% at 3T'C. ,
i
Ethidium bromide-labelling of bacteria >
The bacterial suspensions were washed with PBS, an
fixed with buffered paraformaldehyde (Sigma) 1% ft
30min in a water bath at 37°C. The bacteria wet
washed twice with PBS and incubated with ethidiur
bromide (EB; Sigma) 50 ug.'ml for 20 min in a watt
bath at 3TC. The bacteria were washed twice and th
total count was adjusted to 4 X 108/ml in PBS b
direct microscopy. The labelled bacteria were held ii
small volumes at -20°C for up to 3 months.
THP-1 cells
THP-1 cells (European Collection of Animal Cell:
Cultures, Salisbury, Wilts) were cultured in growtl
medium (GM) which contained the same components
as MM except for the higher concentration of FCS
(10%) and the presence of mercapto-ethanol
(2 X 10~5 M). The suspension was tested as described
earlier for presence of mycoplasma. The cells were
kept at 37°C in C02 5%. Fresh cultures of cells were
infected with RSV at a multiplicity of infection of 2.
Overnight cultures of uninfected and RSV-infected
cells were washed with MM without antibiotics by
centrifugation at 300 g for 7 min and the counts were ;
adjusted to 1 X 106/ml in this medium by microscopy,
for use in the experiments. [
The proportions of monocytes infected with RSV in the
samples were determined by flow cytometry by indirect
immunofluorescence. The proportions were compared
in one experiment with a mouse monoclonal antibody
(MAb) to a viral surface glycoprotein G [10] or a
convalescent serum from a patient with RSV infection
previously absorbed with THP-1 cells and appropriately
diluted in PBS. FITC-conjugated anti-mouse immuno¬
globulin or anti-human immunoglobulin antibodies
(Sigma) were used to detect primary antibodies on
cells. The convalescent serum was used to detect RSV-
infected cells in subsequent experiments. The viability
of RSV-infected and uninfected THP-1 cells was '|
determined by trypan blue exclusion.
Bacterial binding
Uninfected and RSV-infectcd THP-1 cells (2 X 10^) in
capped plastic tubes were mixed with EB-label!ed
bacteria to nrovide a ratio of in 'r^crc-rirr per c?!! art!
incubated at 37°C in an orbital incubator (40 rpm).
Samples were removed after incubation for 0 or 30 min
and washed three times with ice-cold PBS by
centrifugation at 300 g for 7 min to remove unbound
bacteria from the pellet. The cells were suspended in
lml of PBS and stored in the dark at 4°C until
analysed within 24 h by flow cytometry.
Flow cytometric analysis
The main cell population was gated by forward and
side light scatter to exclude debris and cell aggregates.
The percentage of cells with fluorescence greater than
the background was determined on a histogram
produced by log-amplified red fluorescence signals
and mean fluorescence of the positive population on a
histogram produced by linear signals. The values were
multiplied to obtain a binding index (BM) for each
sample.
Ingestion of bacteria
To measure the fluorescence from bacteria ingested by
cells, fluorescence from extracellular bacteria was
quenched in each sample (1 ml) with 20 [A of crystal
violet (BDH) 0.05% in 0.15 N sodium chloride. As the
optical density of the soluble dye and its quenching
effect increases with time, flow cytometry was
performed when the ODj95 reading of the sample was
500-600. In this range >90% of the EB-labelled
bacteria outside the cells were completely quenched.
Crystal violet at higher OD values is membrane
permeable and can quench intracellular bacteria. The
laser power for these samples was adjusted to
compensate for the decrease in background autofluor-
escence of the control samples due to quenching. An
ingestion index (Itad) for each sample was calculated by
multiplying the percentage of fluorescent cells and the
mean fluorescence as described above.
Intracellular survival of bacteria
Uninfected and RSV-infected THP-1 cells were incu¬
sed with live unlabelled bacteria under the above*
conditions for 30 min. Extracellular bacteria were
led by adding gentamicin 30 /rg/ml and ampicillin
, /tg/ml for 15 min at 37°C. After three washes with
S, the cells were resuspended in 100 /A of PBS and
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used in these experiments [26], Uninfected and RSV-
infected THP-1 cells were incubated at 4°C for 30 min
with the following mouse MAbs: CDlla (Dako)
diluted 1 in 20, CD18 (Dako) diluted 1 in 20, CD 15
(Scottish Antibody Production Unit, Carluke) diluted 1
in 20, CD 14 (Dako) diluted 1 in 10 and CD29
(Serotec) diluted 1 in 20. The samples were washed
three times with PBS. Fluorescein isothiocyanate
(FITC)-labelled anti-mouse immunoglobulin antibody
(Sigma) diluted 1 in 100 was used to detect binding of
the primary antibodies to cells. The samples were
washed three times and fixed with buffered parafor¬
maldehyde (Sigma) 0.5%. Cells with fluorescence
greater than the control (cells treated only with the
FITC-labelled second antibody) were assessed for
mean fluorescence and the binding index was calcu¬
lated as described above.
lysed with
1.05% in
an equal volume of sodium lauryl sulphate
"/0 111 ^erile distilled water. Samples were im-
lately plated in triplicate for determination of cfu
• escribed above. For a time course study of
jnc ""ular survival and growth of bacteria, cells were
Plating5^ ^ <^®2rent Periods before lysing and
j.
,nS o} anti-CD antibodies to cells
The fl°W c7t°nietry method described previously to
"~J1 -'-11 antigens on buccal epithelial cells was
TNF-a bioactivity
Uninfected and RSV-infected THP-1 cells were incu¬
bated in CO2 5% at 37°C with unlabelled live or EB-
labelled fixed bacteria at a ratio of 10 bacteria per cell
in 24-well tissue culture plates (Costar). After incuba¬
tion for 24 h, supernates from individual wells were
collected for determination of TNF-a. A bioassay with
L-929 cells (a mouse fibroblast cell line) was used to
determine TNF-a activity [27],
Statistical analysis
Paired t tests were used to analyse data from binding
and ingestion of bacteria, and for binding of anti-CD
MAbs to uninfected or RSV-infected cells. Wilcoxon's
test for matched pairs was applied to the data from
experiments measuring intracellular survival of bacter¬
ia. The data for TNF-a production by uninfected or
RSV-infected THP-1 cells under various conditions
were also analysed by paired t tests.
Results
The proportions of RSV-infected cells were similar
with both mouse anti-G MAb and absorbed human
convalescent serum. At 24 h after infection, 40-50% of
THP-1 cells were infected with RSV RSV infection did
not affect the viability of cells 24 h after infection.
Bacterial binding, ingestion and survival
Bacteria were able to bind to cells at 0 min (data not
shown), but intracellular bacteria were not detected at
this time either by quenching the external bacteria or
by determination of intracellular survival. Data from
nine experiments on binding of H. influenzae, M.
catarrhalis and pneumococci are presented in Fig. 1
and on ingestion of these bacteria in Fig. 2.
fj ipflii,■*>?(!(>. The binding observed for Fill m
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H11 H12 MC1 MC2 SP3 SP6
Bacterial isolate
Fig. 1. Binding indices (SE) of H. influenzae isolates
(HI1 and HI2), M. catarrhalis isolates (MCI and MC2)
and S. pneumoniae types 3 and type 6 (SP3 and SP6) to
THP-1 and RSV-infected THP-1 cells (mean of nine
experiments); ■, uninfected THP-1 cells; E3, RSV-
infected THP-1 cells.
uninfected THP-1 cells was 50% of that observed for
strain HI2 (p<0.05). Strain HI1 also bound signifi¬
cantly less to RSV-infected cells than strain HI2
(p<0.01). Compared with uninfected cells, binding
of both the strains to cells infected with RSV was
significantly reduced: HI1, p<0.01, 95% CI -5520,
-18141; HI2, p < 0.02 95% CI -1588, -25237. RSV
infection of cells reduced the ingestion of both strains,
but this was significant only for HI 1 (p < 0.05, 95% CI
-791, -12 793). Both the isolates survived better in
RSV-infected cells than in uninfected cells (p<0.02,
. HI1, Z =-2.366; p<0.05, HI2, Z =-2.1974)
(Fig. 3).
M. catarrhalis. Compared with strain MC2, strain
MCI bound in greater numbers to uninfected THP-1
cells (p< 0.001) and to RSV-infected cells (p< 0.005).
Both strains MCI and MC2 bound significantly less t
RSV-infected cells than to uninfected cells: MCI
p<0.01, 95% CI -6796, -11 840; MC2, p<0 002
95% CI -12258, -28233. RSV infection of cell
reduced the ingestion of both strains (MCI, NS; MC2
p < 0.05, 95% CI -335, -31328). Neither 'of th<
isolates survived in uninfected or RSV-infected THP-1
cells in the conditions used in the study.
S. pneumoniae. Compared with strain SP6, strain SP3
bound significantly more to uninfected cells (p < 0.05)
and to RSV-infected cells (p<0.05). Compared with
uninfected cells, lower numbers of strain SP3 bound to
RSV-infected cells (p = 0.051, 95% CI 55, -23 737).
There was no significant difference in binding of stfain
SP6 to uninfected or RSV-infected cells. A decrease in
ingestion of strain SP3 by RSV-infected cells was
observed (p = 0.059, 95% CI 1212, -45 717). There
*
was no significant difference for strain SP6 in ingestion
by uninfected or RSV-infected THP-1 cells. Signifi¬
cantly greater numbers of strain SP3 survived in RSV-
infected cells than in uninfected cells (p < 0.05,
Z = -2.0226) (Fig. 3). Strain SP6 showed evidence
of only occasional survival in uninfected cells, which
was twice as high in RSV-infected cells.
Effect of RSV infection on binding of anti-CD
MAbs to cells
Mean B-nci for the MAbs directed towards the cell
surface antigens of THP-1 cells are summarised in Fig.
4a and b. In seven experiments, RSV infection resulted
in significant decreases in binding of the following
MAbs: anti-CD 11a by 35% (p<0.05, 95% CI -20,
-50); anti-CD 18 by 24% (p < 0.001, 95% CI -16,
-32); anti-CD 14 by 28% (p < 0.05, 95% CI -3, -53)
and anti-CD 15 by 30% (p < 0.05, 95% CI -3, -57).
There was an increase of 9% in binding of anti-CD29 1
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Fig. 3. Survival of H. influenzae isolates (HI1 and HI2)
and S. pneumoniae type 3 (SP3) in uninfected and RSV-
infected THP-1 cells (mean of seven experiments); ■,
uninfected THP-1 cells; □ RSV-infected THP-1 cells.
Effect of RSV infection and bacteria on TNF-a
bioactivity of cells
TNF-a bioactivity in supemates of uninfected or RSV-
infected THP-1 cells incubated with either live
unlabelled or fixed EB-labelled bacteria was deter¬
mined (Fig. 5). In seven experiments, compared with
THP-1 cells to which no bacteria were added, the
bioactivity was increased by incubation of THP-1 cells
with live strains: HI1, p<0.01 (95% CI 11.5, 45.9);
RSV AND BACTERICIDAL ACTIVITY OF THP-I CELLS 231
HI2, p<0.001 (95% CI 24.3, 50.6); MCI. p<0.05
(95% CI 8.5, 59.2); MC2, p < 0.05 (95% CI 5.1. 47.2);
SP3, p< 0.001 (95% CI 48.6, 65.9) or SP6, p< 0.005
(95% CI 15.5, 44.5). Differences in the levels of TNF-
a induced were not statistically significant between
strains of the same species.
Compared with THP-1 cells to which no bacteria were
added, the TNF-a bioactivity was increased by
incubation of THP-1 cells with EB-labelled fixed
strains: HI1, p<0.05 (95% CI 4.1, 31.9); HI2,
p<0.001 (95% CI 19, 42.4); MCI, p<0.002 (95%
CI 23.1, 63.2); MC2, p<0.001 (95% CI 38.9, 59);
SP3, p < 0.02 (95% CI 5.9, 29.5) or SP6, NS.
Compared with fixed strain HI1, fixed strain H12
elicited significantly more TNF-a bioactivity (p <
0.005, 95% CI 6, 19.3). Fixed MC2 and SP3 strains
elicited greater TNF-a bioactivity compared with fixed
MCI and SP6 strains, respectively, but the differences
were not statistically significant.
RSV infection increased TNF-a bioactivity from THP-
1 cells incubated with live HI1, HI2 or MC2 strains,
but the differences were not statistically significant.
Compared with uninfected cells, TNF-a bioactivity was
decreased for RSV-infected cells incubated with live
strain MCI, p< 0.002 (95% CI -49.3, -18.4); SP3,
p< 0.001 (95% CI -47.6, -20.4) or SP6, p< 0.005
(95% CI -23.2, -8.2).
RSV infection increased TNF-a bioactivity from THP-
1 cells incubated with fixed HI1 or HI2 strains, but the
differences were not statistically significant. Compared





Fig. 4. (a) Binding of MAbs to CDlla, CD18, CD14 and CD29 to uninfected (■) and RSV-infected (□) THP-I cells
(mean of seven experiments), (b) Binding of MAb to CD15 to uninfected (1) and RSV-infected (□) THP-1 cells (mean
of seven experiments).
HI1 HI2 MC1 MC2 SP3 SP6
Bacterial isolates
Fig. 5. Percentage cytotoxicity for L-929 cells caused by
TNF-a in supernates from uninfected or RSV-infected
THP-1 cells incubated with different isolates of live (□)
or fixed (■) bacteria obtained from seven experiments.
HI, H. influenzae-, MC, M. catarrhalis; SP, S. pneumoniae.
bioactivity with RSV-infected cells incubated with fixed
MCI, MC2, SP3 or SP6 strains, but the results were
significant only for strain SP3 (p<0.01, 95% CI
-25.5, -5.2).
Discussion
Although no significant differences in rates of isolation
of bacterial species during exacerbation and stable
periods were found in patients with COPD [9], the
density of bacterial colonisation of the respiratory tract
might contribute to exacerbation. Secondary bacterial
infections following virus infections are thought to be
associated with enhanced bacterial binding, suppression
of host immune responses and bactericidal functions
associated with viral infections [28].
Previous studies have shown that RSV infection
increases bacterial binding to epithelial cells [10-
12,26], When infected with RSY murine alveolar
macrophages showed increased cytokine and decreased
bactericidal functions [29], As monocytes play an
important role in bactericidal activity in the respiratory
tract, the present study used THP-1 cells as a model to
examine the effect of RSV infection on binding,
ingestion and killing of bacteria.
The bronchial tree has been envisaged as a relatively
sterile organ in healthy individuals, in which contin¬
uous exposure to inhaled micro-organisms is met with
appropriate host defence mechanisms. Heavier growths
of bacteria over prolonged periods in the respiratory
tract in COPD as a result of inefficient bactericidal
mechanisms might cause further damage to the tract
due to release of inflammatory cytokines. With this in
mind, this study examined the levels of TNF-a, a
bactericidal agent [22] and a very potent pro¬
inflammatory cytokine, from THP-1 cells in response
to common microbial pathogens.
The first objective was to compare the differences in
binding of individual isolates of each bacterial species
and their killing by uninfected and RSV-infected THP-
1 cells. RSV-infected cells demonstrated reduced levels
of binding, ingestion and killing of most of the
bacteria. The second objective was to assess the effects
of RSV infection on surface antigens of the phagocytes
that act as receptors for bacteria. Decreased ingestion
of most of the bacteria by THP-1 cells infected with
RSV might be due to the lower levels of initial
bacterial binding observed with these cells. CD 14,
CD 11a, CD 18 and CD15 have been identified as
receptors for several bacterial species [16, 17], Lower
levels of these antigens associated with RSV infection
might contribute to the decreased bacterial binding
observed in this study. However, a correlation test was
<• not performed for Bis of the antibody and bacterial
binding to cells, because the two types of experiments
were performed on different preparations of cells.
Previous studies have demonstrated a significant
relationship between bacterial binding and expression
of blood group antigens that act as receptors on
epithelial cells [26, 30].
Increased TNF-a bioactivity contributes to inflamma¬
tion, whereas a marked decrease can jeopardise
mucosal protection against bacteria and bactericidal
activity [31,22]. The third objective of the present
study was to compare TNF-a produced by uninfected
and RSV-infected THP-1 cells in response to bacteria.
Compared with cells not exposed to bacteria, various
degrees of increased responses were observed with all
the bacterial isolates. RSV infection reduced TNF-a
bioactivity from cells incubated with strains MCI, SP3
and SP6. RSV infection in human alveolar macro¬
phages can persist for at least 25 days after infection in
vitro [32] and in a significant number of patients with
COPD [33]. Persistently lower TNF-a responses to the
bacteria observed with RSV infection combined with
decreased intracellular bactericidal activity might pro¬
long bacterial disease in patients with COPD and cause
chronic damage to the respiratory tract.
In conclusion, the differences observed between unin¬
fected and RSV-infected THP-1 cells in the pattern of
binding, intracellular killing of bacteria and TNF-a
production in response to bacteria may explain the
increased susceptibility of virus-infected patients to
secondary bacterial infections. Bacteria that escape
virus-infected monocytes might have a greater oppor¬
tunity to grow in the milieu of the respiratory tract and
cause disease. Further work to examine the effects of
specific antibodies to S. pneumoniae on intracellular
bacterial survival and production of cytokines from
monocytes is under way.
This work was supported by Cheat. Heart arc Stroke. Scotland.
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